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“Science... never solves a problem without creating ten more”
George Bernhard Shaw
“The need to be right all the time is the biggest bar to new ideas. It is better to have 
enough ideas for some of them to be wrong than to be always right by having no ideas
at all.”
Edward de Bono
“Every truth passes through three stages before it is recognised. In the first it is 
ridiculed, in the second it is opposed, in the third it is regarded as self-evident”
Arthur Schopenhauer
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Abstract
Peptidylglycine a-amidating monooxygenase catalyses the biosynthesis of peptide 
hormones through radical cleavage of the C-terminal glycine residues of the 
corresponding prohormones. The over-production of hormones by PAM has been 
implicated in disease states such as cancer, diabetes and inflammation. Correlations 
between ab initio calculations of radical stabilisation energies (RSE) and rates of free 
radical brominations with the extent of catalysis displayed by peptidylglycine a- 
amidating monoxygenase were used to identify classes of inhibitors of the enzyme.
The substitution of the nitrogen of glycine with electron-withdrawing groups was found 
to decrease rates of free radical brominations by up to a factor of 24 and the RSEs of a- 
carbon centred radicals by up to 9.2 kJ m ol1. This was correlated with a 4.5 fold 
decrease in the rate of turnover by PAM of TV-trifluoroacetylglycine in comparison to 
that of iV-acetylglycine.
The substitution of glycine for ßßß-trifluoroalanine was found to prevent free radical 
bromination and decrease the RSE of an a-carbon centred radical by 39.2 kJ m ol1 in 
comparison to the corresponding glycyl radical. This substitution was found to prevent 
catalysis by PAM, although it was found to have a detrimental effect on binding 
affinity.
The substitution of an acylglycine NH with O to give an acylglyolate was found to 
prevent free radical bromination and decrease the RSE of an a-carbon centred radical by 
34.7 kJ mol"1 in comparison to the corresponding glycyl radical. The substitution of
glycine with glycolate was also found to prevent catalysis by PAM whilst not reducing 
binding affinity with the enzyme. Glycolates were therefore identified as a general class 
of PAM inhibitors.
The substitution of an acylglycine NH for a y-keto acid CPb was found to prevent free 
radical bromination. Further, in comparison to an a-carbon centred glycyl radical, it 
decreased the RSE of the equivalent carbon centred radical by 44.2 kJ mol'1. This 
substitution was also found to prevent catalysis by PAM, however it resulted in a large 
decrease in binding affinity with the enzyme.
The glycolates Oa-(decanoyl)glycolic acid, benzyl 0 'l-(decanoyi)glycolate, AT-acetyI-0(I- 
(phenylalanylphenylalanyl)glycolic acid and benzyl iV-acetyl-O“- 
(phenylalanylphenylalanyl)glycolate were tested for their effects in cell based assays. It 
was found that these systems inhibit the proliferation of the A549 human lung cancer 
cell line, decrease levels of substance P produced in rat dorsal root ganglian cells and 
affect adrenomedullin hormone levels assays with a U87 cell line. In particular, the 
benzyl esters were found to have the highest efficacy presumably due to enhanced 
transport across cell membrances in comparison to the free acids.
The hydrolysis of a-substituted glycines at pH 4.0, 7.5 and 10.0 was investigated for 
their potential use as amide masking groups or to transiently link molecules. The rates 
of the hydrolysis reactions of A-benzoyl-a-hydroxyglycine and A-benzoyl-a- 
hydroxyglycine methyl ester to release benzamide were found to be similar at pH 7.5 
and 10.0. The substitution of N-benzoylglycine methyl ester at the a-position with 
methoxy and ethoxy groups was found to prevent hydrolysis to release a- 
hydroxyglycines at pH 4.0, 7.5 and 10.0 due to the poor leaving abilities of methoxide
xii
and ethoxide. The substitution of /V-benzoylglycine methyl ester at the a-position with 
an acetoxy group was found to result in rapid hydrolysis to A-benzoyl-a-hydroxyglycine 
methyl ester at basic pH whilst being inert at pH 4.0. The substitution of N- 
benzoylglycine methyl ester with a phenoxy group at the a-position provided for the 
controlled hydrolytic release of a-hydroxyglycines at basic pH with a half-life of 0.40 
hours at pH 7.5.
2-Nitrophenylalanine was identified as a new photocleavable amino acid for the release 
of amides under biological conditions. The peptides, A-benzoylvalyl-2- 
nitrophenylalanine methyl ester, /V-benzoyl-2-nitrophenylalanylalanine methyl ester, N- 
benzoy!valy!-2-nitrophenylalanylalanine methyl ester and A/-benzoylvalyl-2-nitro-4,5- 
dimethoxyphenylalanine methyl ester were found to photolyse at 254, 300 and 350 nm 
to release their respective amides, A-benzoylvalinamide, benzamide, N- 
benzoylvalinamide and /V-benzoylvalinamide. Alteration of the carboxyl group of 2- 
nitrophenylalanine was found to have a profound effect on the efficiency of the 
photolysis reaction and the yield of amide released. It was found that if the carboxyl 
group of 2-nitrophenylalanine was protected as a methyl ester rather than an amide, the 
yield and rate of release of amide was increased and the half-life of the aci-nitro 
intermediate decreased. The photolysis of A-benzoylvalyl-2-nitrophenylalanine methyl 
ester was found to be the most efficient and high yielding.
Introduction
Introduction
C-Terminal amidation is a required post translational modification of many bioactive 
peptides. The amides are synthesised via glycine-extended precursors and are 
transformed by peptidylglycine a-amidating monooxygenase (PAM) through the 
oxidative cleavage of the glycine N-C bond (Figure 1).
Peptide
O
A OH PHM
Cu2+, 0 2 
ascorbate
Peptide
O
A OH
PAM
O
PHM
Ox
Peptide"^ NH2
Figure 1. Mechanism ot Catalysis by Peptidylglycine a- 
Amidating Monooxygenase.
The amidation reaction is catalysed by the two active sites of PAM: peptidylglycine a- 
hydroxylating monooxygenase (PHM) and peptidylamidoglycolate lyase (PAL).1 The 
PHM step of the PAM mechanism is copper, molecular oxygen and ascorbate 
dependent.1 The initial step involves the reduction of the resting oxidised form of the 
enzyme converting the two bound copper ions from Cu2+ to Cu+ by two one electron 
transfers from two ascorbates. The two ascorbates in turn are oxidised to the 
semihydroascorbates which disproportionate to yield ascorbate and dehydroascorbate. 
In the presence of substrate, molecular oxygen then binds to Copper B (CuB, Figure 3)
1
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to give Cu'-peroxide. The copper-peroxy radical then abstracts a hydrogen atom from
the terminal glycine's a-carbon of the bound substrate forming an a-carbon centred 
glycyl radical intermediate (Figure 2). Homolysis of the copper bound hydroperoxide
The crystal structure of the active site of PHM in its oxidised, substrate bound form is 
illustrated (Figure 3). Included in the crystal structure are a number of features, which 
provide insight into how the enzyme binds substrates. Of particular note is the arginine 
residue R240 that acts like a claw in binding the terminal free carboxylate of the 
substrate. The importance of this interaction is observed in the fact that peptidic 
systems which do not possess the free carboxylate are known not to bind to PHM.2 
Further interactions involve an asparagine (N316), the side chain oxygen of which is 
hydrogen bonded with the substrate glycine NH. This interaction comes about through 
a large structural change upon substrate binding, which involves the breaking of a 
hydrogen bond with the neighbouring tyrosine (Y318) through a 30° rotation of the 
asparagine side chain. Also of interest is the substrates 3,5-diiodotyrosine residue 
which appears to be occupying a large hydrophobic pocket big enough to accommodate 
any proteinogenic amino acid side chain.1
then forms the a-hydroxyglycine derivative.
Figure 2. Mechanism for Abstraction of a Hydrogen
Atom from the a-Carbon of a Glycine Substrate by PHM.
2
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Figure 3, Crystal Structure of the Oxidised and Substrate 
Bound PHM Active Site.1 Peptide substrate and protein side 
chains are shown coloured by atom type (carbon is grey, 
nitrogen is blue, oxygen is red, sulfur is yellow and iodine is 
turquoise). The copper atoms are green and the water 
molecules are red spheres.
The a-hydroxyglycine modified substrate is then processed by the second active site, 
PAL, where it undergoes zinc dependent cleavage to give glyoxylic acid and the C- 
terminal amidated product (Figure 4).'
Ox
H2N Peptide
Figure 4. Proposed Mechanism of Catalysis by PAL.1
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The expression of PAM is widespread through the body with high concentrations in 
many neurons, endocrine cells (especially the pituitary), ependymal cells, atrial 
myocytes and all major brain areas except the cerebellum. To achieve its function in 
the amidation of peptides, PAM must be co-localised with its hormone precursor 
substrates. Resulting from this, regions known to contain high levels of peptide 
hormones also express high levels of PAM mRNA.
In addition to the bioactivation of a large number of peptides, PAM has also been 
implicated in the biosynthetic pathway of the production of fatty acid primary amides 
known as bioactive lipids.4 As a result of the diversity of compounds that PAM is 
responsible for processing and their wide ranging biological roles, the enzyme has been 
implicated in a number of related disease states. The neuropeptides bombesin and 
calcitonin are bioactivated by PAM3 and are known to stimulate the growth of prostate 
cancer cell lines through the inhibition of apoptosis.6 Substance P is a neuropeptide 
which is known to be a modulator of nociception, involved in the signalling intensity of 
noxious or aversive stimuli.7 Tachykinin peptides, substance P and neurokinin A are 
released from sensory nerves upon exposure to irritant chemicals and endogenous 
agents including bradykinin, prostaglandins and histamines as part of an inflammation
Q
response and are linked to bronchioconstriction (asthma). Pancreastatin has been found 
to have a counter regulatory effect on insulin levels and therefore has been implicated in 
insulin-resistance.9 The concentrations of the peptide hormones somatostatin and 
neuropeptide Y are known to be deficient in the cerebrospinal fluid of Alzheimer’s 
patients, though galanin levels are increased. 10 The fatty acid primary amide, 
oleamide, is known to be involved in the control of sleep and potentiates the 
antiproliferative effects of arachidonoylethanolamide in breast cancer cells.4
4
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Resulting from the large number of disease states associated with the over production of 
bioactive peptides by PAM such as asthma,8 cancer,6 and neuropathic pain,11 PAM has 
become a target for drug development.' A variety of potential drug candidates have 
been developed such as fra/Lv-4-phenyl-3-butenoic acid (PBA) which is an enzyme- 
activated, mechanism based inhibitior. " PBA is one of the most potent PHM inhibitors 
with an apparent K\ in the range of 1 pM. The inactivation of PHM by PBA is time, 
copper and ascorbic acid dependent. PBA is believed to form a reactive intermediate 
which binds covalently to an electron rich amino acid residue in the catalytic core of 
PHM.3 The administration of PBA in rat assays has been shown to reduce carrageenan- 
induced inflammation through the inhibition of substance P production by PAM.14 This 
identifies PAM as an excellent pharmacological target for the reduction of acute 
inflammatory responses.
Other mechanism based inhibitors of PAM include a,ß-unsaturated acids such as trans- 
3-benzoylpropenoic acid, rrans-3-(A-acetylphenylalanyl)propenoic acid and trans-5- 
acetamido-4-oxo-6-(2-thienyl)-hex-2-enoic acid with A'is of 0.16, 0.095 and 0.026 mM,
1 ^  1 c
respectively. ’ * Diastereomers of phenylalanylphenyalanyl-a-styrylglycine have also 
been studied and found to possess IC50 values against PAM in the millimolar range, as 
low as 0.1 mM.16
Other types of reported PAM inhibitors are inorganic sulfite, which appears to give 
irreversible inhibition through the Cu11 oxidation of sulfite (SO2 ,-?) to sulfite radical 
anion (SO’ 3) in the active site. The sulfite radical then reacts with an amino acid 
residue in the PHM active site rendering the enzyme inactive. 17 Benzylhydrazine has 
also been identified as a PAM inhibitor. This occurs through the oxidation of the
5
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hydrazine moiety by Cu" to give a benzylic radical, which then binds covalently to a
18residue in the active site of PHM, blocking the enzyme.
Chapter 1 o f the Results and Discussion section of this thesis outlines a new approach 
to the development of PAM inhibitors. This approach involves the development of 
methods to decrease the stability o f a-carbon centred glycyl radicals such as those 
formed by PAM. Therefore, a short review covering the nature o f a-carbon centred 
amino acid radicals and methods with which they can be studied now follows.
a-Carbon centred amino acid radicals are peculiar in that their stability is much greater 
than that for typical carbon radicals.19 This enhanced stability is the result o f a 
phenomenon termed the ‘captodative effect’ which was first theorised by Dewar." The 
captodative effect involves the extensive and synergistic delocalisation of the unpaired 
spin density, through the action of the electron-donating (dative) amino or amido 
substituent and the electron-withdrawing (capto) carboxy group.19 Figure 5 illustrates 
how resonance forms contribute to the stability o f a-carbon centred glycyl radicals 
formed on substrates by PAM.
a-Carbon centred amino acid radicals have been studied by measuring radical 
stabilisation energies (RSEs) and rates of bromination. RSEs are calculated energies, 
which reflect the stability of radicals whilst rates o f bromination reflect the ease of 
formation of the radicals. A short overview of these studies and how they w ill be 
applied to the development of inhibitors of PAM in Chapter 1 o f the Results and 
Discussion section of this thesis is now presented.
6
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Figure 5. Resonance Contributors of a-Carbon 
Centred Glycyl Radicals.
O O
frv
Br2 ---------- ► 2Br
Br* + RH ----------- ► R* + HBr
R* + Br2 -----------► RBr + Br*
Figure 6. The Mechanism of Radical Bromination as 
Described by Goldfinger et a!.22
The mechanism of radical bromination using NBS, illustrated in Figure 6, involves 
NBS as a provider of a small steady-state concentration of molecular bromine.23 
Photolysis of molecular bromine then releases a smaller steady-state amount of bromine 
atom which acts as the hydrogen abstracting species. This is followed by halogen 
abstraction from molecular bromine by the substrate radical forming the product 
bromide and a bromine atom, which continues the chain reaction.
7
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Rates of reaction often give information about the steric, polar and resonance effects 
involved in free radical processes and provide information that can be utilised, for 
example, in the design of oxidation resistant peptides, enzyme inhibitors and synthetic 
schemes.“ This is true of rates of bromination with NBS of a-amino acids which have 
been extensively used to investigate the effect that their substituents have on the ease of 
formation of their a-carbon centred radicals.24 In the transition state of the reaction 
there exists a substantial degree of bond homolysis and therefore the transition state 
possesses substantial radical character. As a consequence the relative rates of radical 
formation tend to reflect the relative stabilities of the radicals being formed i.e. a 
substituent which stabilises a radical product can be assumed to have a similar effect on 
the stability of the ‘radical-like’ transition state.
RSEs can also be used to determine the effect that different substituents have on a- 
carbon centred glycyl radical stability.“ In this dissertation, RSEs are reported as the 
energy changes in the isodesmic reactions represented in Figure 7. The RSEs 
correspond to the differences between the C-H bond dissociation energies of methane 
and RH,25-26 and reflect the stability of R* compared to CHi* (relative to the 
corresponding closed shell molecules). Therefore the larger the value of the RSE the 
more stable the radical.
R* + CH4 ---------- ► RH + * CH3
Figure 7. Isodesmic Reactions used to obtain RSEs.
The ability of different substituents to affect the rate of bromination of glycine 
derivatives with NBS and the RSEs of their a-carbon centred radicals has been
8
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9 1 97investigated." ' It was established that rates of bromination and RSEs could be 
influenced through both steric and electronic effects induced by /V-substituents and a- 
substituents.
The contribution of the amido or amino nitrogen of glycine derivatives, as part of the 
resonance forms involved in captodative stabilisation o f a-carbon centred glycyl 
radicals, is electron donating.19 The addition of electron withdrawing groups on the 
nitrogen of glycine has been shown to decrease rates of bromination with NBS and 
RSEs o f a-carbon centred glycyl radicals." The rate of radical bromination of N- 
trifluoroacetylglycine methyl ester 4 is 24 times slower than for /V-acetylglycine methyl 
ester 1 (Figure 8). Further the RSE o f the a-carbon centred glycyl radical of N- 
trifluoroacetylglycine methyl ester 5 is 9.8 kJ m o l1 less stable than for the N- 
acetylglycine methyl ester radical 2 (Figure 8).
Figure 8. Bromination Reactions of 1 and 4 to give their a-Carbon 
Centred Radicals 2 and 5 and Brominated Products 3 and 6, 
Respectively.27
9
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Substitution at the a-carbon of /V-acylglycines also affects the stability of the a-carbon 
centred amino acid radicals.21 The favoured conformation adopted by the a-carbon of a 
glycine derivative upon radical formation is sp" trigonal planar. The addition of bulky 
groups at the a-position of N-acylglycines can affect the adoption of the trigonal planar 
geometry. The substitution of /V-acetylglycine with a tert-butyl group results in a 
decrease in the RSE of 28.6 kJ mof1 for the a-carbon centred radical. This is a 
consequence of the buttressing of the tert-butyl group with the amido carbonyl oxygen. 
This interaction inhibits the adoption of a trigonal planar geometry at the a-carbon 
during the formation of the a-carbon centred radical.
The intention of the studies described in Chapter 1 of the Results and Discussion 
section of this thesis was to determine whether the effect that different substituents on 
glycine have on rates of bromination and the RSEs of a-carbon centred radicals 
translates to differences in PAM activity towards analogous substrates. It was the 
further intention to determine whether glycine substituents which decrease the RSEs of 
a-carbon centred glycyl radicals and their ease of formation in radical brominations 
could be used in the development of PAM inhibitors. In order to achieve this, assays of 
various compounds with PAM were required. Therefore an overview of enzyme 
kinetics with respect to the parameters which describe enzyme-inhibitor and enzyme- 
substrate interactions now follows.
• ">8Enzymes accelerate reactions by factors of up to at least a million." Indeed many 
enzymes such as superoxide dismutase, fumarase and triosephosphate isomerase are 
known to process their substrates such that the rate determining step is diffusion.29 
Enzymes are highly specific both in the reaction catalysed and in their choice of
10
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reactants.“ For example, PAM is known to be highly specific for glycine extended 
substrates over substrates terminating in more bulky amino acids such as alanine. 
Much of the catalytic power of enzymes comes from their bringing substrates together 
in favourable orientations in enzyme-substrate complexes (ES). The following diagram 
(Figure 9) describes the simplest case of the reactions that take place between enzymes 
and substrates.
_  _  ^ M A X
E + S ^  w  ES -------------►  EP ------------ ►  E + P
Figure 9. Reaction of an Enzyme (E) and Substrate (S) to 
give an Enzyme-Substrate Complex (ES) Followed by the 
Conversion to an Enzyme-Product Complex (EP) and Release 
of Product (P).
The Km is the Michaelis constant which is equal to the substrate concentration at which 
the reaction rate v is half its maximal rate (Vmax).~ The Km can also be defined as the 
substrate concentration at which the position of equilibrium between free enzyme and 
bound enzyme is such that half the enzyme active sites are occupied. Double reciprocal 
(Lineweaver-Burk) plots of 1/v versus 1/[S] (where [S] is substrate concentration) are 
used in this thesis to obtain KM values (Figure 10). In order to obtain a Km the 
reciprocal of the rate of turnover o f substrate at different substrate concentrations is 
plotted and a trendline fitted. The Km is then obtained from the value of -x where the 
trendline intersects with the jc-axis.
11
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Gradient = KM/v
Figure 10. Double Reciprocal Plot Used to determine KM 
Values.31
The inhibition of enzymatic activity by specific small molecules and ions is important 
because it serves as a major control mechanism in biological systems. Also many 
drugs and toxic agents act by inhibiting enzymes. Furthermore, inhibition can be a 
source of insight into the mechanism of enzyme action. Different types of inhibitors 
include those that are competitive and non-competitive. The latter can act in a 
reversible or irreversible manner. In the majority of cases, inhibitors bind reversibly
T 1and can be released or displaced from the enzyme.' However, some inhibitors can bind 
so strongly that they cannot be detached. These include suicide substrates, which 
initially follow the catalytic process but subsequently form a covalent bond with a 
functional group of the enzyme active site and block the enzyme. The studies outlined 
in Chapter 1 of the Results and Discussion section of this thesis are assumed to involve
12
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the development of competitive reversible inhibitors of PAM. A scheme describing 
enzyme and inhibitor interactions for simple competitive reversible inhibition is 
provided in Figure 11.
E + I ^ ------- ^  El
k , / ic 50
Figure 11. Reaction of Enzyme (E) and Inhibitor (I) to give an 
Enzyme-Inhibitor (El) Complex.
In this thesis, the activity of inhibitors is described using either a K\ or an IC50 value. 
However, it is important to understand the extent to which the two numbers can be 
compared. The differences between an IC50 and a K\ are illustrated by the way in which 
the values are determined. To find a K\ value for an inhibitor, one must determine rates 
of enzyme-catalysed reactions while independently varying the concentration of 
substrate, [S], and the concentration of inhibitor, [I].'“ Specifically, the rate of an 
enzyme-catalysed reaction is measured for a range of substrate concentrations against 
one concentration of inhibitor. This experiment is then repeated, typically five or six 
times, for different concentrations of inhibitor. These data, usually requiring 75-100 
individual rate measurements if the experiment is done in triplicate, are then used to 
determine a K\. By comparison, IC50 values do not require as extensive 
experimentation. The IC50 value is determined at only one concentration of substrate 
over a range of inhibitor concentrations. Since determination of this value requires only 
about 15-20% as many data points and PAM enzyme solutions are highly expensive, 
IC50 values were obtained for the potential inhibitors reported in this thesis. While K\ is 
a constant value for a given compound with an enzyme, an IC50 is a relative value, the
13
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rnagntude of which is dependent on the concentration of substrate used in the assay. 
The jelationship of an IC50 to a K\ is described mathematically in the Cheng-Prusoff 
relatbnship (Figure 12). From this equation it can be seen that the IC50 value of a given 
competitive inhibitor is related to the K\ value of the inhibitor as a function of the 
substrate concentration, [S], used in the assay, and the Michaelis constant, Km, of the 
substrate. It is important to note that this relationship is specific for competitive 
inhib tion and not for other modes such as uncompetitive inhibition. Therefore, IC50 
values and K\ values can only be compared whilst considering the mode of inhibition 
and the concentration of substrate used in the assay. In the case of competitive 
inhibition, IC50 values approximate K\ when the [S] used in the assay is much lower 
than Km- Therefore, in the case of competitive inhibition, IC50 values are always higher 
than K\s.
The IC50 values of the potential inhibitors evaluated in this thesis were obtained using 
the Dixon plot method of 1/v versus [I] (where the initial concentration of substrate is 
constant over each assay and where [I] is different in each assay). The method used to 
determine a K\ for an inhibitor from a Dixon plot is illustrated in Figure 13 to clearly 
show how it relates to the compounds IC50 values. Inhibition data for a range of [I] at a 
constant [S] can be plotted as a Dixon plot to give the IC50 value at that [S] as the 
opposite value of the jc-intercept. As the value of [S] decreases so does the opposite
Figure 12. Cheng-Prusoff Relationship.33
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value of the jc-intercept, illustrating how an IC50 value approximates K\ as the value of 
[S]//^m becomes smaller in the Cheng-Prusoff relationship (Figure 12).
Increasing [S]
max
Figure 13. Dixon Plot as used to determine IC5oand K\ Values.
In this thesis IC50S, /fis and AAiS are used to interpret the structural features of 
compounds, which are necessary for binding. Although only a K\ for an inhibitor is a 
constant which represents the concentration at which half the enzyme active sites are 
occupied, IC50S are used as a general guide and can be considered to represent an upper 
lim it estimation of K\.
Chapter l of the Results and Discussion section o f this thesis w ill outline research 
towards the development of PAM inhibitors for the treatment o f disease states that arise 
from an over-production of peptide hormones. Conversely, Chapter 2 w ill cover
15
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research into the controlled release of peptide hormones for the treatment of disease 
states resultant from their deficiency in the body.
Disease states associated with peptide hormone concentrations are not restricted to 
being due to their overproduction. Indeed, many disease states are treated through the 
direct administration of peptide hormones and suitable analogues.34 Growth hormone 
and insulin-like growth factor are administered to patients with cardiac failure, sepsis,
T C
burns, cancer cachexia, end-stage renal failure, trauma and AIDS. The administration 
of pancreastatin may constitute a method of treatment for insulin resistance.9 Glucogen- 
like peptide 1 is a physiological incretin hormone from the lower gastrointestinal tract 
and it has been identified for possible use in the treatment of diabetes and Alzheimer’s
t z . n n
disease." ’ The somatostatin analogues octreotide, lanreotide and vapreotide are used
T O
clinically to treat pituitary and gastrointestinal cancers. Vasopressin is used to treat 
enuresis.34 Salmon, human and eel calcitonin are commonly used in the treatment of 
osteoporosis.
The use of peptides as therapeutic agents is hampered by their rapid elimination from 
circulation through renal filtration, enzymatic degradation, uptake by the 
reticuloendothelial system and accumulation in non-targeted organs and tissues." In 
spite of the drawbacks of disease treatment with peptides, the worldwide market in 
peptide and protein drugs was worth USD 28 billion in 2000.34 Therefore methods of 
administering peptide hormones as prodrugs which are initially inactive and are then 
rendered active once in contact with a selected stimulus warrants development.
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It has been suggested that the administration of peptides in conjugation with molecules 
that can improve their lifetimes in the body and their selectivity for disease sites may 
allow the drawbacks of their use in disease treatment to be overcome.' Possible 
systems which could be used to this end include large polymers which improve the 
delivery of anti-cancer drugs through exploiting the enhanced permeability and 
retention of solid tumours towards macromolecules.39 Further, antibodies which can 
recognise specific antigens produced in tumours, and immunotoxins which can select 
for specific cancer cells could also be used. However, in order for hormones to be 
attached to such polymers, antibodies and immunotoxins, suitable linkers which allow 
for the liberation of the hormone must be developed.
As discussed above, the C-terminal amide of peptide hormones is essential to their 
bioactivity.1 Therefore one approach towards the development of prodrugs of hormones 
is through the masking of the amide with a suitable protecting group which can be 
removed in vivo 40 It seemed likely that functional amino acids which, upon exposure to 
specific stimuli, cleaved to release amides would constitute suitable protecting groups 
for the C-terminal amide of peptide hormones. Furthermore, such amino acids could 
potentially be utilised as cleavable linkers between hormones and the polymers, 
antibodies and immunotoxins anticipated to improve the selectivity of peptide hormone 
drug delivery. In this dissertation, the development of amino acids, which can be 
cleaved to release amides through hydrolysis will be outlined in Chapter 2 of the 
Results and Discussion section.
On the basis of the mechanism by which PAM catalyses the production of hormones, 
the administration of the a-hydroxyglycine extended precursors of C-terminal amidated
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peptides may seem a suitable method by which to control the rate of hormone release. 
A number of a-hydroxyglycine extended peptides such as /V-acetylphenylalanyl-a- 
hydroxyglycine, A^-benzoylphenylalanyl-a-hydroxyglycine and N-
acetylphenylalanyltyrosyl-a-hydroxyglycine have been studied to determine their rates 
of hydrolysis in aqueous buffered solutions and in 80% blood plasma at 37 °C 40,41 It 
was found that their rates of hydrolysis were accelerated in 80% blood plasma with 
half-lives decreasing from 5.8-13.3 to 1.3-3.9 hours, apparently due to enzyme 
catalysed dealkylation.40 It seemed likely that PAM was the enzyme responsible for the 
catalysed dealkylation as it is known to be present in human blood plasma.42 Therefore 
the administration of a-hydroxyglycine extended peptides may not be suitable as they 
would be processed as soon as they entered the blood stream. It seemed likely that a- 
substituted glycines, which would not be expected to be PAM substrates, but would still 
hydrolyse at biological pH, may be suitable alternatives to a-hydroxyglycines. 
Therefore, a short review covering the chemistry of a-substituted glycines will now be 
outlined.
The hydrolysis of A-benzoyl-a-hydroxyglycine 7, A-benzoyl-a-hydroxyglycine methyl 
ester 8 and A-benzoyl-a-hydroxyglycine benzyl ester 9 to release benzamide 10 and the 
glycolate derivatives 11-13 has been studied.41 A mechanism for the non-enzyme 
catalysed hydrolysis of 7, 8 and 9 to release 10 and 11-13 based on that proposed by 
Bundgaard et a/.41 is illustrated in Figure 14. The reported half-lives for the hydrolysis 
of 7, 8, and 9 to release benzamide 10 at pH 7.4 were 6.7, 0.78 and 4.5 hours, 
respectively. Therefore, an increase in the rate of release of 10 through the hydrolysis 
of 8 and 9 in comparison to the free acid 7 of up to 8.5 times was observed, however, no 
explanation for this change in reaction rate was reported. This result was considered
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surprising, as there is no obvious reason ihat can be derived from the mechanism 
(Figure 14) to explain the observed increase in the rate of amide release. The 
hydrolysis of iV-benzoyl-a-hydroxyglycine methyl ester 8 was therefore studied and is 
discussed in Chapter 2 of the Results and Discussion section of this thesis in order to re­
examine the results previously reported.41
h2o^
HO)H
7 R = H
8 R = CH3
9 R = CH2C6H5
O
o
11 R = H
12 R = CH3
13 R = CH2C6H5
Figure 14. Mechanism of Hydrolysis of A/-Benzoyl-a- 
hydroxyglycine 7, A/-Benzoyl-a-hydroxyglycine Methyl Ester 8 and 
A/-Benzoyl-a-hydroxyglycine Benzyl Ester 9.
In an attempt to extend the half-life of a-hydroxyglycine derivatives, Bundgaard et a / 41 
protected 8 with various acyl groups. However, it was found that the acyl protected 
systems were highly unstable in aqueous conditions at biological pH, converting back 
to their a-hydroxyglycine analogues with a half-life of 1-3 seconds. A mechanism for 
the formation of 8 from N-benzoyl-a-acetoxyglycine methyl ester 14 is illustrated in 
Figure 15. The initial step in the hydrolysis of 14 is the formation of a transient N- 
acyliminium ion 15, which in a subsequent fast step, undergoes attack by hydroxide to
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give the a-hydroxyglycine 8. The rate-determining step in the formation of 8 from 14 
has been suggested to be the elimination of the carboxylate ion.
Figure 15. Mechanism of Hydrolysis of A/-Benzoyl-a- 
acetoxyglycine Methyl Ester 14.
The ability of acetate to stabilise a negative charge is reflected in the relatively low pKa 
of acetic acid, which is 4.O.43 As a result, acetate is a good leaving group. Therefore the 
instability of 14 may be due to the rate of elimination of the acyloxy anion being too 
fast. The hydrolysis of TV-benzoyl-a-acetoxyglycine methyl ester 14 is investigated in 
Chapter 2 of the Results and Discussion section of this thesis to re-examine previously 
published results.41 The development of a-substituted glycines, which hydrolyse to 
release amides slowly in comparison to A-benzoyl-a-acetoxyglycine methyl ester 14 in 
aqueous solution at biological pH, was desired. It seemed likely that this could be 
achieved if the rate of conversion of glycines such as 14 to 15 could be extended 
through the use of suitable alternatives to acyloxy groups as glycine a-substituents. In
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Chapter 2 o f the Results and Discussion section o f this thesis, the a-substituted glycines
which were investigated for their potential rates of hydrolysis in aqueous conditions or
to compare with literature values,41 are 8, 14, 17, 19, 21 and 22 (Figure 16).
16 R = H
17 R = CH3
18 R = H 20 R = H
19 R = CH3 21 R = CH3
Figure 16. a-Substituted Glycine Derivatives 8, 14 and 1 6 -2 2 .
jV-Benzoyl-a-methoxyglycine 16 and N-benzoyl-a-ethoxyglycine 18 have been 
previously synthesised in high yield via the base catalysed hydrolysis o f N-benzoyl-a- 
methoxyglycine methyl ester 17 and /V-benzoyl-a-ethoxyglycine methyl ester 19 
respectively, with sodium hydroxide in aqueous methanol.44 The high yield (96%) of N- 
benzoyl-a-methoxyglycine 16 obtained was surprising as the conditions used were 
aqueous. Using such conditions it would be reasonable to expect that, to some extent, 
jV-benzoyl-a-methoxyglycine methyl ester 17 would have converted to the a- 
hydroxyglycine analogue 8 followed by the release of benzamide 10 in a similar 
manner to the hydrolysis o f the a-acetoxyglycine 14 (Figure 15). The formation of the 
a-hydroxyglycine 8 would however, have required the generation of the transient N- 
acyliminium ion 15 to which water could then add. The yield o f TV-benzoyl-a- 
ethoxyglycine 18 was 94%. No evidence for the formation o f the a-methoxyglycine 17
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or the a-hydroxyglycine 8 from 19 was reported. Exchange of 19 to give 17 or 8 
would have also required the formation of the /V-acyliminium intermediate 15. 
Therefore, the formation of the /V-acyliminium ion 15 from 17 or 19 seems unlikely. 
For 17 and 19 to form the /V-acyliminium ion 15, the respective methoxy and ethoxy 
groups would need to be displaced. Methanol and ethanol have pA/as of 15.0 and 17.5 
respectively.43 This reflects the poor ability of methoxide and ethoxide to stabilise a 
negative charge and as a result, they are poor leaving groups. This may explain the 
high yields o f the a-methoxyglycine 16 and the a-ethoxyglycine 18 produced through 
the hydrolysis of 17 and 19 respectively under the conditions used by Kawai et a l AA 
However, the fact that no /V-acyliminium ion was then produced from 16 or 18 may be 
due to the short length of time over which the reactions were performed, which was one 
hour. The potential for hydrolysis o f a-methoxy and a-ethoxyglycines in aqueous 
media over time periods greater than one hour had not been investigated, a- 
Alkoxyglycines are considered to be unstable due to an electronegative oxygen being 
directly attached to the a-carbon.44 As a result it seemed reasonable to expect that the 
subjection of the a-methoxyglycine 17, and the a-ethoxyglycine 19, to aqueous 
conditions over extended periods of time, rather than one hour, might result in the slow 
formation o f the free acid analogue of the a-hydroxyglycine 8, this would then be 
expected to hydrolyse to release benzamide 10. Studies evaluating the hypothesis that 
and 17 and 19 might slowly hydrolyse via an a-hydroxyglycine to release benzamide 10 
in aqueous conditions over extended time periods are outlined in Chapter 2 of the 
Results and Discussion section of this thesis.
Attempts by Kawai et a l AA at the base catalysed hydrolysis of /V-benzoyl-a- 
phenoxyglycine methyl ester 21 by stirring in a solution of sodium hydroxide in
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aqueous methanol were found not to yield the free acid, yV-benzoyl-a-phenoxyglycine 
20, but rather the a-methoxyglycine 16. This indicated that methanol was adding to the 
yV-acyliminium ion 15 (which was most likely forming through the elimination of 
phenoxide) to give 17. Saponification of 17 then gave the free acid 16. It would also 
be expected that water would have added to the yV-acyliminium ion 15 to give the a- 
hydroxyglycine 8 followed by subsequent hydrolysis to release benzamide 10, however 
this possibility was not addressed. When the hydrolysis of yV-benzoyl-a-
phenoxyglycine methyl ester 21 was performed using sodium hydroxide in aqueous 
isopropanol, only benzamide 10 was isolated,44 however no reasoning for its formation 
was provided. This may have been due to isopropanol being too poor a nucleophile (in 
comparison to methanol) to attack the yV-acyliminium. ion 15. This would then allow 
water to add to 15, forming the a-hydroxyglycine 8, which presumably then hydrolysed 
to release benzamide 10. It therefore seemed likely that under biological conditions, N- 
benzoyl-a-phenoxyglycine methyl ester 21 would also react, forming the a- 
hydroxyglycine 8. Phenol has a pKa of 10.0, which is in between that of acetic acid 
(4.0) and methanol and ethanol (15.0 and 17.5 respectively).44 As a result phenoxide is 
a poorer leaving group than acetate and a better leaving group than both methoxide and 
ethoxide. It was therefore hypothesised that if yV-benzoyl-a-phenoxyglycine methyl 
ester 21 was found to react to form the a-hydroxyglycine 8 in aqueous conditions, it 
would be at a slower rate than 14 and faster than the rates of the potential hydrolysis of 
17 and 19. Succinimide has a p/fa of 9.6 which is similar to that of phenol and as such, 
yV-benzoyl-a-succinimidoglycine methyl ester 22 would also be expected to exchange to 
the a-hydroxyglycine 8 in aqueous conditions. Therefore the potential hydrolysis of 21 
and 22 to release benzamide 10 in aqueous conditions was studied and the results are 
presented in Chapter 2 of the Results and Discussion section of this thesis.
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In addition to hydrolytically cleavable derivatives of glycine, the C-terminal amide of 
peptide hormones could also be masked with photochemically removable groups 
resulting in photoactivatable hormone prodrugs. Chapter 3 of the Results and 
Discussion section of this thesis outlines research towards the photochemical release of 
C-terminal amidated peptide hormones. Therefore a short review of the chemistry of 
relevant photochemically cleavable groups follows.
Figure 17. NBOC Photolysis Mechanism, X = NH or O 45
One of the most commonly used photolytic protecting groups is the 2- 
nitroveratroyloxycarbonyl group (NVOC), w'hich was originally introduced by
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Patchornik, Amit and Woodward."5'46 NVOC and the analogous 2- 
nitrobenzyloxycarbonyl protecting group (NBOC)46 have been used to protect alcohols 
and amines. NVOC and NBOC differ in that NVOC is methoxy substituted at the 4- 
and 5-positions of the aromatic ring. However, their mechanism of photolysis is the 
same. The mechanism of photolysis of NBOC is illustrated in Figure 17. Irradiation of 
23 results in the formation of the diradical 24 . This is followed by abstraction of a 
hydrogen atom from the benzylic carbon by the oxygen-centred radical of 24 to give 25 . 
The aci-nitro intermediate 26 , which is a resonance form of 25 , then reacts to give the 
bicyclic species 27 . The bicyclic species 27 then spontaneously collapses45 to release 2- 
nitrosobenzaldehyde 28 and the carbonate or carbamate anion 29 which through 
decarboxylation give the respective amine or alcohol 30 . The spontaneous degradation 
of the bicyclic species 27 is most likely related to the high efficiency of the resonance 
stabilised carbonate or carbamate anions to act as leaving groups. The rate determining 
step of NBOC photolysis is the ring closure of the aci-nitro species 26 to give the 
bicyclic intermediate 27 41 This is not surprising as the ring closure of 26 constitutes a
485-endo-trigonal process and as such is disfavoured.
The 2-nitrophenethyloxycarbonyl group (NPEOC), which is a variant of NBOC, has 
been used to protect amines and alcohols and to mask carboxylic acids.49'50 NPEOC 
differs from NBOC or NVOC in that it is derived from 2-(2-nitrophenyl)ethyl alcohol 
rather than 2-nitrobenzyl alcohol. The mechanism of NPEOC photolysis to unmask 
carbonate, carbamate or carboxylate anions is illustrated in Figure 18.
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Figure 18. Mechanism of Photolysis of NPEOC R = Ac, COOMe, 
C0-5'-0-thymidine or CO-Phe-OH.4950
Upon irradiation of 31 in the first absorption band, the Si(/m*) of the NPEOC
chromophore is populated. It decays by intersystem crossing to the triplet state T|(/?7t*) 
and by internal conversion to the singlet ground state. It is believed that hydrogen atom 
transfer from the benzylic carbon to the nitro group is the mechanism by which the
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triplet state relaxes. The primary product produced this way is a triplet biradical 32 that 
rapidly relaxes to the o-quinoid singlet ground state of the aci-nitro form 33. Since the 
ad-nitro compound 33 represents an unstable tautomer of the starting compound 31, its 
reversion to the stable tautomer 31 is also a possible pathway at this stage of the 
mechanism although other processes appear to out compete this. The aci-nitro form 33 
can then either degrade to form unknown by-products, form the bicyclic compound 37 
followed by degradation to the benzylic alcohol 38 or after deprotonation of the nitro 
group to give 34, undergo elimination to form 2-nitrostyrene 35 and the anion 36. In 
the case of 36 being a carbonate or carbamate anion, subsequent decarboxylation 
releases the alcohol or amine respectively.
The research described in Chapter 3 o f the Results and Discussion section of this thesis 
is concerned with the release of amides through the photolysis of a photocleavable 
group. The protection of amides with NVOC, NBOC or NPEOC groups would not be 
viable as the corresponding acylcarbamates (Figure 19) would be too unstable.
Figure 19. NVOC (FT = OCH3), NBOC (FT = H), or 
NPEOC Protected Amides.
Amides have been masked using systems derived from NBOC such as 2- 
nitrobenzylamine 39 and 2-nitrophenylglycine (Npg) 40 “ (Figure 20). A review of 
the chemistry and applications of Npg 40 now follows.
27
Introduction
Figure 20. 2-Nitrobenzylamine 39 and Npg 40.
The mechanism of photolysis of the Npg 41 (Figure 21) follows a similar pathway 
that of NBOC 23 photolysis (Figure 17).
Figure 21. The Mechanism of Npg Photolysis.
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Upon irradiation of the Npg 41 , the diradical 42 is formed. A hydrogen atom is then 
abstracted from the benzylic carbon of 42 by the oxygen centred radical to give 43 . The 
aci-nitro intermediate 44 , which is a resonance form of the diradical species 43 , then 
reacts further to give the transient bicyclic intermediate 45 . The degradation of the 
bicyclic species 45 has been thought to directly release an amide 47 and a nitrosoketone 
48 , bypassing the formation of the a-hydroxy species 46 .52 Alternatively, it has been 
suggested that the bicyclic intermediate 45 degrades via the transient formation of the 
a-hydroxy species 46 followed by hydrolysis to the amide 47 and the nitrosoketone 
48.53
The use of Npg 40 as a photochemically cleavable amino acid has been applied in a 
number of research areas, though with some limitations. Using the in vivo nonsense 
codon suppression method for incorporating unnatural amino acids into proteins 
expressed in Xenopus oocytes, England et al.* incorporated Npg 40 into two ion 
channels: the Drosophila Shaker B K+ channel and the nicotinic acetylcholine receptor. 
Irradiation of the proteins in vivo led to peptide backbone cleavage at the site of the Npg 
residue. This method was used to investigate the functional role of the Cysl28-Cysl42 
disulfide loop in the nAChR a subunit. Npg photolysis has also been utilised in the 
synthesis of C-terminal amidated peptides.51 Micro-organisms lack the necessary 
enzymatic machinery to produce peptide hormones. As a result, in these systems, such 
hormones cannot be produced using gene technology. In order to overcome the 
difficulties in synthesising peptide hormones, a method was developed which involved 
their enzymatic synthesis (using the yeast derived carboxypeptidase-Y) with an Npg 
residue connected to their terminal amino acids. Irradiation of the peptides then cleaved 
the Npg residue, releasing the C-terminal amidated hormones. Production of hormones
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via this method was achieved with high levels of efficiency provided the pH of the 
solution in which the photolysis of the Npg extended peptides was performed was 
basic. Although the photolysis of Npg has many novel applications, it has been 
reported to be very slow and inefficient at biological pH with calls being made in the 
literature for the development of more efficient alternatives. “ It seemed likely 
therefore, that the development of an unnatural amino acid, which could be photolysed 
to release amides efficiently at biological pH, was warranted. However, before this can 
be addressed, an understanding of why Npg photolysis is inefficient at biological pH is 
necessary.
The rate-determining step of the photolysis of NBOC 23 to release carbonate or 
carbamate anions has been established to be the degradation of the ad-nitro 
intermediate 26 to form the bicyclic system 27 (Figure 17).47 The bicyclic species 27 
then breaks down spontaneously to give the carbonate or carbamate anion 29 which 
decarboxylates to give the respective alcohol or amine 30 . In this way, NBOC groups 
can be efficiently photolysed to release the typical alcohols and amines 30 , which are 
poor leaving groups. It appears that the rate-determining step of the photolysis of the 
Npg 41 has been assumed to be the degradation of its equivalent aci-nitro intermediate 
44 , 51’52'54’55 in Spite of the fact that in this case cleavage releases an amide 47 which is a 
poor leaving group in comparison to a carbonate or carbamate anion 29 .
Recent work by Corrie et a l41 on the photolysis of l-(2-nitrophenyl)ethyl ethers (the 
photolysis mechanism of which is analogous to that of Npg in that the cleavage step 
involves the release of a poor leaving group) found that the degradation of its ad-nitro 
intermediate 49 was not rate-determining (Figure 22).
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Figure 22. Proposed Two-Path Mechanism for Breakdown of 
the ac/'-Nitro Intermediate 49, Generated Through the Photolysis 
of a 1-(2-Nitrophenyl) Ether.47
Flash photolysis studies performed by Corrie et al.41 identified two elimination 
pathways from the aci-nitro species 49 generated through irradiation of a l-(2- 
nitrophenyl)ethyl ether. In the mechanism outlined in Figure 22, the ad-nitro 
intermediate 49 can react via a 1,4- shift of the nitro OH to the benzylic carbon to give 
the hemiacetal intermediate 52 followed by hydrolysis to release the alcohol 53. 
Alternatively the aci-nitro intermediate 49 can undergo a 5-endo-trigonal4* ring closure 
to form the bicyclic species 51, which then ring opens to give the hemiacetal 52, 
followed by the hydrolysis of 52 to release the alcohol 53. The aci-nitro dianion 50 was 
found to not undergo ring closure. It was found that in the case of l-(2-
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nitrophenyl)ethyl ether photolysis to release alcohols, the degradation of the hemi- 
acetal intermediate 52 rather than the aci-nitro intermediate 49 was rate-determining. 
Interestingly a similar intermediate to the hemi-acetal 52 was isolated during the 
photolysis of /V-(2-nitrobenzyl)-l-napthalamide 54 to release an amide, except in this 
case the intermediate was a hemi-amidal 55 (Figure 23).36
Figure 23. Photolysis of A/-(2-Nitrobenzy!)-1-napthalamide 54 to 
Give the Hemi-amidal 55 Isolated by Itsuno et a l56
Corrie et al.41 identified from the photolysis o f l-(2-nitrophenyl)ethyl ethers, that the 
hemi-acetal intermediate 52 was the precursor to cleavage (Figure 22) and that its 
hydrolysis to release the alcohol 53 was the rate-determining step. The fact that this 
step, rather than the disfavoured 5-endo-trigonal ring closure of 49 to give 51 was rate 
determining may be related to the instability o f alkoxy anions. As was stated earlier, 
alkoxides are considered to be poor leaving groups. This was shown to be reflected in 
the pKds o f methanol and ethanol which are 15.0 and 17.5 respectively.43 The p ^ a of the 
alcohol 53 illustrated in Figure 22 would be expected to be similar to that o f methanol 
and ethanol and as such it would also be a poor leaving group. This may explain why 
the degradation of the bicyclic intermediate 51 resulted in the formation of the hemi- 
acetal 52 rather than spontaneous release of the alcohol 53. Primary amides have pK.ds 
in the region and above that of acetamide which is 15.0.43 Their p/fas are therefore of a
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similar value to those of methanol and ethanol and correspondingly, amides are 
considered to be poor leaving groups. This may account for the ability of the hemi- 
amidal 55 to be isolated from the photolysis of 54.56 It is therefore apparent that in the 
photolysis of 2-nitrobenzyl groups (such as in the photolysis of 54) or analogues (such 
as in the photolysis of a l-(2-nitrophenyl)ethyl ether) to release poor leaving groups, the 
cleavage step is rate-determining. The photolysis of the Npg 41 releases an amide 47 
via a similar mechanism to that of the release of the alcohol 53 through the irradiation 
of a l-(2-nitrophenyl)ethyl ether compound. Therefore, as the amide 47 is a poor 
leaving group, the a-hydroxy system 46 would be expected to form during the 
photolysis of the Npg 41. Furthermore, the hydrolysis of 46, rather than the 
degradation of the arZ-nitro intermediate 44, would be expected to be rate-determining. 
The poor efficiency of photolysis of Npg at biological pH, as reported in the 
literature52'53 may therefore be due to the formation of a-hydroxy intermediates such as 
46 (Figure 21) and their subsequent slow hydrolysis. Indeed, in comparison to the rates 
of the other steps during the photolysis of Npg 41, it would be reasonable to expect that 
the a-hydroxy intermediate 46 would hydrolyse slowly at biological pH in a similar 
manner to that of a-hydroxyglycines such as 7 and 8 which have half-lives of 6.7 and 
0.78 hours, respectively.41 It is therefore apparent that the development of a 
photochemically cleavable amino acid that does not involve the formation of 
intermediates that are slow to breakdown at biological pH is warranted.
NPEOC has been used to protect alcohols and amines. NPEOC has also been used to 
mask carboxylic acids, however no equivalent system based on NPEOC has been 
developed to mask amides. The cleavage step in the mechanism of photolysis of 
NPEOC 31 comes from the aci-nitro intermediate 34 and does not involve the
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formation of species that would be expected to be slow to breakdown at biological pH 
(Figure 18). It was therefore hypothesised that, an amino acid, which was analogous to 
NPEOC might photolyse more efficiently at biological pH than Npg 40. 2-
Nitrophenylalanine was therefore designed and investigations into its potential 
photolysis to release amides are outlined in Chapter 3 of the Results and Discussion 
section of this thesis. A reaction scheme for the photolysis of a 2-nitrophenylalanine 
system 56 is illustrated in Figure 24.
By analogy to the mechanism of NPEOC photolysis (Figure 18), the photolysis of the 
2-nitrophenylalanine 56 to cleave the N-Cu bond may release an amide 47 and a 
cinnamyl derivative 57 (Figure 24).
57
Figure 24. Proposed Photolysis of a 2-Nitrophenylalanine 
System 56 to Unmask an Amide 47 and Release a Cinnamyl 
Derivative 57, R = NH2, NHR\ OH or OR’.
The potential photolysis of 2-nitrophenylalanine to unmask amides efficiently at 
biological pH may have many applications. 2-Nitrophenylalanine could be use as an 
alternative to Npg in site-selective photochemical proteolysis. It would constitute a 
photocleavable linker, which could be used to connect hormones to the polymers, 
antibodies and immunotoxins that were described earlier for their potential to improve
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the lifetime and selectivity of peptide hormones in vivo. Photodynamic therapy (PDT) 
involves the administration of a photosensitising drug, which preferentially accumulates 
in target tissues.' PDT is generally associated with the generation of singlet oxygen in 
cancer cells, which then results in their death. However, it may be that the technology
co
used in PDT could also be utilised in ‘Laser PhotochemotherapyV Submillimeter 
diameter laser fibreoptics can be inserted via vascular or interstitial access providing a 
precise, minimally invasive method of activating light sensitive drugs in tumours. The 
masking of the C-terminal amide of peptide hormones with 2-nitrophenylalanine may 
result in light-activated hormone prodrugs that may find application in the area of 
‘Laser Photochemotherapy’ . The potential photolysis of 2-nitrophenylalanine may be 
applied to a number of other research areas. Photoprobes are becoming increasingly 
common as remotely controllable tools in the drug discovery process.59 The 
photochemical release of neurotransmitters (which are C-terminal amidated peptides) 
from ‘caged’ compounds can be used to study fast kinetic processes (in the 
submillisecond range) o f neurotransmitter release and cell signalling through second 
messenger pathways. Such studies have allowed the elucidation of the activation 
mechanisms of learning and memory. This technique has also been used in the study of 
neurological disorders such as epilepsy and anxiety. The potential photolysis o f 2- 
nitrophenylalanine might also be employed in the area of compound release from solid 
support.
This dissertation w ill now outline research towards the inhibition of peptide hormone 
production by PAM, the development o f a- substituted glycines for the controlled 
hydrolytic release of C-terminal amidated peptides and the release of amides through 
the photolysis of 2-nitrophenylalanine residues.
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Chapter 1. Inhibition of Peptidylglycine a-Amidating 
Monooxygenase by Exploiting Factors Affecting the 
Stability and Ease of Formation of Glycyl Radicals.
1.1 Project Rationale
As discussed in the Introduction, peptidylglycine a-amidating monooxygenase (PAM) 
catalyses the biosynthesis of a wide variety of C-terminal peptide amides through 
oxidative cleavage of the corresponding glycine-extended precursors (Figure 1). PAM 
has been implicated in a large number of disease states such as cancer,6 asthma8 and 
neurological disorders.10 Therefore the development of systems for the inhibition of 
PAM could provide methods for the treatment of such diseases.
The natural substrates of PAM all have in common an N-acylated glycine, and they are 
therefore comprised of acyl, amido, methylene and carboxyl groups. The common 
features possessed by PAM substrates, which contribute to a-carbon centred radical 
stability, were targeted for alteration in order to establish their effect on enzyme 
activity. The free carboxylate has been established as very important for substrate 
binding to PAM," therefore all systems designed were to retain this functionality. PAM 
is known to accept a wide variety of acyl substituents and so variations of this group 
were investigated. Although derivatives of a-substituted amino acids tend not to bind 
to PAM, small a-alkyl substituents, such as the methyl group of (/?)-alanine,30,60 the 
vinyl moiety of (/?)-vinylglycine61 and the hydroxyethyl group of (/?)-threonine are
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accommodated.60 The incorporation of a trifluoromethyl group was therefore studied 
since ß,ß,ß-trifluoroalanine derivatives are known to be resistant to a-carbon centred 
radical formation.21 Further to this, the amido group of PAM substrates was varied 
through substitution of the glycine unit with a glycolic acid or y-keto acid. Glycolate 
inhibitors of PAM have been previously reported13,61 in studies of broad ranges of 
compounds, but there has been no analysis of, nor explanation for, their behaviour. One 
y-keto acid has been previously reported but it was found not to interact with PAM, 
either as a substrate or an inhibitor.6“
The intention o f these studies was to investigate factors affecting the formation o f a- 
carbon centred glycyl radicals in order to design analogues of PAM substrates that 
competitively bind to but are not processed by the enzyme, and therefore inhibit the 
reaction of substrates. In order to achieve this, the results of ab initio calculations and 
studies of reaction rates in free radical brominations, which identify factors affecting the 
stability and ease o f formation o f a-carbon centred glycyl and related radicals, were 
compared with the kinetic parameters defining the interactions of analogous compounds 
with PAM.
1.2 Synthesis of Compounds for Investigation
A variety of compounds were required in order to study their reactivity in radical 
brominations or their interactions with PAM. The synthesis o f these compounds w ill 
now be described.
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1.2.1 Methyl (^-Benzoylglycolate 59
The synthesis of methyl 0 <x-benzoylglyeolate 59 was performed as depicted in Figure 
25.
Br
O
58
Benzoic Acid 
Potassium Carbonate 
Acetone
-------------------------------►
Figure 25. Synthesis of Methyl C^-Benzoylglycolate 59
Benzoic acid in acetone along with methyl bromoacetate 58 and potassium carbonate 
was heated at reflux overnight. The product 59 was purified by recrystallisation from 
ethyl acetate/hexanes. Characterisation of the product by ‘H NMR spectroscopy 
displayed resonances for the a-carbon, methyl ester and aromatic protons at 54.87, 
53.80 and 57.44 - 8.12 ppm, respectively.
1.2.2 A/-Benzoylglycine Methyl Ester 61
The synthesis of N-benzoylglycine methyl ester 61 followed previously established
z: o
chemistry (Figure 26).
Benzoyl Chloride 
Triethylamine
H2N - r ° -  Ethyl Acetate ^
O
60 61
Figure 26. Synthesis of /V-Benzoylglycine Methyl Ester 61
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Glycine methyl ester 60 along with benzoyl chloride and triethylamine was heated to 
reflux in ethyl acetate overnight to give /V-benzoylglycine methyl ester 61. The 'H 
NMR spectrum of the product showed multiplet resonances for the aromatic protons at 
b7.44 - 7.82 ppm confirming the presence of the benzoyl protecting group. This along 
with the glycine a-carbon protons’ and methyl ester resonances at 54.26 and 53.79 ppm 
respectively indicated the reaction to have proceeded.
1.2.3 (^-(/V-Acetyl^SJ-phenylalanyl-tSJ-phenylalanyOglycolic Acid 64
In the above synthesis of methyl Ou-benzoylglycolate 59, methyl bromoacetate 58 was 
used to install a methyl glycolate. However, as 64 is a free acid, synthesis via a methyl 
glycolate would not be suitable as the conditions required for methyl ester hydrolysis 
would also cleave the glycolate ester. Benzyl esters can be cleaved through 
hydrogenolysis, which could be performed without hydrolysis of the glycolate ester. 
Thus, benzyl bromoacetate was used to install the glycolate unit in compound 63. The 
synthesis of Oa-(ALacetyl-(1S)-phenylalanyl-(S)-phenylalanyl)glycolic acid 64 is 
illustrated in Figure 27. /V-Acetyl-^-phenylalanyl-^-phenylalanine 62 was purchased 
from Aldrich Chemical Company and converted to benzyl Oa-(A^-acetyl-(5')- 
phenylalanyl-OS)-phenylalanyl)glycolate 63 by reaction with benzyl bromoacetate and 
potassium carbonate in refluxing acetone. The !H NMR spectrum of the product 
displayed resonances for the benzylic protons o f the benzyl ester at 55.20 ppm and 
glycolate a-carbon protons at 54.68 and 54.75 ppm indicating that the glycolate unit had 
been installed. Hydrogenolysis of 63 in tetrahydrofuran with 10% palladium on carbon 
under an atmosphere of hydrogen gave the free acid 64. The absence of a resonance in
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the 'H NMR spectrum of the product in the region of 55.20 ppm characteristic of the 
benzylic protons of a benzyl ester indicated the loss of the benzyl group. The presence 
o f the glycolic acid a-carbon protons was confirmed by the presence of a resonance at 
54.64 ppm. During the synthesis of 64, racemisation was a possibility due to the basic 
conditions required for the installation of the benzyl glycolate moiety. However as the 
synthesis o f 64 began with the chirally pure 62 and as there was only one set of 
resonances in the 'H NMR spectrum of either 63 or 64 for each a-carbon proton the 
absence of diastereomers and therefore the retention of (^-stereochemistry was 
established.
Benzyl Bromoacetate 
Potassium Carbonate 
Acetone
Hydrogen
10% Palladium on Carbon 
Tetrahydrofuran
Figure 27. Synthesis of (^-(/V-Acetyl-fSJ-phenylalanyl-fS)- 
phenylalanyl)glycolic Acid 64
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1.2.4 {^-(/V-BenzoyKSJ-valylJglyeolic Acid 70
The synthesis of Oa-(/V-benzoyl-(S)-valyl)glycolic acid 70 is depicted in Figure 28. (Si- 
Valine 65 was stirred in methanol that had been pre-treated with thionyl chloride to give 
66. Compound 66 was then treated with benzoyl chloride in refluxing ethyl acetate to 
give V-benzoyl-(S)-valine methyl ester 67. The 1H NMR spectrum of the product 
displayed resonances for the aromatic protons at 57.26-7.82 ppm, the a-carbon proton at 
54.79 ppm and the methyl ester protons at 53.77 ppm. Compound 67 was then 
saponified in a 1:1 mixture of tetrahydrofuran and 1M sodium hydroxide to give N- 
benzoyl-(S)-valine 68. The absence of a resonance indicative of methyl ester protons in 
the region of 53.77 ppm in the products’ ’H NMR spectrum was evidence that the 
deprotection had occurred. The melting point o f the product was 129 °C which 
corresponded closely with that recorded in the literature for /V-benzoyl-(S)-valine 68 
(127 °C).64 jV-Benzoyl-(S)-valine 68 along with benzyl bromoacetate and potassium 
carbonate in acetone were heated at reflux overnight to give 69. The 'H NMR spectrum 
of the product displayed resonances for the a-glycolate protons at 54.64 and 54.86 ppm, 
benzylic protons at 55.21 ppm and the valine a-carbon proton at 54.91 ppm. 
Hydrogenolysis o f 69 using 10% activated palladium on carbon in tetrahydrodrofuran 
under an atmosphere of hydrogen gave 70. The product was purified by HPLC using 
water and acetonitrile as solvents. Care was taken not to use 0.01% trifluoroacetic acid 
in water as an eluent as the glycolic acid ester was found to be acid labile. The ’H NMR 
spectrum of the purified product showed resonances for the glycolic acid a-carbon 
protons at 54.36 and 54.64 ppm and the valine a-carbon proton at 54.63 ppm.
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Thionyl Chloride 
Methanol
Benzoyl Chloride 
Triethylamine 
Ethyl Acetate
Benzyl Bromoacetate 
Potassium Carbonate 
Acetone
Hydrogen 
10% Palladium 
on Carbon 
Tetrahydrofuran
70
Figure 28. Synthesis of (^-(AZ-Benzoyl-fSJ-valyOglycolic Acid 70
The melting point recorded for N-benzoy\-(S)-vaYme 68 corresponded closely with that 
recorded in the literature indicating that racemisation up to this point in the synthesis 
had not taken place. The conditions used in the above synthesis of 64 were found not to 
cause racemisation. The methods used to install the glycolate moieties as part of the 
syntheses of 64 and 70 were similar. This, along with the fact that 70 was synthesised 
from chirally pure starting materials and was optically active with a rotation of -12.5° 
lead to the assumption that it was the single enantiomer.
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1.2.5 A/-Benzoyl-(S)-valylglycine 72
yV-Benzoyl-(S)-valylglycine 72 was synthesised as outlined in Figure 29.
Glycine tert-Butyl Ester 
BOP
OH Diisopropylethylamine 
Dichloromethane
68
Trifluoroacetic Acid 
Dichloromethane
u
72
Figure 29. Synthesis of A/-Benzoyl-(S)-valylglycine 72
Compound 68 was synthesised following the method described above (Figure 28). N- 
Benzoyl-^-valine 68 was then stirred in dichloromethane along with BOP, 
diisopropylethylamine and glycine tert-butyl ester to give dipeptide 71. The resonances 
in the 'H NMR spectrum of the product for the glycine a-carbon protons at 83.85 and 
84.04 ppm, the ?cr/-butyl ester protons at 81.46 ppm and the valine a-carbon proton at 
84.55 ppm indicated the coupling to have proceeded. Compound 71 was then 
deprotected by stirring in a mixture of dichloromethane and trifluoroacetic acid, 
removing the tert-butyl group. The 'H NMR spectrum of the product 72 did not display 
a resonance for tert-butyl ester protons in the region of 81.46 ppm indicating the 
deprotection to have been successful. The conditions selected for the reaction of 68 to 
give 71 are known to cause negligible levels of racemisation.63 Furthermore, the 
conditions used to deprotect 71 to give 72 would not be expected to cause racemisation.
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Therefore, as 72 was synthesised from chirally pure A^-benzoyl-(5')-valine 68 and was 
optically active with an optical rotation of -32.2°, it was assumed that it was present as 
a single enantiomer.
1.2.6 A^-Benzoyl^SJ-valinamide 73
A^-BenzoyHSTvalinamide 73 was synthesised as shown in Figure 30.
Figure 30. Synthesis of Af-BenzoyKSJ-valinamide 73
/V-BenzoyHSFvaline methyl ester 67, synthesised by the method described in Figure 
28, was treated with ammonia to give the amide 73. The absence of resonances that 
could be attributed to methyl ester protons in the *H NMR spectrum of the product in 
the region of Ö3.77 ppm along with a peak at m /z  221.1 in the electrospray mass 
spectrum for the protonated molecular ion and m /z  243.1 for the sodiated molecular ion 
indicated the reaction to have been successful. The melting point of compound 67 was 
86 °C which corresponded with that provided in the literature for AM)enzoyl-GS)-valine 
methyl ester 67 (86 °C )66 Therefore as 73 was synthesised from the chirally pure 67 and 
the conditions used would not be expected to cause racemisation, 73 was assumed to be 
a single enantiomer. However, 73 was required purely for its retention time in UV- 
HPLC analysis and so the nature of its chiral centre was of no consequence to these 
studies.
44
Chapter 1. Results and Discussion
1.2.7 (^-(DecanoyOglycolic Acid 76
Oa-(Decanoyl)glycolic acid 76 was synthesised as illustrated in Figure 31.
74
Benzyl Bromoacetate 
Potassium Carbonate 
Acetone
Hydrogen
10% Palladium on Carbon 
Tetrahydrofuran
v
76
Figure 31. Synthesis of (^-(Decanoyljglycolic Acid 76
Decanoic acid 74, benzyl bromoacetate and potassium carbonate in acetone were heated 
at reflux overnight to give benzyl Oa-(decanoyl)glycolate 75. The !H NMR spectrum of 
the product displayed resonances for the benzylic protons at 55.19 ppm and the 
glycolate a-carbon protons at 54.65 ppm. Hydrogenolysis of 75 by stirring in a 
suspension of 10% palladium on carbon in tetrahydrofuran under an atmosphere of 
hydrogen gave Oa-(decanoyl)glycolic acid 76. The absence of a benzylic proton 
resonance in the region of 55.19 ppm in the 'H NMR spectrum of the product indicated 
the deprotection to have been successful.
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1.2.8 ^-(Benzoyljglycolic Acid 79
The synthesis of Ou-(benzoyl)glycolic acid 79 is shown below in Figure 32. Benzoic 
acid 77 in acetone along with benzyl bromoacetate and potassium carbonate were 
heated at reflux overnight to give compound 78. A benzylic protons’ resonance at 55.20 
ppm and glycolate a-carbon protons’ resonance at 54.86 ppm were observed in the *H 
NMR spectrum of the product. Hydrogenolysis of compound 78 by stirring in a 
suspension of 10% palladium on carbon in tetrahydrofuran under an atmosphere of 
hydrogen gave the free acid 79. The absence of a benzylic protons’ resonance in the 
region of 55.20 ppm in the 'H NMR spectrum of the product indicated the reaction to 
have been successful.
Benzyl Bromoacetate 
Potassium Carbonate 
Acetone
77
O
79
Hydrogen
10% Palladium on Carbon 
Tetrahydrofuran
OH
O
Figure 32. Synthesis of C^-fBenzoylJglycolic Acid 79
1.2.9 3-(A/-Acetylphenylalanyl)propionic Acid 85
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The synthesis o f 3-(iY-acetylphenylalanyl)propionic acid 85 is illustrated below in 
Figure 33. ./V-AcetyHSFphenylalanine 80, purchased from Aldrich Chemical 
Company, was stirred in tetrahydrofuran along with M ’-carbonyldiimidazole to give 
the intermediate 81 which was then treated in situ with a solution of lithium tert-butyl 
acetate in tetrahydrofuran to give 82. The !H NMR spectrum of the product displayed 
resonances for the tert-butyl ester protons at 51.45 ppm and the phenylalanine a-carbon 
proton at 54.92 ppm indicating the reaction to have been successful. Compound 82 was 
then stirred in tetrahydrofuran along with sodium hydride followed by treatment with a 
solution of benzyl bromoacetate in dichloromethane to give 83 as a mixture of 
diastereomers. The 'H NMR spectrum of the product displayed resonances for the tert- 
butyl ester protons at 51.37 and 51.40 ppm, the phenylalanine a-carbon protons at 54.04 
and 54.22 ppm and the benzyl ester benzylic protons at 55.08 and 55.10 ppm indicating 
the reaction to have proceeded. Compound 83 was then stirred in a solution of 
dichloromethane and trifluoroacetic acid and heated to reflux overnight to give 84. The 
absence o f resonances characteristic of tert-butyl ester protons in the 'H NMR spectrum 
o f the product in the region o f 51.37 or 51.40 ppm indicated the deprotection to have 
been successful. Hydrogenolysis of compound 84 by stirring in a suspension of 10% 
palladium on carbon in tetrahydrofuran under an atmosphere of hydrogen gave the free 
acid 85. The ’H NMR spectrum of the product did not display resonances characteristic 
o f benzyl ester benzylic protons in the region o f 55.08 or 55.10 ppm indicating the 
deprotection to have proceeded. Although the synthesis of 85 began with chirally pure 
/V-acetyl-(S)-phenylalanine 80, it was not optically active and was probably therefore a 
racemate. Racemisation during the synthesis of 85 was most likely due to the use of the 
strong bases, sodium hydride and lithium diisopropylamine, as reagents.
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1,1 ’-Carbonyldiimidazole 
Tetrahydrofuran______
80
i) Sodium Hydride 
Tetrahydrofuran
ii) Benzyl Bromoacetate 
Dichloromethane
Trifluoroacetic Acid
Dichloromethane
Reflux
v
tert-Butyl Lithium 
Diisopropylamine 
tert-Butyl Acetate 
n Tetrahydrofuran
Hydrogen
10% Palladium on Carbon 
Tetrahydrofuran
Figure 33. Synthesis of 3-(A/-Acetylphenylalanyl)propionic Acid 85
48
Chapter 1. Results and Discussion
1.3 Relative Rates of Bromination, Radical Stablisation 
Energies and PAM Activity
As covered in the Introduction, rates of bromination of glycine derivatives and related 
compounds using NBS were to be used in the development of PAM inhibitors. The 
systems that were investigated for their rates of bromination are illustrated in Figure 34.
Figure 34. Systems Investigated for their Rates of Bromination.
The relative rates of bromination for compounds 1, 4, 61 and 86 - 89 were obtained 
from the literature.“ ’ ’ However the bromination of 59 had not been studied. The 
treatment of methyl Ou-(benzoyl)glycolate 59 with NBS is illustrated in Figure 35 along 
with that of its glycine analogue 61.
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Figure 35. Reaction of /V-Benzoylglycine Methyl Ester 61 and 
Treatment of Methyl CP-Benzoylglycolate 59 with NBS
Compound 59 was stirred in carbon tetrachloride with NBS and the mixture was heated 
to reflux under irradiation from a 300W sun lamp. A sample of the crude solution was 
dissolved in deuterated chloroform and analysed by ’H NMR spectroscopy. The 'H 
NMR spectrum displayed resonances for the starting material 59 and no evidence for 
the formation of its a-brominated analogue. In order to eliminate the possibility that 
this result was caused by a contaminant inhibiting bromination, a competitive 
experiment was performed. Compound 59 along with 61 was treated with NBS under 
the same conditions as the previous experiment. A sample of the crude solution was 
dissolved in deuterated chloroform and analysed by 'H NMR spectroscopy. The 'H 
NMR spectrum showed a resonance at 86.68 ppm characteristic of the a-carbon proton 
of 90 whilst there was no evidence of reaction of 59. Therefore, the relative rate of 
bromination of 59 was determined to be < 0.005. The relative rates of bromination of 
59 along with those for compounds 1, 4, 61 and 86 - 89 are provided in Table 1. Since 
the reactions involve radical brominations, with hydrogen atom transfer from the carbon 
adjacent to the ester group of each substrate determining the relative rate at which the
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compound is brominated, the relative rates of reaction correspond to the relative ease of 
formation of the radicals 2, 5, 91, 92 and 93b - 96b illustrated in Figure 36.
Table 1. Relative Rates of Reaction of the Amino Acid Derivatives 1, 4, 59, 61 
and 86 - 89 with NBS to give the Corresponding Radicals 2, 5, 95b, 91, 92, 
93b, 94b and 96b
Compound
Relative Rate of 
Reaction
61 1.0a
86 0.256
1 1.2b
4 0.05b
87 0.33®
88 <0.005d®
59 <0.005®
89 <0.005®
aAssigned as unity. öData from reference 27. cData
from reference 68. dData from reference 21. eNo
detectable bromination.
For comparison with the relative rates of bromination o f 1, 4, 59, 61 and 86 - 89 and the 
relative ease of formation of the radicals 2, 5, 91, 92 and 93b - 96b (Figure 36) in those 
reactions, RSEs for the radicals 2, 5 and 93a - 96a (Figure 36) were determined (Table 
2).
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O
2 R = CH3 
91 R = C6H5
O
5 R = CF3 
92 R = C6F5
93a R = CH3 
93b R = C6H5
O
o
95a R = CH3 
95b R = C6H5
94a R = CH3 
94b R = C6H5
O
o
96a R = CH3 
96b R = C6H5
Figure 36. Radicals Investigated either for their RSEs (2, 5 and
93a -  96a ) or their Ease of Formation in Bromination Reactions 
(2, 5, 91,92, and 93b-96b).
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Table 2. RSEsa [0 K, RMP2/G3large, kJ mol'1] of Derivatives of Glycyl and 
Related Radicals
Radical RSE
2 79.1
5 69.9
93a 78.8
94a 39.9
95a 44.4
96a 34.9
•C H 2C 0 2M e 20.2
M eC O N H C H 2* 41.3
M e C 0 2C H 2* 17.1
"Radical stabilisation energies (RSEs) were calculated as the 
energy change in the isodesmic reaction R* +  CH4 —> RH +
*CH3. The RSEs correspond to the differences between the 
bond dissociation energies (BDEs) of methane and RH,25’26'68 
and reflect the stability of R* compared with *CH3, relative
to the corresponding closed-shell systems. These RSEs 
correspond to values at 0 K.
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As discussed in the Introduction, RSEs relate the stability of the radicals in question to 
that of the methyl radical (relative to the corresponding closed shell species), with a 
more stable radical having a more positive RSE.25,26,68 The geometries and zero-point 
vibrational energies were determined at the B3-LYP/6-3 lG(d) level, while improved 
relative energies were obtained by carrying out single-point calculations on these 
optimised structures at the RMP2 level with the 6-311+G(2df,p) and G31arge basis 
sets.69 The results quoted in Table 2 correspond to RMP2/G31arge//B3-LYP/6-31G(d) 
RSEs at 0 K. The radicals 91, 92 and 93b -  96b (Figure 36) were not studied because 
their aryl groups would substantially increase the complexity of the calculations. The 
acetamides 93a -  96a were examined instead of the benzamides 93b -  96b. The effect 
of different acyl groups was examined with only 2 and 5 and not 91 and 92.
The data compiled in Tables 1 and 2 were to be used to investigate whether relative 
rates of bromination and RSEs of various compounds could be related to PAM activity 
towards comparable systems. To this end the kinetic parameters that describe the 
activity of PAM towards a number of suitable compounds (illustrated in Figure 37) 
were obtained either through assay with the enzyme or from literature sources.
In Figure 37 the acetamides 97a,b, the ßßß-trifluoroalanines 98a,b, the glycolates 64, 
70, 76, 79, 100a and 103a, the glycines 72, 99, 100b, 101, 102 and 103b and the y-keto 
acids 85 and 104 are illustrated. The kinetic data for the interactions of compounds 
97a,b, 99, 100a,b, 101, 102 and 103a,b with PAM were obtained from the 
literature 4,61,67 The kinetic parameters for the interactions of 64, 70, 72, 76, 79, 85, 
98a,b and 104 with PAM were unknown and therefore had to be obtained through assay 
with the enzyme. The assays of 64, 70, 72, 76, 79, 85, 98a,b and 104 with PAM were
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performed using modified literature procedures as outlined in the Experimental.13'1470
The results of the assays of compounds 64, 70, 72, 76, 79, 85, 98a,b and 104 with PAM
along with the literature data for compounds 97a,b, 99, 100, 101a,b, 102, 103a,b and
104 are supplied in Table 3.
97a R = CH3 98a diastereomer 1
97b R = CF3 98b diastereomer 2
O
79 X = O 
99 X = NH
100a X = 0  
100b X = NH 64 X = 0  
101 X = NH
103a X = O
103b X = NH 85 104
Figure 37. Systems Investigated for their Activity with PAM.
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Table 3. Kinetic Parameters for Interactions of Various Substrates and 
Inhibitors with Peptidylglycine a-Amidating Monooxygenase
Compound
W/,app QJM
min1 mg'1) ^M.app (mM) K\ (mM) IC50a (mM)
97a 6.4 '’ 9.3* - -
97b 1.4/7 4 A b - -
99 6.5 '’ 1.3* - -
100b 5.6 '' 0.0079* - -
101 3.3" 0.0012" - -
72 - 0.03 - -
102 12.6* 0.1* - -
103b OO io c
s
0.096" - -
98a Inhibitor - - 5
98b Inhibitor - - 5
64 Inhibitor - - 0.05
70 Inhibitor - - 0.5
76 Inhibitor - - 0.04
79 Inhibitor - - 0.25
100a Inhibitor - 0.0452" -
103a Inhibitor - 0.0598" -
85 Inhibitor - - 3
104 Inhibitor - - 6
"Corresponds to loss of 50% of the catalytic activity of PAM in processing the substrate 
(/?)-tyrosyl-(5')-valylglycine at a concentration of 0.1 mM, under conditions where the
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^M.app for the substrate is 0.2 mM. Although ATi.app, K\ and IC50 values are not directly 
comparable as measures of enzyme binding affinity, they are adequate as used in this 
thesis to establish that compounds interact with PAM. '’’Data from reference 4. ‘ Data 
from reference 61.
The data for the glycine derivatives 97a,b and 99, and the glycolate 79 allow for a 
direct comparison with the rates of bromination of the analogous esters 1, 4, 61 and 59 
and the stability and ease of formation of the corresponding radicals 2, 5, 91 and 95b. 
The properties of the glycolates 64, 70, 76, 79, 100a and 103a and the analogous 
glycine derivatives 101, 72, 102, 99, 100b and 103b allow for further analysis of the 
relationships between these two classes of compounds. It was not feasible to examine 
the interaction of the free acids jV-benzoyl-ßßß-trifluoroalanine or 3-benzoylpropionic 
acid with PAM for comparison with the glycine derivative 99, due to their anticipated 
poor enzyme-binding affinities. Instead the effect o f these substitutions was explored 
using the trifluoroalanine derivatives 98a,b and the y-keto acids 85 and 104 and relating 
their behaviour to that of the analogous glycinated dipeptide derivatives 100b and 
103b.
The above results for rates of bromination, RSEs and PAM activity w ill now be 
discussed.
1.4 Relationship Between Relative Rates of Bromination, 
Radical Stabilisation Energies and PAM Activity
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A-Acetyl-, trifluoroacetyl-, benzoyl-, and pentafluorobenzoyl-glycine methyl ester 1, 4, 
61 and 86 differ only in their /V-acyl substituents. In their reactions with NBS, the 
benzamide 61 is 4 times more reactive than the pentafluorobenzamide 86, and the 
acetamide 1 is 24 times more reactive than the trifluoroacetamide 4 (Table 1). These 
relative reactivities can be attributed to differences between the 7t-electron-donating 
abilities of the various amido groups, to stabilise and therefore facilitate formation of 
the corresponding radicals 91, 92, 2 and 5. The inductively electron-withdrawing 
fluorines of the pentafluorobenzamide 86 and the trifluoroacetamide 4 decrease the 
extent of resonance stabilisation of the radicals 92 and 5, relative to those radicals 91 
and 2 derived from the non-halogenated precursors 61 and 1, respectively. This effect 
of the fluorines is reflected in the calculated RSEs in the cases of the radicals 2 and 5, 
where the trifluoroacetamide 5 is less stable than the acetamide 2 by 9.2 kJ m ol1 (Table 
2). The fluorines also exert an inductive effect that decreases the pK ds of the carboxylic 
acid analogues of the amido groups, due to stabilisation of the corresponding 
carboxylate anions (the p/fas of benzoic acid, pentafluorobenzoic acid, acetic acid, and 
trifluoroacetic acid are 4.2, 1.5, 4.8 and 0.6, respectively71). As a result, there is a 
strong correlation between the effect of the fluorines on the relative reactivity of the 
glycine derivatives 61, 86, 1 and 4, the relative acidity of the acids, and the RSEs of the 
radicals 2 and 5. The effect of the fluorines on the reactivity of 61, 86, 1 and 4 and the 
acidity of the corresponding carboxylic acids is greatest with the trifluoroacetamide 4 
and trifluoroacetic acid, relative to the acetamide 1 and acetic acid, respectively.
In analogous systems, the fluorines have a related impact on the interactions of N -  
acetylglycine 97a and jV-trifluoroacetylglycine 97b with PAM. They decrease the 
overall rate of turnover (Vivi.app) °f 97b relative to 97a, via the corresponding glycyl
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radicals, by a factor of 4.5 (Table 3). Consequently, the correlation of the differences 
between RSEs of the /V-acetyl- and trifluoroacetyl-glycyl radicals 2 and 5, the relative 
rates of bromination of yV-acetyl- and trifluoroacetyl-glycine methyl ester 1 and 4, and 
the pKas of acetic acid and trifluoroacetic acid extends to the relative rates of the 
enzyme-catalysed reactions of A-acetyl- and trifluoroacetyl-glycine 97a and 97b. The 
fluorines reduce the RSE of the radical 5 (by 9.2 kJ mol'1), the rate of bromination of 
the ester 4 (by a factor of 24), the pA'a of trifluoroacetic acid (by 4.2 units), and the rate 
of turnover of the acid 97b by the enzyme (by a factor of 4.5). By way of comparison, 
replacing the acetyl substituent of /V-acetylglycine methyl ester 1, /V-acetylglycine 97a, 
and acetic acid with the benzoyl group of /V-benzoylglycine methyl ester 61, /V- 
benzoylglycine 99 and benzoic acid 77 has relatively little effect on any of these 
properties. It decreases the rate of bromination of the ester 61 by a factor of only 1.2, 
decreases the pKa of benzoic acid 77 by only 0.6, and changes the rate of the enzyme 
catalysed reaction of the acid 99 by less than 2%.
The effect of the fluorines, although reducing the rate of turnover, is clearly insufficient 
to prevent the PAM catalysed reaction of /V-trifluoroacetylglycine 97b. On the basis of 
the calculations with the /V-acetyl- and trifluoroacetyl-glycyl radicals 2 and 5, this 
indicates that a reduction in the RSE of 9.2 kJ m ol1 is not sufficient to stop glycyl 
radical formation by the enzyme. This is consistent with reductions in the RSEs of 
alanyl and threonyl radicals relative to those of the corresponding glycyl radicals of 0.3 
and 7-14 kJ m ol1, respectively,21'72 being too small to prevent the enzyme-catalysed 
reactions of alanine and threonine derivatives.60 The effect of the trifluoromethyl 
substituent on the stability of the trifluoroalanyl radical 94a is much larger, reducing the 
calculated RSE relative to that of the corresponding glycyl radical 2 by 39.2 kJ m ol1
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(Table 2). The substituent also prevents bromination of /V-benzoyl-ß,ß,ß-
trifluoroalanine methyl ester 88 (Table 1) and the processing of the trifluoroalanine 
containing dipeptides 98a,b by PAM (Table 3). 7/-Benzoyl-ß,ß,ß-trifluoroalanine 
methyl ester 88 was inert on treatment with /V-bromosuccinimide, either alone or as a 
mixture with A-benzoylglycine methyl ester 61, that nevertheless reacted smoothly to 
give the corresponding a-bromoglycine derivative 90. There was no evidence of 
reaction of either of the trifluoroalanine-containing dipeptides 98a or 98b being 
catalysed by PAM, even though competitive experiments with (/?)-tyrosyl-(lS)- 
valylglycine established that both 98a and 98b bind to the enzyme, albeit with IC50 
values of around 5 mM (Table 3). It is therefore apparent that the decrease in RSE 
brought about by introducing the trifluoromethyl group is sufficient to prevent radical 
formation by PAM. However, this does not give effective enzyme inhibitors, as the 
trifluoromethyl substituent prevents tight binding to the enzyme. This is seen from the 
IC50 value of 5 mM for each of the trifluoroalanine derivatives 98a and 98b. As an 
indirect comparison, the AAupp value of the corresponding glycine derivative 100b is 
7.9 pM.
In a manner similar to the effect of introducing the trifluoromethyl group, replacing the 
glycine moiety with glycolate, which is a simple substitution of the glycine NH by O, 
reduces the RSE of the glycolyl radical 95a compared with that o f the corresponding 
glycyl radical 2 by 34.7 kJ mol'1 (Table 2). This can be attributed to the decreased n -  
electron-donating and increased o-electron-withdrawing ability o f the acetoxy group of 
95a relative to the acetamido substituent o f 2, as reflected in the RSEs of the radicals 
MeCONHCH2* and MeCCEC^* of 41.3 and 17.1 kJ m o l1, respectively.73 The effect is 
magnified in the captodatively stabilised74 73 glycyl and glycolyl radicals 2 and 95a
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where the extent of synergy displayed by the acetamido and acetoxy substituents in 
combination with the carboxyl group corresponds to 17.6 and 7.1 kJ mol"1. These 
values are based on the differences between the RSEs of MeCONHCPE’ (41.3 kJ mol'1), 
'CH 2C 0 2Me (20.2 kJ mol'1), and 2 (79.1 kJ m o l1) and M eC 02CH2’ (17.1 kJ mol"1), 
*CH2C 0 2Me, and 95b (44.4 kJ m o l1), respectively. The substitution of glycine by 
glycolate prevents bromination of methyl (9a-benzoylglycolate 59 (Table 1). It also 
prevents catalysis of the reactions of the glycolates 64, 70, 76, 79, 100a and 103a by 
PAM (Table 3). The glycine derivatives 101, 72, 102, 99, 100b and 103b are all turned 
over by the enzyme, but there is no evidence of reaction of the corresponding glycolates 
64, 70, 76, 79, 100a and 103a. In this case substitution does not severely disrupt 
binding to the enzyme. The IC50 and K\ values of the glycolates 64, 70, 76, 79, 100a 
and 103a are all in the 0.04-0.5 mM range. The corresponding glycine derivatives 101, 
72, 102, 99, 100b and 103b have A'M.app values between 1 pM and 1 mM. Therefore, the 
glycolates constitute a general class of inhibitors of the enzyme because they do not 
readily undergo hydrogen atom transfer, yet they bind effectively to PAM, the further 
implication being that the substitution of the terminal glycine of tight binding PAM 
substrates with glycolate should yield inhibitors of the enzyme with high binding 
affinity.
Replacing the acylglycine with a y-keto acid or ester, through substitution of the glycine 
NH by CH2, has similar effects to the swapping of glycine for glycolate. The RSE of 
the keto ester radical 96a is less than that of the analogous glycyl radical 2 by 44.2 kJ 
mol' 1 (Table 2). The y-keto ester 89 is inert to bromination (Table 1), and the y-keto 
acids 85 and 104 are not processed by PAM (Table 3), even though, unlike the example
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reported previously, “ these keto acids 85 and 104 do bind to some extent with the 
enzyme, with IĈ o values of 3 and 6 mM, respectively. Again it is apparent that a 
reduction in the RSE of around 35-45 kJ m ol1 is sufficient to stop both the bromination 
with NBS and the catalysis by the monooxygenase.
From the Kwi.app values of the glycine derivatives 100b and 103b of 7.9 and 96 pM, 
respectively, the K\ values of the corresponding glycolates 100a and 103a of 45.2 and 
59.8 pM, and the IC50 values of the analogous y-keto acids 85 and 104 of 3 and 6 mM 
(Table 3), it appears that the replacement of an acylglycine with a y-keto acid has a 
more adverse effect on the binding to PAM than does the substitution of glycine by 
glycolate.
1.5 Comparisons of the Binding Strengths of PAM Substrates 
and ßßß-Trifluoroalan'me, Glycolate and y-Keto Acid Enzyme 
Inhibitors and the Implications for Inhibitor Design
The substitution of the acylglycine of a typical PAM substrate with a trifluoroalanine or 
y-keto acid results in a reduction in binding affinity to the enzyme. This loss of binding 
affinity with PAM was not observed for the conversion of the acylglycine of the PAM 
substrates 101, 72, 102, 99, 100b and 103b to their equivalent glycolates 64, 70, 76, 79, 
100a and 103a, respectively. The poor binding affinity of the a-trifluoromethyl systems 
98a and 98b can be rationalised as being due to the intolerance of PAM towards 
increased steric bulk on the a-carbon of glycine. However an understanding of the
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reasons that acylglycines and acylglycolates exhibit similar binding affinities for PAM, 
whilst the y-keto acids do not requires more consideration.
In the Introduction, the features of a crystal structure of PAM with bound substrate 
(Figure 3) were discussed. The crystal structure indicated that the acylglycine NH was 
acting as a hydrogen bond donor to the enzyme through interactions with an asparagine 
residue’s side chain amide. The ability of glycolates to bind effectively to PAM may be 
due to hydrogen bonding interactions between a glycolate ester O and the side chain 
amide of the same asparagine residue. In this case, the asparagine side chain amide 
would be acting as a hydrogen bond donor (Figure 38).
Figure 38. Hypothesised Hydrogen Bond Interaction 
between a Glycolate Ester Oxygen and the Side Chain 
Amide of an Asparagine Residue in the PHM Active Site.
A y-keto acid possesses a methylene at the position which is equivalent to an 
acylglycines amido NH. This methylene could not form a hydrogen bond such as 
illustrated in Figure 38, therefore reducing a y-keto acid’s binding strength in 
comparison to analogous glycines and glycolates.
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However it has been hypothesised that hydrogen bonds such as illustrated in Figure 38 
have a minimal contribution to the overall binding strength of a substrate or inhibitor 
with an enzyme.76 In the absence of bound substrate or inhibitor, PAM would be fully 
hydrated, with all possible hydrogen bonds in the active site being formed either 
between amino acids or between residues and water. As was covered in the 
Introduction, the asparagine (N316, Figure 3) must break a hydrogen bond with a 
neighbouring tyrosine (Y318, Figure 3) in order to form a new hydrogen bond with the 
glycine amido NH of bound substrate. Therefore, there may be no net change in overall 
energy. I f  this is the case, further therories are required to rationalise why acylglycines 
and acylglycolates exhibit similar binding affinities for PAM, whilst the y-kcto acids do 
not.
The hybridisation of a secondary carbon radical is sp" adopting a trigonal planar 
geometry. a-Carbon centred glycyl radicals preferentially adopt near planar 
orientations. It is therefore likely that PAM, in order to reduce the activation energy 
required for the formation o f an a-carbon centred glycyl radical, binds its substrates in a 
complimentary way. As a result o f the conjugation of the amide NH of an acylglycine 
and the analogous ester O of an acylglycolate, in each case there is free rotation only 
around the bonds to the a-carbon. In the case of a y-keto acid there is free rotation 
around the bonds to the a- and ß-carbons. This may allow acylglycines and 
acylglycolates to adopt conformations which are closer to the planar conformation 
preferred by the enzyme than a y-keto acid. Further, assuming that acylglycines, 
acylglycolates and analogous y-keto acids bind to PAM with similar orientations, and
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that the planarity of the amide and ester groups of acylglycines and acylglycolates is 
maintained, there would be a greater degree of conformational constraint and loss of 
entropy on binding of a y-keto acid. A direct comparison of the kinetic parameters that 
describe the interactions of the glycines 100b and 103b and their analogous glycolates 
100a and 100b and y-keto acids 85 and 104 with PAM along with the bond angles of 
their atoms which are at the position of (or equivalent position to) an acylglycines 
amido N (Figure 39 and Table 4), may help to elucidate a further theory.
Figure 39. PAM Inhibitors and Substrates for Comparison of 
Bond Angles and Binding Affinities
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Table 4. Binding Affinities of Compounds and Relevant Bond 
Angles
Angle (a-N-C(O) or
Compound IC5o/Kr|/KM,app
analogue)
100a 0.0452a 115
100b 0.0079b 120
85 3C 109.6
103a 0.0598a 115
103b 0.0096d 120
104 6e 109.6
105 0 .001a 120
106 0.16b 120
IC5o and K\ values are quoted as mM concentrations. Data 
for 85, 100a,b, 103a,b and 104 taken from Table 3, 
Apparent K\ value obtained from reference 13, bK\ value 
obtained from reference 13. Bond angles are quoted as 
those typical of sp2 and sp3 hybridised atoms77,78 and were 
not calculated via computational methods.
The nitrogen of amides and ether oxygens of esters are known to be sp2 hybridised, 
adopting trigonal planar geometries.78 The acyglycine N of 100b and 103b is sp2 
hybridised, adopting a trigonal planar geometry with bond angles to the adjacent 
carbons of 120°. In the equivalent position to an acylglycines N, the glycolates 100a 
and 103a possess an oxygen atom which is sp" hybridised, also adopting a trigonal
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planar geometry with bond angles to the adjacent carbons of 115°. These compounds, 
100a,b and 103a,b possess binding affinities with PAM of 0.0452, 0.0079, 0.0598 and 
0.096 mM respectively (Table 4). The inhibitors 85 and 104 possess, at the position 
equivalent to an acyglycines N, a carbon atom that is sp hybridised adopting a 
tetrahedral geometry with a bond angle between the adjacent carbons of 109.6°. The 
IC50S °f 85 and 104 of 3 and 6 mM respectively, are significantly higher than the A ŝ of 
the corresponding glycines and glycolates 100a,b and 103a,b (Table 4). Therefore a 
reduction in binding affinity of two to three orders of magnitude is incurred when the 
sp“ hybridised atoms in 100a,b and 103a,b, that are at the position (or equivalent) of an 
acylglycines N, are substituted for an sp hybridised carbon. The simple inhibitors 105 
and 106 possess carbon atoms at the equivalent position to an acyl-glycines N which 
are sp“ hybridised and possess a trigonal planar geometry with bond angles to the 
adjacent carbons of 120°. The binding strengths of 105 and 106 to PAM are 0.001 and 
0.16 mM, respectively. Although their binding affinities with PAM are not directly 
comparable with those of 100a,b, 103a,b, 85 and 104, the fact that such simple systems 
with sp“ hybridised atoms at the equivalent position to an acylglycines N, exhibit 
tighter binding than the more complex 85 and 104 may be significant. It was therefore 
hypothesised that the poor binding affinities exhibited by 85 and 104 to PAM may be 
due to the change in geometry that is incurred when substituting an acylglycine with a 
y-keto acid, thereby resulting in the displacement of the recognition points required for 
tight binding with the enzyme. As a result it seems apparent that PAM is tolerant of the 
substitution of an acylglycines NH, providing that the geometry of the new substituent 
does not significantly deviate from an sp2 hybridised trigonal planar conformation.
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Chapter 2. a-Substituted Glycines for the Controlled 
Hydrolytic Release of C-Terminal Amidated Peptide 
Hormones.
2.1 Project Rationale
The PAM enzyme was discussed in the Introduction with respect to its role in the 
production of C-terminal amidated peptide hormones. Chapter 1 of the Results and 
Discussion outlined the development of inhibitors of this enzyme with the aim to their 
use in the treatment of conditions resultant from an over-production of hormones. 
However, a deficiency of peptide hormones can also lead to various disease states. 
Such disease states are commonly treated through the direct administration of peptide 
hormones or suitable analogues.34 For example, growth hormone is administered in the 
treatment of cardiac failure, sepsis, burns, cancer cachexia, end-stage renal failure, 
trauma and AIDs.35 The somatostatin analogues, octreotide, lanreotide and vapreotide 
are used clinically in the treatment of pituitary and gastrointestinal cancers. The need 
for the development of hormone prodrugs, which, upon administration to a patient, 
slowly release active hormones in a controlled manner was outlined in the Introduction.
The C-terminal amide of peptide hormones is essential to their bioactivity,1 and as such 
it constitutes an appropriate site to block in the design of hormone prodrugs. However, 
any method used to block the C-terminal amide of peptide hormones would need to 
allow for the eventual liberation of the hormone. a-Substituted glycines that hydrolyse
68
Chapter 3. Results and Discussion
slowly at biological pH to release amides were proposed as suitable masking groups 
which could be used for this purpose. The conjugation of peptide hormones through 
the linking of their C-terminal amide with molecules such as large polymers, antibodies 
and immunotoxins has also been proposed as a suitable approach towards the 
development of hormone prodrugs. To this end, a-substituted glycines which 
hydrolyse in a controllable manner at biological pH were proposed as potentially 
suitable systems that could be used to transiently link peptide hormones with other 
molecules. The intention of these studies was to determine whether the rate of 
hydrolysis o f a-substituted glycines in aqueous solution to release amides might be 
controlled through the variation o f the glycine a-substituent.
2.2 Synthesis of a-Substituted Glycine Derivatives
A variety of compounds were required in order to investigate the extent to which the 
rate o f hydrolysis o f a-substituted glycines to release amides in aqueous solution might 
be controlled through variation o f the glycine a-substituent. /V-Benzoyl-a- 
hydroxyglycine 7 and /V-benzoyl-a-hydroxyglycine methyl ester 8 used in these studies 
were donated as generous gifts.79,80 The synthesis o f the other systems chosen for 
investigation w ill now be outlined.
2.2.1 A/-Benzoyl-a-acetoxyglycine Methyl Ester 14
The synthesis of /V-benzoyl-a-acetoxyglycine methyl ester 14 is depicted in Figure 40. 
N-benzoylglycine methyl ester 61 and NBS in carbon tetrachloride were heated with 
stirring at reflux whilst being irradiated by a 300W sun lamp. The bromide 90 was
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then treated in situ with sodium acetate to give 14. The jH NMR spectrum of the 
product displayed resonances for the a-carbon proton at 56.77 ppm, the methyl ester 
protons at 53.81 ppm and the acetyl protons at 52.77 ppm indicating the reaction to 
have been successful.
A/-Bromosuccinimide 
Carbon Tetrachloride 
hv
Sodium Acetate
O O
O
A
Figure 40. Synthesis of A/-Benzoyl-a-acetoxyglycine 
Methyl Ester 14
2.2.2 A/-Benzoyl-a-methoxyglycine Methyl Ester 17
The synthesis o f N-benzoyl-a-methoxyglycine methyl ester 17 is now described 
(Figure 41). The bromide 90, synthesised as described above, was treated in situ with a 
solution of methanol and diisopropylethylamine to give 17. The ’H NMR spectrum of 
the product displayed resonances for the a-carbon proton at 55.77 ppm, the methyl 
ester protons at 53.81 ppm and the a-methoxy protons at 53.50 ppm.
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Figure 41. Synthesis of A/-Benzoyl-a-methoxyglycine 
Methyl Ester 17
2.2.3 A/-Benzoyl-a-ethoxyglycine Methyl Ester 19
The synthesis of /V-benzoyl-a-ethoxyglycine methyl ester 19 is illustrated in Figure 42. 
The bromide 90, synthesised as illustrated in Figure 40, was treated in situ with a 
solution of ethanol and diisopropylethylamine to give 19. Excess 
diisopropylethylamine was added to act as an acid scavenger to prevent acid catalysed 
transesterification of the methyl ester of 19 with ethanol. The jH NMR spectrum of the 
product displayed resonances for the a-carbon proton at 85.85, the methyl ester protons 
at 83.85, the ethoxy methyl and the ethoxy methylene protons at 81.25 and 83.79 ppm, 
respectively.
Figure 42. Synthesis of A/-Benzoyl-a-ethoxyglycine 
Methyl Ester 19
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2.2.4 A/-Benzoyl-a-phenoxyglycme Methyl Ester 21
The synthesis o f iY-benzoyl-a-phenoxyglycine methyl ester 21 is depicted in Figure 43.
21
Figure 43. Synthesis of A/-Benzoyi-a-phenoxyglycine 
Methyl Ester 21
The bromide 90, synthesised as described above, was treated in situ with a solution of 
phenol and diisopropylethylamine in carbon tetrachloride to give 21. The ’H NMR 
spectrum of the product displayed resonances for the u-carbon proton at Ö6.44 ppm and 
the methyl ester protons at 83.85 ppm. The electrospray mass spectrum o f the product 
showed a peak for the protonated molecular ion at m/z 286 and the sodiated molecular 
ion at m/z 308 providing further evidence for the success of the synthesis.
2.2.5 /V-Benzoyl-a-succinimidoglycine Methyl Ester 22
The synthesis of iV-benzoyl-a-succinimidoglycine methyl ester 22 is shown in Figure 
44. The bromide 90, synthesised as illustrated in Figure 40, was treated in situ with a 
solution of succinimide and diisopropylethylamine in carbon tetrachloride to give 22. 
The 1 FT NMR spectrum o f the product displayed resonances for the a-carbon proton at
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56.77 ppm, the methyl ester protons at 53.81 ppm and the succinimido methylene 
protons at 52.78 ppm.
Succinimide 
Diisopropylethylamine 
Carbon Tetrachloride
Figure 44. Synthesis of A/-Benzoyl-a-succinimidoglycine 
Methyl Ester 22
2.3 Hydrolysis of a-Substituted Glycines to Release 
Benzamide
Solutions o f the a-substituted glycines 8, 14, 17, 19, 21 and 22 were made up in 25% 
acetonitrile and 75% 50 mM carbonate buffer (made up in deuterated water at pD 4.4, 
7.9 and 10.4; pD corresponds to pH + 0.4) and were incubated at 37 °C. The hydrolysis 
experiments were analysed by 'H NMR spectroscopy. The starting concentration of 8 
was 5 mM, whilst the starting concentrations of 14, 17, 19, 21 and 22 were 20 mM. 
This was to aid analysis, due to the hydrolysis reactions of 14, 17, 19, 21 and 22 
producing more products, at lower concentrations, than those formed during the 
reaction of 8.
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The aim o f these studies was to develop a-substituted glycines that would hydrolyse to 
release amides in a slow and controlled manner in vivo and so hydrolysis experiments 
were performed on the a-substituted glycines 8, 14, 17, 19, 21 and 22 at pH 7.5 to 
approximate biological conditions. Studies were also performed at pH 4.0 and 10.0 to 
investigate their reactions over a range of pH. No evidence for the hydrolysis of 8, 14, 
17, 19, 21 or 22 at pH 4.0 was obtained over three weeks of reaction monitoring, 
indicating that their half-lives at this pH are conservatively greater than 500 hours 
corresponding to pseudo-first order rate constants o f <4 x 10 7 sec1. The estimation of 
the psuedo-first order rate constants for the hydrolysis of 8, 14, 17, 19, 21 and 22 at pH 
4.0 was calculated from Equation 1 (where ty2 is 18 x 10‘ seconds (504 hours)). A 
hypothesis as to why no reactions were observed for the hydrolysis of 8, 14, 17, 19, 21 
or 22 at pH 4.0 is provided later in this Chapter.
Equation 1. ty2 = \nl/k
The !H NMR spectra obtained for the hydrolysis o f 8 at pH 7.5 and 10.0 over three 
weeks showed evidence for the hydrolysis of 8 to give benzamide 10. A 'H NMR 
spectrum of the pH 10.0 reaction solution after 30 minutes is provided in Figure 45.
The 'H NMR spectrum illustrated in Figure 45 displays resonances for the a-carbon 
proton of 8 at 55.52 ppm. The resonances at 55.21 ppm and 54.88 ppm were attributed 
to the a-carbon proton of 7 and the acetal proton of 108, respectively by spiking of the 
reaction solution with authentic samples.79 The resonances at 55.33 and 53.61 ppm 
were assigned to the a-carbon and methyl ester protons of the acetal 107 respectively.
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These resonances were also observed in the 'H NMR spectra obtained during the 
hydrolysis reaction of 8 performed at pH 7.5, although they formed at different rates.
hydroxyglycine Methyl Ester 8 at pH 10 after 30 Minutes.
In order to investigate the kinetics of the hydrolysis of 8 at pH 7.5 and 10.0, 'H NMR 
spectra were taken after various reaction times. The integration of the characteristic 
resonances of 7, 8, 107 and 108 at 65.21, 65.52, 65.33 and 64.88 ppm, respectively, was 
used to determine the ratios/concentrations of the individual components. From 
analysis of the 'H NMR spectra it was apparent that the hydrolysis of 8 at pH 7.5 and 
10.0 proceeded via two separate pathways (Figure 46). Firstly, 8 hydrolysed to give 
benzamide 10 and hydrated methyl glyoxylate 107 {ki). Alternatively 8 hydrolysed to
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give the free acid 7 (^2) which then reacted further to give the amide 10 and 108 (£3). 
As these studies were concerned with the control of the rate of release of amides from 
a-substituted glycines, the hydrolysis of 107 to give 108 (£4) will not be discussed in 
detail. A description of the methods used to determine the combined rate constant k\ + 
k2, and the pseudo-first order rate constants k\ and ki for the hydrolysis of 8 and £3 for 
the hydrolysis of 7 at pH 7.5 follows.
Figure 46. Routes for Hydrolysis of 8 at pH 7.5 and 10.0
A graph of ln([A]/[A]o) versus time (where [A] is the concentration of 8 at a given time 
and [A]o is the original concentration of 8) for the hydrolysis of 8 at pH 7.5 was plotted 
(Figure 47). The rate constant for the consumption of starting material (k\ + ^2) was 
determined from the gradient of the line of best fit. The individual values of k\ and k2 
were determined from the ratio of the concentrations of 107 and 7 respectively after 30 
minutes, as no concentration of 108 could be detected by this time. A graph of 
ln([A]/[A]o) versus time (where [A] is the concentration of 7 at a given time and [A]o is 
the concentration of 7 after 11.25 hours) is illustrated in Figure 48. The zero point 
concentration ([A]o) of 7 was taken at 11.25 hours as by this time the amount of 8 
remaining was negligible and so no significant amount of 7 was being produced. The
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rate of hydrolysis of 7 to give 10 and 108 (£3) was then determined from the gradient of 
the line of best-fit in Figure 48. A similar method was used to determine the combined 
rate constant k\ + k2, and the pseudo-first order rate constants k\ and ki for the 
hydrolysis of 8 and k3 for the hydrolysis of 7 at pH 10.0. The combined rate constants 
k\ -1- k2 and the psuedo-first order rate constants k\ and ki for the hydrolysis reaction of 8 
to give 10 and ki for the reaction of 7 to give 10 at pH 7.5 and 10.0 are provided in 
Tables 5 and 6, respectively.
5000
^  - 0.2
y = -9.0E-05X - 5.6E-02 
^  R2 = 9.7E-01>. -0.3
Time (seconds)
Figure 47. Plot of ln([A]/[A]0) versus Time (seconds) for the 
Degradation of 8 at pH 7.5
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Figure 48. Plot of ln([A]/[A]0) versus Time (seconds) for the 
Degradation of 7 at pH 7.5
Table 5. Rate Constants k^+k2 and k̂  -  k3 for the Hydrolysis of 8 
at pH 7.5 Along with Corresponding Half-lives for the Consumption 
of 8 and the Hydrolysis of 7 to Give the Amide 10 .
Rate Constant sec'1
Half-life
(hrs)
k: + k2 9.0 x 10'5 2.1
3.6 x 10‘5 -
k2 5.4 x 10'5 -
kz 3.3 x 10'5 5.8
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Table 6. Rate Constants k^+k2 and k̂  -  k3 for the Hydrolysis of 8 
at pH 10.0 Along with Corresponding Half-lives for the 
Consumption of 8 and the Hydrolysis of 7 to Give the Amide 10 .
Rate Constant sec'1
Half-life
(hrs)
Ai + k2 2.6 x 10'4 0.64
5.8 x 10'5 -
k2 1.9 x 10‘4 -
k3 5.4 x 10'5 3.5
The psuedo-first order rate constants k\ and k3 relate to the release of amide 10 from 8 
and 7 respectively. Their values of 3.6 x 10° sec 1 (k\) and 3.3 x 10 s sec 1 (k3) provided 
in Table 5 are very similar, indicating that there is minimal difference between the rates 
of release of 10 from 8 or 7 at pH 7.5. However, the rate constant k2 was found to 
increase 3.5 fold when increasing the pH from 7.5 to 10.0, which would be expected for 
the base catalysed hydrolysis of a methyl ester. No marked increase in k\ or k3 was 
observed between reactions at pH 7.5 and 10.0, indicating minimal base sensitivity. 
The amide 10 can be considered to be a poor leaving group, in accordance with its pA'a 
which could reasonably be expected to be similar to that o f acetamide (15.0).43 The 
cleavage mechanism of 8 and 7 to release the amide 10 most likely involves the 
deprotonation o f the a-hydroxy group and the protonation of the amide upon leaving in 
a concerted manner. Therefore, as this step requires a basic proton abstraction and an 
acidic protonation, it is not suprising that the hydrolysis reactions of 8 and 7 to give 10 
show little base sensitivity over this range of pH.
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In independent experiments, Bundgaard et a/.41 determined the half-lives for the 
hydrolysis reactions of 7 and 8 to give the amide 10 at pH 7.4 to be 6.7 and 0.78 hours 
respectively (Figure 49). However, no explanation was provided as to why the methyl 
ester 8 hydrolysed 8.6 times faster than the free acid 7. The half-life of the hydrolysis 
of 7 to give 10 at pH 7.5 (Table 5) of 5.8 hours is comparable with the value obtained 
by Bundgaard et al.41 of 6.7 hours at pH 7.4. However, the half-life determined from 
the psuedo-first order rate constant k\ for the hydrolysis of 8 to give 10 at pH 7.5 (Table 
5) of 5.3 hours is in contradiction to the value quoted by Bundgaard et a/.41 of 0.78 
hours at pH 7.4. Although the pH used by Bungaard et al.4{ for these experiments was 
7.4 rather than 7.5, this would not be expected to result in such a large difference in 
reaction rate for the hydrolysis of 8 to give 10. It seems likely that this discrepancy is 
due to Bundgaard et al.4{ having monitored starting material consumption rather than 
amide production. The results for the hydrolysis of 8 at pH 7.4 reported by Bundgaard 
et al.41 were obtained by monitoring the rate of starting material consumption by UV- 
HPLC. However, this method of reaction monitoring for the hydrolysis of 8 would be 
following both the direct release of the amide 10 (k \) and the saponification of 8 to give 
the free acid 7 (fo). Thus, the half-life for the release of 10 from 8 at pH 7.4, as 
reported by Bungaard et a l 4] is actually the value of the combined rate constant, k\ + kz, 
and as such it is invalid with respect to the rate of the direct release of amide 10 (k\). 
Indeed the reaction scheme for the hydrolysis of 8 illustrated in the paper published by 
Bundgaard et a l41 (represented in Figure 49) does not depict hydrolysis of the methyl 
ester of 8 to give the free acid 7. The combined rate constant k\ + £2 for the hydrolysis 
of 8 at pH 7.5 provided in Table 5 corresponds to a half-life of 2.1 hours which is 2.8 
times longer than the rate of hydrolysis of 8 at pH 7.4 reported by Bundgaard et al.41 
This error may be due to the different experimental conditions used, however, it
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remains apparent that the previously published rate of hydrolysis of 8 to give 10 in the 
region of pH 7.5 was incorrect and has now been addressed.
Figure 49. Reactions Schemes for the Hydrolysis of 8 and 7 and 
their Half-lives as Reported by Bundgaard et al.41 in Independent 
Experiments.
The proposed use of a-substituted glycines to transiently link peptide hormones with 
other molecules has been outlined in the Introduction. The mechanism of hydrolysis of 
the a-acetoxyglycine 14 involved the formation of the a-hydroxyglycine 8 followed by 
hydrolysis to release the amide 10 (Figure 15). Accordingly it would be expected that 
the a-substituted glycines 17, 19, 21 and 22 would also hydrolyse to release the amide 
10 via the formation of an a-hydroxyglycine intermediate. The a-hydroxyglycine 
methyl ester 8 can be considered to be a system where a methyl group and a benzoyl 
group are transiently linked by an a-hydroxyglycine residue. The a-hydroxyglycine 7 
can be considered to be a system where benzamide 10 is masked by a-hydroxyglycine. 
As outlined above, rates of hydrolysis of 7 and 8 to release 10 at biological pH reported 
by Bundgaard et a/.41 differed by a factor of 8.6. This implied that the hydrolysis of a-
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substituted glycines would be significantly different when used to transiently link 
peptide hormones with other molecules in comparison to when they were being used to 
mask hormone C-terminal amides. However, the rates of hydrolysis of 7 and 8 to 
release 10 at pH 7.5 (outlined above) have been found to be essentially identical. 
Therefore the studies of the a-substituted glycines 14, 17, 19, 21 and 22 outlined below 
can be considered to be suitable for modelling both the hydrolysis of their a-substituted 
glycine residues when being used as amide masking agents and as transient linkers 
between molecules.
The hydrolyses of the a-substituted glycines 14, 17, 19, 21 and 22 in aqueous solution 
at pH 7.5 and 10.0 were then performed using the method described above. Due to the 
complexity of the 'H NMR spectra obtained for the hydrolysis of 22, UV-HPLC was 
used to analyse these reactions. The concentration of 22 used for the reactions 
monitored by UV-HPLC was 1 mM, all other conditions remained the same as 
described above. The results of these experiments are summarised in Table 7 and a 
description of how these values were obtained follows.
The hydrolysis of 14 at pH 7.5 and 10.0 to the a-hydroxyglycine 8 was extremely rapid 
such that 100% of the starting material had reacted within the time required to begin 
reaction monitoring. Therefore the half-lives of 14 at pH 7.5 and 10.0 were estimated 
to be <2 minutes (Table 7). Correspondingly the psuedo-first order rate constant for the 
hydrolysis of 14 to give 8 must be >5 x 10" sec" . The mechanism of hydrolysis of 14 
at basic pH is illustrated in Figure 50. The hydrolysis of 14 to give 109 followed by 
110 was a possibile outcome of this experiment and as such is depicted in Figure 50,
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however, this was not observed as the rate of conversion of 14 to 15 was too fast. The 
a-hydroxyglycines 8 and 7 formed during this reaction hydrolysed to release benzamide 
10 in accordance with the mechanism illustrated in Figure 46.
Figure 50. Mechanism of Hydrolysis of 14 at pH 7.5 and 10.0
The 'H NMR spectra obtained for the reactions of 17 and 19 in aqueous solution at pH 
7.5 and 10.0 over three weeks showed only the hydrolysis o f their methyl esters to give 
their respective free acids 16 and 18 and no evidence for the release of amide 10 was 
observed. Therefore, the half-lives for the hydrolysis reactions to release the amide 10 
from 16 and 18 at pH 7.5 and 10.0 must be >500 hours (Table 7). Correspondingly, the 
psuedo-first order rate constants of these reactions must be <4.0 x 10'7 sec1.
The 'H NMR spectra obtained for the hydrolysis o f the a-succinimidoglycine 22 
performed at pH 7.5 and 10.0 showed the formation of new resonances, although none 
were attributable to the methyl ester 8 or the free acid 7. Evidence for the formation of
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the amide 10 was not observed. It is likely that at pH 7.5 and 10.0 the succinimido ring 
of 22 is hydrolysing to give the new species 113, the proposed routes to which is 
illustrated in Figure 51. The hydrolysis of 22 could give the ring opened intermediate 
111 followed by saponification to give 113. Alternatively, saponification of 22 may 
yield 112, followed by hydrolysis to produce 113. Evidence for the formation of 113 
was obtained by electrospray mass spectrometry o f the reaction solution, which showed 
a peak for the protonated molecular ion at m/z 277. As no evidence for the formation of 
the amide 10 was observed, the half-life for the hydrolysis o f 113 to release 10 must be 
conservatively >500 hours, corresponding to a pseudo-first order rate constant <4.0 x 
10"7 sec"1.
112 H 3
Figure 51. Mechanism of Hydrolysis of 22 at pH 7.5 and 10.0
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Traces obtained by UV-HPLC of the reactions of 21 at pH 7.5 and 10.0 are provided in 
Figures 52 and 53. The peaks in Figures 52 and 53 with a retention time of 5.6 minutes 
are attributable to the starting material 21. Through comparison to the UV-HPLC trace 
of an injection of an authentic sample, the peak with a retention time of 2.9 minutes 
was assigned to the amide 10. The peak with a retention time of 4.0 minutes in Figure 
52 and 3.9 minutes in Figure 53 was assigned to phenol through comparison to the 
retention time and UV-absorbance profile of the peak in a UV-HPLC trace of an 
injection of an authentic sample. The peak with a retention time of 5.0 minutes was 
assumed to be the free acid 20 as it possessed the same UV absorbance profile as the 
starting material 21. Furthermore, this peak was larger in the UV-HPLC traces in 
Figure 53 than in Figure 52, which would be consistent with increased base catalysed 
methyl ester hydrolysis at pH 10.0 in comparison to pH 7.5. This peak in Figures 52 
and 53 never reached a substantial size, indicating that 20 did not reach a high 
concentration during the hydrolysis of 21 at pH 7.5 and 10.0. This was consistent with 
the 'H NMR spectra obtained during the hydrolysis of 21 at pH 7.5 and 10.0, which 
also did not show any significant evidence for the formation of 20. Therefore, any 
effect that that rate of hydrolysis of 21 to give 20 might have on the calculated rate of 
formation of 8 from the rate of starting material consumption would not be substantial. 
The rate of formation of 8 from 21 at pH 7.5 and 10.0 was therefore estimated from the 
rate of starting material consumption and the values are provided in Table 7.
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Figure 52. UV-HPLC Traces (225 nm) Obtained During the Hydrolysis of 
21 at pH 7.5, A = 5 min, B = 35 min, C = 65 min and D = 155 min
Figure 53. UV-HPLC Traces (225 nm) Obtained During the Hydrolysis 
of 21 at pH 10.0, A = 5 minutes, B = 20 minutes and C = 155 minutes
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The half-lives for the hydrolysis of 21 to release the a-hydroxyglycine 8 at pH 7.5 and 
10.0 were estimated to be 0.40 hours and 0.08 hours respectively (Table 7). The 
psuedo-first order rate constants for the hydrolysis of 21 to give the a-hydroxyglycine 8 
at pH 7.5 and 10.0 were therefore estimated to be 4.7 x 10 4 sec’1 and 2.4 x 10 3 sec’1 
respectively by applying the corresponding half-lives to Equation 1. The yield of 
amide 10 from the hydrolysis of 21 at pH 10.0 and 7.5 was found to be quantitative 
through comparison of the area of the peak for 10 in reaction UV-HPLC traces to that 
in the UV-HPLC trace of an injection of a standard solution of an authentic sample. 
Therefore the hydrolysis of 22 to give 10 was found to be efficient and high yielding. 
The routes for hydrolysis of 21 at basic pH is illustrated in Figure 54. This is derived 
from the proposed ways in which the a-acetoxyglycine 14 hydrolyses (Figure 50). The 
hydrolysis of 21 to produce the a-hydroxyglycines 8 and 7 was proposed to have 
proceeded via the yV-acyliminium ions 15 (directly) and 110 (indirectly). The a- 
hydroxyglycines 8 and 7 then hydrolysed further to ultimately release the amide 10 in 
accordance with the mechanism illustrated in Figure 46.
Figure 54. Mechanism of Hydrolysis of 21 at pH 7.5 and 10.0.
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Table 7. Half-lives of 14 , 16 , 18 , 21 and 113 at 
pH 7.5 and 10.0 in Aqueous Solution.
Compound pH 7.5 pH 10.0
14 <2 min <2 min
16 >504 hrs >504 hrs
18 >504 hrs >504 hrs
113 >504 hrs >504 hrs
21 0.40 hrs 0.08 hrs
The hydrolysis reactions of 8, 14, 17, 19, 21 and 22 to release the amide 10 at pH 4.0 
were unsuccessful. The mechanism of hydrolysis o f 8, 14, 17, 19, 21 and 22 at acidic 
pH would most likely involve the protonation of the amide and release of the amide 
tautomer 114 as illustrated in Figure 55. This may not readily occur at pH 4.0 thus 
explaining the resistance of 8 , 14, 17, 19, 21 and 22 to hydrolysis under these 
conditions.
8 R = Hydroxy 
14 R = Acetoxy 
17 R = Methoxy 
19 R = Ethoxy
21 R = Phenoxy
22 R = Succinimido
Figure 55. Proposed Mechanism of Hydrolysis of the a- 
Substituted Glycines 8 , 14, 17 , 19 , 21 and 22 to Release Amide 
10 at Acidic pH.
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The hydrolysis o f the a-acetoxyglycine 14 at pH 7.5 and 10.0 to form the a- 
hydroxyglycine 8 was very fast with a half-life of <2 minutes. This was rationalised in 
accordance with acetate being a good leaving group, resulting in the reaction of 14 to 
give the A-acyliminium ion 15 being very fast. Although the hydrolysis o f 14 at pH 7.5 
and 10.0 gave 8 which then hydrolysed to release benzamide 10, the rate of conversion 
of 14 to 8 was too fast. Therefore, a-acetoxyglycines would be unsuitable to use as 
hydrolytically cleavable masking groups of the C-terminal amide of peptide hormones, 
or to transiently link hormones with other molecules. The hydrolysis reactions o f the a- 
methoxyglycine 17 and the a-ethoxyglycine 19 at pH 7.5 and 10.0 formed only their 
respective free acids 16 and 18. By analogy to the mechanism of hydrolysis of 14, the 
hydrolysis o f 16 and 18 to give the a-hydroxyglycine 7 would have to involve the 
formation of the A-acyliminium ion 110. However, this would involve the elimination 
of methoxide from 16 and ethoxide from 18. As both 16 and 18 did not hydrolyse to 
release the a-hydroxyglycine 7, methoxide and ethoxide must be too inefficient as 
leaving groups to allow the A-acyliminium ion 110 to form, even over extended periods 
o f time. The hydrolysis o f the a-succinimidoglycine 21 at pH 7.5 and 10.0 was 
unsuccessful with respect to the release of the amide 10. The reaction of 21 at pH 7.5 
and 10.0 was found to give the ring opened product 113. The hydrolysis o f 113 to give 
the a-hydroxyglycine 7 would have to involve the formation of the A-acyliminium ion 
110. Acetamide is considered a poor leaving group in accordance with its pKa of 
15.0.43 The a-carbon substituent of 113 can be considered to be analogous to acetamide 
and as such it would also be a poor leaving group. Therefore, as the hydrolysis o f 113 
at pH 7.5 and 10.0 to release the amide 10 was unsuccessful, the a-carbon substituent of 
113 must be too inefficient as a leaving group to allow for the formation of the A- 
acyliminium ion 110. The hydrolysis o f the a-phenoxyglycine 21 at pH 7.5 and 10.0 to
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release benzamide 10 was successful. The half-lives for the release of the a- 
hydroxyglycine 8 from the hydrolysis of a-phenoxyglycine 21 at pH 7.5 and 10.0 were 
0.40 and 0.08 hours respectively. This result was rationalised in accordance with the 
pÄ’a of phenol (10.0)43 being sufficient to allow phenoxide to be eliminated from 21 
resulting in the formation of the /V-acyliminium ion 15. A discussion of how the results 
for the hydrolysis of 14, 18, 19, 21 and 22 at pH 7.5 and 10.0 relate to each other 
follows.
The pKas of ethanol, methanol, acetamide, phenol and acetic acid are 17.5, 15.0, 15.0, 
10.0 and 4.0, respectively.43 This reflects the ability of ethoxide, methoxide, acetamide, 
phenoxide and acetate to stabilise a negative charge which increases in the order 
ethoxide < methoxide, acetamide < phenoxide < acetate. Their efficiencies as leaving 
groups therefore increase in the same order. The a-phenoxyglycine hydrolysed at pH 
7.5 and 10.0 faster than the a-alkoxyglycines 16 and 18 and slower than the a- 
acetoxyglycine 14. This correlates with the p o f  phenol being lower than for 
methanol and ethanol and higher than for acetic acid. It is therefore apparent that the 
rate of hydrolysis of a-substituted glycines at pH 7.5 and 10.0 is related to the pA'a of 
the a-substituents corresponding acid. Therefore, the initial hypothesis that the rate of 
hydrolysis of a-substituted glycines could be controlled through variation of the a- 
substituents was correct.
The aim of this research was to increase the time required for amides to be 
hydrolytically released from a-substituted glycines. The half-life of the a- 
phenoxyglycine 21 at biological pH was 0.40 hours. Therefore, it would be reasonable 
to expect that, the use of a-phenoxyglycine as a hydrolytically cleavable masking group
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of the C-terminal amide of clinically administered peptide hormones would allow 
suitable time for drug dispersal and transport across cell membranes before exposure of 
the active drug form. Methods by which the rate of hydrolysis of a-substituted glycines 
to release amides could be extended further will be outlined in the Future Work and 
Conclusions section of this thesis.
Chapter 3. 2-Nitrophenylalanine - a
Photochemically Cleavable Amino Acid for Efficient 
Amide Release Under Biological Conditions.
3.1 Project Rationale
In Chapter 2 of the Results and Discussion, research towards the development of a- 
substituted glycines as hydrolytically cleavable amide masking groups or as systems 
that could be used to transiently link the C-terminal amide of peptide hormones to other 
molecules was outlined. As covered in the Introduction, the development of 
photocleavable amino acids that could be used for similar purposes is warranted. Npg 
40 has been used to mask the C-terminal amide of peptide hormones and to transiently 
link amides with other molecules, however, its photolysis at biological pH is known to 
be inefficient.51'32,82 It was reasoned that Npg photolysis was inefficient at biological 
pH due to the formation of a-hydroxy intermediates such as 46 (Figure 21) which 
would be slow to hydrolyse under these conditions.
91
Chapter 3. Results and Discussion
The photolysis of the NPEOC 31 (Figure 18) did not involve the formation of reaction 
intermediates which would be expected to be slow to breakdown at biological pH. It 
was therefore hypothesised that 2-nitrophenylalanine derivatives, which were designed 
through analogy to NPEOC, would photolyse more efficiently at biological pH in 
comparison to Npg. The potential applications of the photolysis of 2- 
nitrophenylalanine derivatives include, light activated peptide hormone drugs for use in 
PDT, site-selective photochemical proteolysis, photoprobe research, peptide hormone 
synthesis and the release of molecules from solid support. Therefore, studies were 
performed to determine whether 2-nilrophenylalanine derivatives could be photolysed 
to unmask amides.
3.2 Synthesis of 2-Nitrophenylalanine Peptidic Systems and 
Analogues
A variety of compounds were required in order to investigate the potential photolysis of 
2-nitrophenylalanine derivatives to unmask amides. A-Benzoyl-(/?,^-valine purchased 
from Aldrich Chemical Company was used throughout the syntheses described in this 
Chapter. The synthesis o f the systems chosen for investigation w ill now be outlined.
3.2.1 A/-Benzoylvalyl-2-nitrophenylalanine Methyl Ester 119
The synthesis of A-benzoylvalyl-2-nitrophenylalanine methyl ester 119 is now 
described (Figure 56).
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NH
i) Sodium 
Ethanol
ii) 1-Bromomethyl-2-nitrobenzene 
Benzene
O O
115
HN O
Hydrochloric Acid 
Reflux
Thionyl Chloride 
Methanol
BOP
Dichloromethane
Diisopropylethylamine
A/-Benzoylvaline
Figure 56. Synthesis of A/-Benzoylvalyl-2-nitrophenylalanine 
Methyl Ester 119
Diethyl 2-acetamidomalonate 115 was stirred in a solution of sodium ethoxide in 
ethanol and treated with l-bromomethyl-2-nitrobenzene in benzene to give 116. The 
‘id NMR spectrum of the product showed resonances for the acetyl protons at 81.16 
ppm and the aromatic protons at 87.25 -  7.90 ppm. Compound 116 was heated to 
reflux in concentrated hydrochloric acid to give 2-nitrophenylalanine 117. The ’H
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NMR spectrum of the product showed resonances for the 2-nitrophenylalanine a- 
carbon proton at 54.35 ppm and the ß-carbon protons at 53.42 and 53.67 ppm 
respectively. 2-Nitrophenylalanine 117 was stirred in methanol which had been 
pretreated with thionyl chloride to give 118. The appearance of the methyl ester 
protons’ resonance at 53.71 ppm in the H NMR spectrum of the product indicated the 
reaction to have been successful. 2-Nitrophenylalanine methyl ester 118 was stirred in 
dichloromethane along with BOP, diisopropylethylamine and yV-benzoylvaline to give
119 as diastereomers in a ratio of 1:4 as determined by 'H NMR spectroscopy. The 'H 
NMR spectrum o f the product showed resonances for the valine a-carbon proton at 
54.91 ppm and methyl ester protons at 53.70 and 53.76 ppm.
3.2.2 A/-Benzoyl-2-nitrophenylalanylalanine Methyl Ester 122
The synthesis of yV-benzoyl-2-nitrophenylalanylalanine methyl ester 122 is now 
described (Figure 57). 2-Nitrophenylalanine methyl ester 118 was synthesised via the 
established method illustrated in Figure 56. The ester 118 was then heated at reflux in 
ethyl acetate along with benzoyl chloride and triethylamine to give compound 120. 
The 'H NMR spectrum of the product displayed resonances for the aromatic protons at 
57.48 -  7.92 ppm and the 2-nitrophenylalanine a-carbon proton at 55.10 ppm and the ß- 
carbon protons at 53.46 and 53.58 ppm. yV-Benzoyl-2-nitrophenylalanine methyl ester
120 was then saponified by stirring in aqueous sodium hydroxide and tetrahydrofuran 
to give the free acid 121. The 'H NMR spectrum of the product did not display any 
resonances characteristic o f methyl ester protons in the region o f 53.00 - 54.00 ppm 
indicating the deprotection to have proceeded. The free acid 121 was then stirred in 
dichloromethane along with BOP, diisopropylethylamine and alanine methyl ester,
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which was purchased from Aldrich Chemical Company, to give 122 as diastereomers in 
a 1:2 ratio as determined by 'H NMR spectroscopy. The appearance of resonances for 
the alanine a-carbon protons at 84.36 and 84.45 ppm, ß-carbon protons at 51.31 and 
51.39 ppm and methyl ester protons at 53.68 and 53.70 ppm in the 'H NMR spectrum 
of the product indicated the reaction to have proceeded.
Benzoyl Chloride 
Triethylamine 
Ethyl Acetate
Sodium Hydroxide 
Tetrahydrofuran
BOP
Alanine Methyl Ester
Diisopropylethylamine
Dichloromethane
Figure 57. Synthesis of A/-Benzoyl-2-nitrophenylalanylalanine 
Methyl Ester 122
3.2.3 A/-Benzoylvalyl-2-nitrophenylalanine 123
Af-Benzoylvalyl-2-nitrophenylalanine 123 was synthesised as depicted in Figure 58. N- 
Benzoylvalyl-2-nitrophenylalanine methyl ester 119 was synthesised as illustrated in
Figure 56 and then saponified by stirring in aqueous sodium hydroxide and
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tetrahydrofuran to give 123 as diastereomers in a ratio of 1:4 as determined by 'H NMR 
spectroscopy. The 'H NMR spectrum of the product did not display any resonances for 
methyl ester protons in the region of 53.70 - 53.76 ppm indicating the deprotection to 
have proceeded.
Sodium Hydroxide 
Tetrahydrofuran
Figure 58. Synthesis of A/-Benzoylvalyl-2-nitrophenylalanine 123
3.2.4 /V-^-NitrophenylethylJ-Af’-benzoylvalinamide 128
A^-(2-Nitrophenylethyl)-A^-benzoylvalinamide 128 was synthesised as depicted in 
Figure 59. 2-Phenylethylamine 124 was stirred in water along with acetic anhydride 
and triethylamine to give the amide 125. The 'H NMR spectrum of the product showed 
resonances for the acetyl protons at 51.93 ppm and the aromatic protons at 57.17 -  
57.33 ppm indicating the reaction to have proceeded. Nitration of compound 125 by 
stired in a mixture of nitric acid and sulfuric acid gave the two isomers, /V-acetyl-2-(2- 
nitrophenyl)ethylamine 126 and yV-acetyl-2-(4-nitrophenyl)ethylamine. The desired 
ortho isomer 126 was separated from N-acetyl-2-(4-nitrophenyl)ethylamine by HPLC. 
The ' f l  NMR spectrum of the product showed resonances for the protons of an ortho 
substituted aromatic ring in the region o f 57.67 -  8.78 ppm. Compound 126 was stirred 
in hydrochloric acid and the mixture was heated to reflux to give the amine 127. The 
'H NMR spectrum of the product did not display a resonance characteristic of acetyl
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protons in the region o f 51.97 ppm indicating the reaction to have been successful. 2- 
Nitrophenethylamine 127 was stired in dichloromethane along with BOP, 
diisopropylethylamine and /V-benzoylvaline to give /V-benzoylvalyl-2- 
nitrophenethylamide 128. The 'H NMR spectrum o f the product displayed resonances 
for the valine a -  and ß-carbon protons at 54.95 ppm and 52.10 ppm and the benzylic 
protons at 54.46 ppm.
124
Acetic Anhydride 
Water
Triethylamine
H
125
© ©
Cl HoN
Hydrochloric Acid 
Reflux
/V-Benzoylvaline
BOP
Dichloromethane
Diisopropylethylamine
v
128
Nitric Acid 
Sulfuric Acid
v
Figure 59. Synthesis of A/-(2-Nitrophenylethyl)-Af- 
benzoylvalinamide 128
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3.2.5 A/-Benzoylvalyl-2-nitropheny!alanylalanine Methyl Ester 129
/V-Benzoylvalyl-2-nitrophenylalanylalanine methyl ester 129 was synthesised as 
illustrated in Figure 60. Alanine methyl ester was stirred in dichloromethane along with 
BOP, diisopropylethylamine and the free acid 123 (the synthesis of 123 is described 
above in Figure 58) to give the tripeptide 129 as diastereomers in a ratio of 1:1:2:2.5 as 
determined by 'H NMR spectroscopy. The spectrum obtained by high resolution fast 
atom bombardment mass spectrometry of the product showed a peak for the protonated 
molecular ion at m/z 499.2186 which corresponds closely with the calculated accurate 
mass of m/z 499.2193.
123
Dichloromethane
BOP
Diisopropylethylamine 
Alanine Methyl Ester
129
Figure 60. Synthesis of A/-Benzoylvalyl-2- 
nitrophenylalanylalanine Methyl Ester 129.
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3.2.6 A/-Benzoylvalyl-2-nitro-4,5-dimethoxyphenylalanine Methyl Ester 133
A^-benzoylvalyl-2-nitro-4,5-dimethoxyphenylalanine methyl ester 133 was synthesised
as illustrated in Figure 61.
O '
i) Sodium 
Ethanol
ii) 1-Bromomethyl-2-nitro-4,5 
-dimethoxybenzene 
Benzene
Thionyl Chloride 
Methanol
BOP
t
/V-Benzoylvaline
Dichloromethane
Diisopropylethylamine
Hydrochloric Acid 
Reflux
v
131
Figure 61. Synthesis of A/-Benzoylvalyl-2-nitro-4,5- 
dimethoxyphenylalanine Methyl Ester 133.
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The malonate 115 was stirred in sodium ethoxide in ethanol and then treated with 1- 
bromomethyl-2-nitro-4,5-dimethoxybenzene in benzene to give 130. The 'H NMR 
spectrum o f the product displayed singlet resonances for the aromatic protons at 56.76 
and 57.57 ppm and the acetyl protons at 51.37 ppm. Compound 130 was heated at 
reflux in concentrated hydrochloric acid to give 2-nitro-4,5-dimethoxyphenylalanine 
131. The 'H NMR spectrum of the product displayed resonances for the a-carbon 
proton at 54.34 ppm, the ß-carbon protons at 53.39 and 53.72 ppm and the methoxy 
protons at 53.91 and 53.97 ppm. Compound 131 was stirred in methanol that had been 
pretreated with thionyl chloride to give the ester 132. The 'H NMR spectrum of the 
product displayed a resonance for the methyl ester protons at 53.98 ppm indicating the 
reaction to have proceeded. Compound 132 was stirred in dichloromethane along with 
BOP, diisopropylethylamine and 77-benzoylvaline to give the dipeptide 133 as 
diastereomers in a ratio o f 1:2 as determined by 'H NMR spectroscopy. The 'H NMR 
spectrum of the product displayed resonances for the valine a-carbon proton at 54.94 
ppm, along with the 2-nitrophenylalanine a-carbon proton at 54.56 and the ß-carbon 
protons at 53.28 and 53.51 ppm, respectively, indicating the reaction to have been 
successful.
3.3 Photolysis of 2-Nitrophenylalanine Systems and 
Analogues
The aim of these studies was to design an unnatural amino acid, which could be 
photolysed efficiently under biological conditions. Photolysis experiments were 
therefore performed in a solution containing 75% 50 mM HEPES buffer at pH 7.4. 
Due to the solubility requirements of the systems outlined in this chapter, 25%
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acetonitrile was also used. Photolysis experiments were performed at a concentration 
of 50 pM to minimise possible intermolecular interactions and internal filtering by 
reaction intermediates and side products. The irradiation of solutions was performed in 
a Luzchem Photoreactor using three different lamp types which emit radiation at 254, 
300 or 350 nm and the level of light flux was controlled by manipulation of the number 
of lamps used with the maximum number being ten. Although irradiating 2- 
nitrophenylalanine derivatives at 254, 300 and 350 nm would not be ideal in biological 
experiments, they are used in these studies for method and system development. 
Experiments were analysed by UV-HPLC at 225 nm through comparisons of injections 
of reaction mixtures with those of 50 pM standards of authentic samples of starting 
material and the amides to be released.
The anticipated mechanism of photolysis of the 2-nitrophenylalanine derivative 56 
(Figure 62) was derived from that of the NPEOC 31 (Figure 18). The irradiation of 56 
would give the diradical 134. The oxygen centered radical of 134 would then abstract a 
hydrogen atom from the benzylic carbon to give the diradical 135. After abstraction of 
a proton from the aci-nitro intermediate 136, which is a resonance form of 135, to give 
137, elimination of the amide 47 and a cinnamyl derivative 57 would occur.
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Figure 62. Anticipated Mechanism of 2-Nitrophenylalanine 
Photolysis. R = NH2) NHR\ OH, OR’
Initial studies to determine whether 2-nitrophenylalanine derivatives could be 
photolysed to release amides were performed on A^-benzoylvalyl-2-nitrophenylalanine 
methyl ester 119. In the Introduction it was outlined that the generation of the ad-nitro 
dianion 34 during NPEOC 31 photolysis was necessary for the desired cleavage 
mechanism to proceed (Figure 18). It was hypothesised that this process would be 
facilitated through the presence of a protic solvent, such as water, in the reaction media.
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/V-Benzoylvalyl-2-nitrophenylalanine methyl ester 119 was therefore selected for these 
initial studies as it possessed a suitable level of solubility in water.
A reaction scheme for the photolysis of 119 is illustrated in Figure 63. The photolysis 
of 119 was anticipated to release A-henzoylvalinamide 73 and the cinnamate 138 in 
accordance with the mechanism of photolysis of the 2-nitrophenylalanine derivative 56 
(Figure 62).
The photolysis o f 119 was performed using the conditions described above at 254 nm 
using 2 lamps. The UV-HPLC trace of the reaction solution after 55 minutes of 
irradiation and that for 50 pM standard solutions o f ALbenzoylvalinamide 73 and the 
starting material 119 are provided in Figures 64, 65 and 66, respectively.
Figure 63. Reaction Scheme for the Photolysis of 119
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Figure 64. UV-HPLC Trace of the Reaction Solution of N- 
Benzoylvalyl-2-nitrophenylalanine Methyl Ester 119 after 55 
Minutes of Irradiation at 254 nm using 2 Lamps
Figure 65. UV-HPLC Trace of a 50 pM Standard Solution of N- 
Benzoylvalinamide 73
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Figure 66. UV-HPLC Trace of a 50 pM Standard Solution of N- 
Benzoylvalyl-2-nitrophenylalanine Methyl Ester 119
The peak at 3.67 minutes in Figure 64 was of a similar retention time to that for 73 in 
Figure 65. Spiking of the reaction solution with an authentic sample of 73 resulted in 
an increase in the area of the peak at 3.67 minutes. Furthermore, the UV-absorbance 
profiles of the peaks at 3.67 minutes in Figure 64 and 3.60 minutes in Figure 65 were 
identical. Therefore the peak at 3.67 minutes in Figure 64 was assigned to 73 proving 
the photolysis of 119 to have been successful. It was anticipated that the photolysis of 
119 would also result in a large peak due to the formation of the 2-nitrocinnamate 138. 
However, no large peak was observed that could be assigned to the cinnamate 138. It 
was hypothesised that this might be a consequence of 138 being photoactive due to the 
presence of the nitro functionality, thereby resulting in its degradation via other 
photochemical pathways as yet not elucidated. Therefore, future studies of the 
photolysis of 2-nitrophenylalanine systems concentrated on the release of amides 
exclusively.
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The release of the amide 73 from the photolysis of 119 at 225, 300 and 350 nm using 1, 
10 and 10 lamps, respectively, was then studied through continuous reaction 
monitoring by UV-HPLC (Figure 67). The photolysis of 119 at 254 nm using 10 
lamps was found to give 73 in ~ 50% yield with complete loss of starting material after 
10 minutes. Therefore 1 lamp was used at this wavelength as the resultant slower rate 
of photolysis was more suitable for reaction monitoring.
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Figure 67. Release of Amide 73 from the Photolysis of 119 at 
254, 300 and 350 nm using 1,10 and 10 Lamps, Respectively.
The photolysis of 119 at 254, 300 and 350 nm gave yields of 73 of 80 -  100% over a 2 
hour period (Figure 67). The rate of amide 73 release at the three different wavelengths 
was found to be similar. In order to rationalise this result, the UV absorbance profile of 
119 was analysed (Figure 68). The UV-absorbance profile of 119 shows a maximum 
absorbance at 234 nm and minimal absorbance at 300 nm and above. Although only 1
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lamp was used at 254 nm and 10 lamps were used at 300 and 350 nm, the reaction rates 
were similar due to 119 having a larger level o f absorbance at 254 nm.
0.17!
0 .05
340.00 360.00220.00 240.00 260.00 280.00 300.00 320.00 380.00
Figure 68. Absorbance Profile of A/-Benzoy!valyl-2- 
nitrophenylalanine Methyl Ester 119
The high yields obtained for the photolysis o f 119 are significant when compared to 
those obtained by Henriksen et a l.53 for the photolysis of the Npg derivative 139 shown 
in Figure 69.
139 140 141
Figure 69. Photolysis of a 2-Nitrophenylglycine Derivative, R - N -  
Benzoylalanyl.
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The photolysis of the Npg 139 (Figure 69) was found to exhibit a large degree of pH 
dependence." At pH 9.5, a quantitative yield of amide 141 was observed over two 
hours of photolysis, however at pH 7.4 only 30% of 141 was produced over the same 
time period. As 100% of the starting material was consumed over two hours in both 
experiments, the poor yield of amide at biological pH is most likely due to the slow 
hydrolysis of the a-hydroxy intermediate 140. By contrast, the photolysis of 119 at pH 
7.4 gave yields of the amide 73 in the region of 70-80% after 1 hour and up to 100% 
after 2 hours (Figure 67). Therefore the photolysis of the 2-nitrophenylalanine 119 was 
more efficient than that of the Npg 139 at biological pH, indicating that photocleavage 
of 2-nitrophenylalanine is more efficient that Npg under these conditions. This is 
presumably due to their being no formation of intermediates that are slow to break 
down at biological pH during the photolysis of the 2-nitrophenylalanine 119.
In the Introduction, the use of photolysis to release biologically active molecules from 
inactive precursors in PDT and photoprobe research was discussed. It may be 
advantageous to such research if the rate of release of biologically active compounds 
from inactive precursors could be controlled through the manipulation of light intensity. 
In order to achieve such flexibility the rate of photochemical consumption of a 
biologically inactive precursor must be closely related to the release of the active form. 
In other terms, the rate determining step must be the initial photochemical step. This 
would require there to be no formation of intermediates during the photolysis of 2- 
nitrophenylalanine systems that have half-lives which are significantly longer than the 
rate of the initial photochemical step. In the Introduction, the mechanism of photolysis 
of Npg 41 was discussed with respect to the slow hydrolysis of the a-hydroxy 
intermediate 46 at biological pH (Figure 21). Therefore the rate of photolysis of Npg
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systems at biological pH cannot be enhanced through manipulation of light intensity or 
wavelength as the rate determining step is hydrolytic rather than photochemical. 
Studies were therefore performed to investigate the extent to which the manipulation of 
light intensity and wavelength influences the rate of amide release in 2- 
nitrophenylalanine derivative photolysis. This was performed by monitoring the effect 
that doubling the number of lamps used to photolyse 119 at 254 and 300 nm has on the 
rate of release of the amide 73 (Figure 70 and 71).
100%
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i  40%
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Figure 70. Release of Amide 73 Through Photolysis of 119 at 254
nm using 1 and 2 Lamps
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Figure 71. Release of Amide 73 Through Photolysis of 11S at 300 
nm using 5 and 10 Lamps.
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If the rate of amide production during 2-nitrophenylalanine photolysis is directly 
related to light intensity, a doubling of the number of lamps used would result in a two 
fold increase in the yield of 73 from 119 at any given time in the initial stages of the 
reaction. However, it is clear from the curves illustrated in Figures 70 and 71 that this 
was not the case. The photolysis of 119 at 254 nm using 1 lamp for 25 minutes gave a 
30% yield of 73 whilst increasing the number of lamps used to 2 resulted in only a 42% 
yield of 73 over the same time period. Similarly, the photolysis of 119 at 300 nm using 
5 lamps for 20 minutes gave a 35% yield of 73 whilst increasing the number of lamps 
to 10 resulted in only a 44% yield of 73 over the same time period. It was hypothesised 
that this discrepancy might be due to the formation of an intermediate during the 
photolysis of 119, the rate of breakdown of which was of a similar order to that of 
starting material consumption. To further investigate this theory the rate of
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consumption of 119 and production of amide 73 were compared at 254 nm using 1 and 
2 lamps (Figure 72).
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Figure 72. Consumption of 119 vs Amide 73 Production 
Through Irradiation at 254 nm using 1 and 2 Lamps. L = 
Lamp, SM = Starting Material
Through comparison of the curves in Figure 72, a discrepancy is observed between the 
rate of consumption of 119 and the respective rate of release of the amide 73. After 15 
minutes of irradiation, 20% and 40% of 119 was consumed using 1 lamp and 2 lamps, 
respectively. This indicated a ratio of 1:2 as expected i f  the rate of the loss of starting 
material during 2-nitrophenylalanine photolysis is directly related to the level o f light 
intensity used. However, after 15 minutes of irradiation a 19% and 28% yield of the 
amide 73 was obtained using 1 and 2 lamps, respectively. This indicated a ratio of
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1:1.5 as might be expected if the rate of amide release during 2-nitrophenylalanine 
photolysis is not directly related to the intensity of light used. Therefore although the 
rate of consumption of 119 appeared to be directly related to light intensity, the rate of 
amide 73 production was not. These results are consistent with the hypothesis that an 
intermediate is forming during the photolysis of 119 and that the rate of its breakdown 
is of a similar order to that of starting material consumption.
After photolysing 119 for 15 minutes at 254 nm using 1 lamp, a 19% yield of the amide 
73 was observed, whilst 20% of 119 had been consumed (Figure 72). This essentially 
constitutes a complete mass balance, indicating that any intermediate formed during the 
photolysis of 119 had reacted to completion before analysis of the reaction was 
performed. After 15 minutes of photolysis of 119 with 2 lamps the mass balance was 
approximately 75%. If all the intermediate had been produced at t = 0, this would 
correspond to 2 half lives and so ty2 would be equal to 7.5 mintues. However, as 
intermediate is continually being produced during irradiation, the half life must be 
significantly <7.5 minutes. Further discussion of this intermediate with respect to its 
structure, and implications to the photolysis of 2-nitrophenylalanine systems, is 
provided later in the chapter.
In order to extend the series of 2-nitrophenylalanine systems studied, the photolysis of 
yV-benzoyl-2-nitrophenylalanylalanine methyl ester 122 was performed. The reaction 
scheme for the photolysis of 122 is illustrated in Figure 73. The photolysis of 122 was 
expected to release benzamide 10 and the cinnamide 142.
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Figure 73. Reaction Scheme for the Photolysis of 122.
The photolysis of 122 was performed using the conditions described above at 254 nm 
using 2 lamps. A UV-HPLC trace of the reaction solution after irradiation for 70 
minutes along with that for 50 pM standard solutions of benzamide 10 and starting 
material 122 are provided in Figures 74, 75 and 76, respectively.
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Figure 74. UV-HPLC Trace of a Solution of /V-Benzoyl-2- 
nitrophenylalanylalanine Methyl Ester 122 after 70 Minutes of 
Irradiation at 254 nm using 2 Lamps.
Figure 75. UV-HPLC Trace of a 50 pM Standard Solution of 
Benzamide 10
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Figure 76- UV-HPLC Trace of a 50 pM Standard Solution of N- 
Benzoyl-2-nitrophenylalanylalanine Methyl Ester 122
The peak at 2.89 minutes in Figure 74 was assigned to benzamide 10 through 
comparison with an authentic sample by the established method used to identify the N- 
benzoylvalinamide 73 peak at 3.67 minutes in Figure 64. It was therefore apparent that 
the photolysis of 122 to release the amide 10 at 254 nm using 2 lamps was successful 
and so further studies of this reaction were performed. Compound 122 was photolysed 
at 254, 300 and 350 nm using 2, 10 and 10 lamps, respectively, and the rate of release 
of the amide 10 was plotted (Figure 77).
The highest yield of the amide 10 through the photolysis of 122 was obtained at 300 nm 
with 10 lamps, reaching 38%. The rate of release of benzamide 10 from the photolysis 
of 122 as illustrated in Figure 77 increases in the order 350<254<300 nm. The UV- 
absorbance profile of 122 is provided in Figure 78. Although 122 is more absorbent at 
254 nm than at 300 nm, the increased number of lamps used at 300 nm resulted in the 
rate of amide production being faster.
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Figure 77. Release of Benzamide 10 Through the Photolysis of
122 at 254, 300 and 350 nm using 2, 10 and 10 Lamps,
Respectively.
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Figure 78. Absorbance Profile of A/-Benzoyl-2-nitrophenylalanylalanine 
Methyl Ester 122
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As outlined above, the photolysis of 119 was believed to involve the formation of an 
intermediate, the breakdown of which was at a similar rate to that of starting material 
consumption. Through comparison of the plots for the photolysis of 122 and 119 in 
Figures 77 and 67, respectively, it can be seen that the rate of release of amide from 
122 was slower. It therefore seemed likely that in the case of the photolysis of 122 the 
half-life o f the intermediate formed might be longer. In order to test this hypothesis, 
the consumption of 122 and the release of 10 during photolysis at 254 and 350 nm 
using 2 and 10 lamps, respectively, was plotted (Figure 79). Only the experiments 
performed at 254 and 350 nm were selected for this study as the UV-HPLC traces 
obtained from these experiments were the cleanest at lower starting material yields, 
making integration of the starting material peak more reliable.
100% m
0% *
♦ Amide 254 nm
■ Amide 350 nm 
▲ SM 254 nm
■ SM 350 nm
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Figure 79. Release of the Amide 10 and the 
Consumption of 122 Through Photolysis at 254 and
350 nm using 2 and 10 Lamps Respectively.
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After 20 minutes of photolysis of 122 at 254 nm, 80% of the starting material was 
consumed, however only a 7% yield of 10 was recorded (Figure 79). Similarly 
photolysis of 122 for 20 minutes at 350 nm resulted in 60% of the starting material 
having been consumed, however only a 6% yield of 10 was recorded. These results 
show that there is minimal relationship between the rate of starting material 
consumption during the photolysis of 122 and the rate of release of the amide 10. It 
was therefore apparent that starting material consumption during the photolysis of 122 
to release the amide 10 was not rate determing. It is clear from the data illustrated in 
Figure 79 that after 30 minutes when the consumption of 122 was almost complete, the 
yield of amide 10 continued to increase. These results are consistent with the slow 
breakdown of an intermediate during the photolysis of 122. In order to test this 
hypothesis further, 122 was photolysed for 70 minutes at 300 nm using 10 lamps, after 
which the yield of amide 10 was continuously monitored by UV-HPLC (Figure 80). It 
was anticipated that if an intermediate was forming during the photolysis of 122 and its 
half-life was sufficiently long, the yield of amide 10 would continue to increase after 
irradiation had ceased.
Through continuous monitoring after the photolysis of 122 had ceased, an increase in 
the yield of amide 10 from 38% to approximately 53% was observed (Figure 80). This 
result indicates that the photolysis of 122 can be used to release benzamide 10 in 
satisfactory yield. The monitoring of the release of the amide 10, after irradiation had 
ceased, began at approximately 38% yield, increasing by 14% to level out at 
approximately 52%. The half-life for the breakdown of the intermediate formed during 
the photolysis of 122 was calculated as the time required for the yield of amide to 
increase by 7% which was 1 hour. Therefore the half-life of the intermediate formed
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during the photolysis reaction of 122 was at least an order of magnitude longer than for 
the intermediate formed from the irradiation of 119 which was <7.5 minutes. An 
hypothesis as to why the intermediates formed during the photolysis of 119 and 122 
possess different half-lives and the consequences of this to the photolysis of 2- 
nitrophenylalanine systems w ill be provided later in this Chapter.
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Figure 80. Release of the Amide 10 After the Photolysis of 122 
at 300 nm using 10 Lamps had Ceased.
Through continuous monitoring after the photolysis of 122 had ceased, an increase in 
the yield of amide 10 from 38% to approximately 53% was observed (Figure 80). This 
result indicates that the photolysis of 122 can be used to release benzamide 10 in 
satisfactory yield. The monitoring of the release o f the amide 10, after irradiation had 
ceased, began at approximately 38% yield, increasing by 14% to level out at
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approximately 52%. The half-life for the breakdown of the intermediate formed during 
the photolysis of 122 was calculated as the time required for the yield of amide to 
increase by 7% which was 1 hour. Therefore the half-life o f the intermediate formed 
during the photolysis reaction of 122 was at least an order of magnitude longer than for 
the intermediate formed from the irradiation of 119 which was <7.5 minutes. An 
hypothesis as to why the intermediates formed during the photolysis o f 119 and 122 
possess different half-lives and the consequences of this to the photolysis o f 2- 
nitrophenylalanine systems w ill be provided later in this Chapter.
The photolysis of /V-benzoylvalyl-2-nitrophenylalanylalanine methyl ester 129 was also 
studied. The reaction scheme for the photolysis of 129 is illustrated in Figure 81.
129
Figure 81. Reaction Scheme for the Photolysis of 129
The photolysis o f 129 was expected to give A-benzoylvalinamide 73 and the cinnamide 
142. The photolysis of 129 was to be used as a comparison to that o f 119 and 122.
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This was because the photolysis of 129 would release 73 (as observed with 119) and 
the cinnamide 142 (as expected with 122). In this way it was reasoned that potential 
causes of the differences observed between the reactions of 119 and 122 might be 
elucidated.
The photolysis of 129 was performed using the conditions described above at 254 nm 
using 2 lamps. A UV-HPLC trace of the reaction solution after 105 minutes of 
irradiation along with that for a 50 pM standard solution of the starting material 129 are 
provided in Figures 82 and 83, respectively. For comparison, the UV-HPLC trace of a 
50 pM standard solution of V-benzoylvalinamide 73 is provided above in Figure 65. 
The photolysis of 129 resulted in a peak at 3.67 minutes which was attributed to N- 
benzoylvalinamide 73 through comparison to an authentic sample by means of the 
standard procedure outlined above. It was therefore apparent that the photolysis of 129 
to release 73 at 254 nm using 2 lamps was successful and as a result further studies of 
this reaction were performed.
Figure 82. UV-HPLC Trace of a Solution of /V-Benzoylvalyl-2- 
nitrophenylalanylalanine Methyl Ester 129 after 105 Minutes of 
Irradiation at 254 nm using 2 Lamps
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Figure 83. UV-HPLC Trace of a 50 pM Standard Solution of N- 
Benzoylvalyl-2-nitrophenylalanylalanine Methyl Ester 129
The photolysis of 129 at 254, 300 and 350 nm using 2, 10 and 10 lamps, respectively, 
was then monitored by UV-HPLC and the release o f amide 73 plotted with respect to 
time (Figure 84).
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Figure 84. Release of the Amide 73 Through the
Photolysis of 129 at 254, 300 and 350 nm, L =
Number of Lamps
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The highest yield of amide 73 obtained through the irradiation of 129 was at 254 nm 
after 110 minutes, reaching 37% (Figure 84). Through comparison of the plots for the 
release of 73 from 119 and 129 in Figures 67 and 71, respectively, it is apparent that the 
rate of release of amide 73 from the photolysis of 129 at 254, 300 and 350 nm was 
slower. It was hypothesised that the slower rate of amide release was due to a reaction 
intermediate being formed that possessed a similar half-life to that observed during the 
irradiation of 122. The tripeptide 129 was therefore photolysed at 300 nm using 10 
lamps for 20 minutes after which the yield of amide 73 was continuously monitored by 
UV-HPLC and plotted (Figure 85).
1 10%
Time (min)
Figure 85. Release of Amide 73 After the Photolysis of 129 at 
300 nm for 20 minutes had Ceased.
The yield o f amide 73 was observed to increase by 6% from 8% to 14% after 
photolysis of the tripeptide 129 at 300 nm for 20 minutes had ceased (Figure 85). The 
half-life of the intermediate was calculated as the time required for the yield of amide
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to increase to 11% which was 1 hour. Therefore the half-life for the intermediate 
formed during the photolysis of 129 is similar to that observed for the intermediate 
formed during the irradiation of 122.
By analogy to the mechanism of 2-nitrophenylalanine photolysis illustrated in Figure 
62, a hypothesis was formed that the intermediates observed to build up in 
concentration during the irradiation of 119, 122 and 129 were the respective ac/-nitro 
systems 143, 144 and 145, respectively (Figure 86).
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Figure 86. ac/-Nitro Intermediates 143, 144 and 145 Hypothesised 
to Form During the Photolysis of 119, 122 and 129 Respectively
Intermediates such as 143, 144 and 145 would also be resonance stabilised. Figure 87 
illustrates how the aci-nitro intermediate 136, proposed to form as part of the 
mechanism of photolysis of the 2-nitrophenylalanine 56 (Figure 62), could be 
resonance stabilised through extensive delocalisation of the charges on the nitro group 
through the aromatic ring to the benzylic carbon. Due to this delocalisation of charge it 
would not be surprising if the ac/-nitro systems 143, 144 and 145 were found to be 
stable enough to be the intermediates observed during the photolysis reactions of 119, 
122 and 129, respectively.
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Investigations into the mechanism of photolysis of the NPEOC 31 (Figure 18) 
performed by Walbert et a 149 found that an alternative product of the reaction was the 
benzylic alcohol. The mechanism of this proposed step as applied to 2- 
nitrophenylalanine photolysis is illustrated in Figure 88.
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Figure 88. Alternative Pathway for the Breakdown of 
the ac/-Nitro Intermediate 136.
The nitro oxy-anion of 136 attacks the benzylic carbon to give the bicyclic species 148 
via a 5-endo-trigonal ring closure. However, on formation of the benzylic alcohol 149 
the mechanism cannot proceed towards amide release. This intermediate 149 may still
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be photoactive due to the presence of the nitroso functional group and may degrade via 
further photochemical pathways not yet elucidated. Therefore the intermediate 136 
may constitute a point of partition in the mechanism of 2-nitrophenylalanine photolysis 
in that it can either proceed to form a benzylic alcohol 149 or cleave to release the 
amide 47. As amides are poor leaving groups and the mechanism of photolysis of the 
NPEOC 31 released the anion 36, amide release during 2-nitrophenylalanine photolysis 
could reasonably be considered surprising in light of there being an alternative reaction 
pathway. However, as 5-endo-trigonal ring closures are disfavoured processes, it 
appears that amide release is able to out-compete this during 2-nitrophenylalanine 
photolysis.
The photolysis of 119 released the amide 73 in high yield and the half-life of the 
intermediate formed during the reaction was <7.5 minutes. The photolysis reactions of 
122 and 129 released the amides 10 and 73 respectively in lower yields and the half- 
lives of the intermediates formed during their reactions were approximately 1 hour. It 
was therefore apparent that the slower the rate of breakdown of the intermediate formed 
during the photolysis of a 2-nitrophenylalanine system, the less efficient the reaction 
may be with respect to amide release. It may be that the longer half-lives of the 
proposed intermediates 144 and 145 formed during the photolysis of 122 and 129, 
respectively, may result in the disfavoured 5-endo-trigonal ring closure having more 
time to occur, thus lowering the yield of amide from these reactions in comparison to 
that of 119.
The differences in the half-lives of the aci-nitro intermediates 143, 144, and 145 
proposed to form during the photolysis of 119, 122 and 129, respectively, may be
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related to differences in the stabilities of the products released during their reactions. 
The photolysis of the dipeptide 119 and the tripeptide 129 released the amide 73 in 
different yields and at different rates. It was therefore considered unlikely that the 
stabilities of amide fragments released during 2-nitrophenylalanine photolysis would be 
responsible for differences in intermediate half-lives. Although no evidence for the 
formation of 2-nitrocinnamyl products from the photolysis reactions of 119, 122 and 
129 was observed, it is reasonable to expect that they were produced as part of the final 
cleavage step in accordance with the mechanism of 2-nitrophenylalanine photolysis 
illustrated in Figure 62. The stabilities of the cinnamate 138 and the cinnamide 142 
were therefore considered. The peptides 122 and 129 possess an amide at the 
equivalent position to the ester of 119. This results in the photolysis of 122 and 129 
producing the proposed cinnamide 142, whereas the irradiation of 119 would produce 
the proposed cinnamate 138. It was therefore hypothesised that the formation of 
cinnamides might be less favoured as products of 2-nitrophenylalanine photolysis than 
cinnamates. This implied that the nature of the carbonyl group of 2-nitrophenylalanine 
(either being an ester or an amide) may have a large effect on the success of its 
photolysis. Therefore, the effect of variations of this group on 2-nitrophenylalanine 
photolysis was studied.
A reaction scheme for the photolysis of 128 is illustrated in Figure 89. The photolysis 
of 128 would release A-benzoylvalinamide 73 which was also a product of the 
irradiation of the dipeptide 119. The two systems 128 and 119 vary in that the 
proposed nitro fragments released from their photolysis are 2-nitrostyrene 35 and 
methyl 2-nitrocinnamate 138 respectively. The peptide 119 possesses a methyl ester 
and 128 does not possess an equivalent carbonyl group. Therefore, studies of the
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photolysis of 128 would allow for further insight into the importance of the carbonyl 
group of 2-nitrophenylalanine to its photolysis.
Figure 89. Proposed Reaction Scheme for the Photolysis of N- 
2-(Nitrophenylethyl)-A^-benzoylvalinamide 128.
A solution of A-2-(Nitrophenylethyl)-A<1-benzoylvalinamide 128 was irradiated at 300 
nm for 20 minutes using 10 lamps and the reaction was analysed by UV-HPLC. 
Analysis of the reaction mixture, whilst showing complete loss of starting material, 
provided no evidence for the formation of the amide 73. It was hypothesised that this 
result may have been due to the formation of an act-nitro intermediate with a half-life 
much longer than previously observed during 2-nitrophenylalanine photolysis. The 
solution was therefore allowed to stand overnight and then analysed by UV-HPLC to 
test this theory. No evidence for the formation of 73 was observed proving the 
photolysis of 128 to have been unsuccessful. These results indicated that the carbonyl 
group of 2-nitrophenylalanine derivatives is critical to the success of their photolysis. It 
seems likely that the formation of styrene is disfavoured in comparison to cinnamate or 
cinnamide release. The cinnamyl derivatives 138 and 142 are stabilised through the 
conjugation of the n electrons of their carbonyl groups to their aromatic rings. As 119 
photolysed more efficiently than 122 and 129, this effect may be more pronounced with 
cinnamates than cinnamides.
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To further investigate the importance of the carbonyl group of 2-nitrophenylalanine 
derivatives to their photolysis, the reaction of the free acid 123 was studied. The 
proposed reaction scheme for the photolysis of 123 is illustrated in Figure 90. The 
photolysis of 123 would produce iV-benzoylvalinamide 73, as was observed from the 
photolysis of 119, and the cinnamic acid 150 rather than the methyl cinnamate 138 
would be the nitro fragment released. Comparisons between the photolysis of 123 and 
119 would therefore provide further insight into the contribution that the carbonyl 
group of 2-nitrophenylalanine makes to photolysis efficiency.
Figure 90. Proposed Reaction Scheme for the Photolysis of 
A/-Benzoylvalyl-2-nitrophenylalanine 123.
A solution of 123 was irradiated at 300 nm with 10 lamps for 20 minutes and analysed 
by UV-HPLC. The trace obtained revealed the complete loss of starting material, but 
only a 5% yield of 73. The solution was allowed to stand overnight and then analysed 
by UV-HPLC, which showed a negligible increase in the yield of amide 73. These 
results contrast with the efficiency of photolysis of the analogous methyl ester 119 at 
300 nm using 10 lamps, which resulted in an 80% yield of amide 73 (Figure 67). In 
order to establish that this result was not attributable to some form of contaminant or 
other influence absent in previous experiments, a solution containing 25 pM 
concentrations of 123 and 119 was photolysed at 300 nm for 20 minutes. The UV-
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HPLC trace of the reaction solution showed a 40% yield o f the amide 73. Therefore 
the photolysis of 123 to give the amide 73 was not unsuccessful due to contamination.
It may be possible to explain the different yields of the amide 73 obtained through the 
photolysis of 123 and 119 by consideration of their reaction mechanisms and a possible 
alternative pathway for the free acid 123 not possible for the methyl ester 119 (Figure 
91).
153
Figure 91. Potential Decarboxylation Pathways for 
Reaction of the aci-Nitro Intermediate 151 Proposed to 
Form During the Photolysis of 123, R = A/-Benzoylvalyl.
Figure 91 illustrates the aci-nitro intermediate 151 and its benzylic cation resonance 
contributor 153 proposed to form during the photolysis of 123. At pH 7.4 carboxylic 
acids are deprotonated, forming the corresponding carboxylate anions. It is likely that
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the compound represented by the resonance structures 151 and 153 undergoes 
decarboxylation as illustrated in Figure 91. The new product 152 is then unable to 
release the amide 73. However, it would still be photoactive due to the presence of the 
nitro group and could possibly undergo further photochemical degradation. This may 
explain the absence of any evidence for the formation of compound 152 in the UV- 
HPLC trace obtained from the reaction solution. These results indicate that the use of 
2-nitrophenylalanine free acids, to potentially increase water solubility, is not viable.
One of the aims of the development of 2-nitrophenylalanine as a photocleavable amino 
acid was that it would be efficiently photolysed under biological conditions. The use of 
2-nitrophenylalanine as a photocleavable amino acid in biologically related experiments 
may ultimately require it to be photolysed efficiently at wavelengths above 300 nm. 
Analysis of the absorbance profiles of 119 and 122 (Figures 68 and 78) shows that the 
2-nitrophenylalanine chromophore has minimal absorbance above 300 nm. It was 
believed that enhancing the absorbance of the 2-nitrophenylalanine chromophore above 
300 nm may allow for faster photolysis at wavelengths more amenable to use in 
biological experiments. It has been established that the methoxy substituents of the 
NVOC group enhance its rate of photolysis at 350 nm in comparison to that of 
NBOC.83 Therefore the dimethoxy substituted 2-nitrophenylalanine dipeptide 133 was 
designed (Figure 92). The photolysis of 119 was efficient and high yielding and so the 
dimethoxy system 133 was designed to be analogous. The dimethoxy system 133 and 
the anticipated products of its photolysis 73 and 154 are illustrated in Figure 92.
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Figure 92. Reaction Scheme for the Photolysis of 133
The photolysis of 133 was performed at 254, 300 and 350 nm. Initial studies at 254 nm 
using 2 lamps showed that the consumption of starting material was too slow for 
analysis with only 18% of the starting material 133 being consumed after 40 minutes of 
irradiation. Thus 4 lamps were used at this wavelength to allow for a reasonable 
analysis time frame. Other reaction conditions were identical to previous studies. The 
release of the amide 73 at the three different wavelengths along with the consumption 
of starting material 133 during photolysis was then plotted (Figures 93, 94 and 95).
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Figure 93. Photolysis of A/-Benzoylvalyl-2-nitro-4,5-
dimethoxyphenylalanine Methyl Ester 133 to give the Amide 73 at 
254 nm using 4 Lamps, SM = Starting Material
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Figure 94. Photolysis of A/-Benzoylvalyl-2-nitro-4,5-dimethoxyphenylalanine 
Methyl Ester 133 to give the Amide 73 at 300 nm using 10 Lamps, SM = 
Starting Material
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Figure 95. Photolysis of A/-Benzoylvalyl-2-nitro-4,5-
dimethoxyphenylalanine Methyl Ester 133 to give the Amide 73 at 
350 nm using 10 Lamps, SM = Starting Material
The highest yield of the amide 73 obtained through the photolysis of 133 was observed 
after irradiation at 300 nm using 10 lamps (Figure 94) and was 50%. The yields of the 
amide 73 obtained through the photolysis of 133 at 254, 300 and 350 nm of 12, 50 and 
32%, respectively, contrast significantly with those observed from the photolysis of the 
analogous dipeptide 119 which was at least 80% (Figure 67). The rate of starting 
material consumption illustrated in Figures 93, 94 and 95 is much faster than that of 
amide release. This indicated that starting material consumption was again not the rate 
determining step. The amide yields obtained from the reaction of 133 are comparable 
to those obtained for the photolysis of 122 and 129. It was therefore hypothesised that 
the low yields of amide produced through the photolysis of 133 could be related to a 
long-lived reaction intermediate forming during photolysis as was observed for the 
reactions of 122 and 129. In order to investigate this hypothesis, a new experiment was
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performed where 133 was photolysed at 300 nm for 240 minutes, after which the 
release o f the amide 73 was monitored continuously by UV-HPLC (Figure 96).
<u 30%
<  28% <►
Time (min)
Figure 96. Release of Amide 73 after 240 minutes of 
Irradiation of 133 at 300 nm using 10 Lamps had Ceased.
The yield o f the amide 73, after irradiation o f 133 had ceased, was observed to increase 
by 7% over six hours o f continuous reaction monitoring (Figure 96). This indicated a 
half-life for the intermediate formed during the photolysis o f 133 of at least 3 hours, 
which is significantly longer than that observed for the analogous 119. These results 
are therefore consistent with the theory that extended intermediate half-lives result in 
lower amide yields from 2-nitrophenylalanine photolysis.
The intention o f investigations into the photolysis o f 133 was to determine whether the 
use o f methoxy ring substituents on 2-nitrophenylalanine could enhance its rate o f 
photolysis at wavelengths higher than 300 nm. A comparison o f the rates o f starting
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material consumption during the photolysis of 119 and 133 at 350 nm using 10 lamps 
found that this was not the case (Figure 97).
100% »
.«> 50%
♦ 119 
■ 133
Time (min)
Figure 97. Starting Material Consumption tor the 
Photolysis of 119 and 133 at 350 nm, using 10 
Lamps.
It is apparent from Figure 97 that the rate of starting material consumption for the 
photolysis of 119 and 133 at 350 nm using 10 lamps is essentially the same. Indeed the 
consumption of 119 could be considered to be proceeding at a slightly faster rate. 
Comparison of the UV absorbance profile of 133 (Figure 98) to that of 119 (Figure 68) 
shows that the methoxy substituents of 133 enhanced its absorbance at 350 nm in 
relation to 119. Therefore, the rates of starting material consumption for the photolysis 
of 119 and 133 at 350 nm appear to be in contradiction with those predictable from the
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respective UV absorbance profiles. This decrease in the rate of starting material 
consumption might be due to the ability of methoxy-aromatic systems to fluoresce.
220.00 240.00 260.00 280.00 300.00 320.00 340.00 360.00 380.00
Figure 98. UV-absorbance Profile of 133
The mechanism of NPEOC protecting group photolysis, as outlined in the Introduction 
(Figure 18), involves the intersystem crossing of the singlet state Si(/77i*) populated 
chromophore to the triplet state T F l u o r e s c e n c e  occurs through the relaxation of 
a singlet state excited species to the ground state.43 The methoxy substitution of 2- 
nitrophenylalanine may enhance singlet state relaxation. Consequently, this relaxation 
may be out-competing intersystem crossing to the triplet state thereby inhibiting 
starting material consumption. This would correlate well with the findings of Hasan et 
a/.83 who found that although the methoxy substituents of the NVOC group enhanced 
its rate of photolysis at 350 nm in comparison to that of NBOC, they decreased the 
quantum yield of the reaction.
The half-life o f the intermediate formed during the photolysis of 133 is of a similar 
order to that observed during the photolysis of 122 and 129 and therefore longer than
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that observed from the reaction of 119. The aci-nitro intermediate 155 proposed to 
form during the photolysis of 133 is illustrated in Figure 99. An understanding as to 
why the half-lives of the ad-nitro intermediates 155 and 143, proposed to form during 
the photolysis of 133 and 119, respectively, are different may come from a 
consideration of the resonance forms of 155 (Figure 99).
158 157
Figure 99. The ac/-Nitro Intermediate 155 and Some 
of its Resonance Contributors 156, 157 and 158, R = 
A/-Benzoylvalyl.
Methoxy substituents on aromatic rings are known to be o electron withdrawing and n 
electron donating.77 It is this feature which allows a positive charge to be stabilised
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during electrophilic aromatic substitution of methoxy substituted aromatic rings and 
therefore governs the ortho-para selectivity of such reactions. The resonance forms 
illustrated in Figure 99 show that the 4-methoxy substituent of the aromatic ring may 
stabilise the aci-nitro intermediate 155 through similar n electron donation to the 
positively charged carbon.
In Figure 100, the ad-nitro intermediate 155 and its benzylic anion and benzylic cation 
resonance forms 159 and 156, respectively, are illustrated. From the two resonance 
forms 155 and 159, mechanisms can be drawn to allow for release of the amide 73. 
However no reasonable mechanism can be drawn for the release of the amide 73 from 
the benzylic cation resonance form 156. The ability of the 4-methoxy ring substituent 
to stabilise a positive charge (as illustrated in Figure 99) may make this resonance form 
of the fld-nitro intermediate 155 more dominant. This may therefore make the final 
cleavage step during the photolysis of 133 less likely, resulting in the extended aci- 
nitro intermediate half-life observed and consequently lower yield of amide 73 in 
comparison to the photolysis of the analogous 119.
It is therefore apparent that the substitution of the ring of 2-nitrophenylalanine with 
methoxy substituents does not enhance its photolysis at wavelengths above 300 nm, 
although reasonable amide yields in the region of 50% may be obtained. These results 
indicate that in the design of future 2-nitrophenylalanine systems, ring substituents 
should be selected which would not stabilise an <sc/-nitro intermediates benzylic cation 
resonance form and should preferably enhance intersystem crossing to the triplet state 
Ti(/77T*) chromophore. In the Future Work and Conclusions section of this thesis, 
methods by which this could be investigated are outlined.
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Figure 100. Mechanisms of Release of 73 from the aci- 
Nitro Intermediate 155 and its Resonance Form 159. R = 
A/-Benzoylvalyl
These studies have therefore established that amides can be released through 2- 
nitrophenylalanine photolysis. The photolysis of 119 was found to be efficient and
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high yielding at pH 7.4. Therefore 2-nitrophenylalanine methyl ester may be a suitable 
photoremovable masking group for amides that could be used at biological pH in 
preference to Npg. Although the photolysis reactions of 122, 129 and 133 were not as 
efficient as that of 119, amide yields of up to 50% were obtained from their reactions. 
Potential methods by which the photolysis of 2-nitrophenylalanine to release amides 
might be enhanced w ill be outlined in the Future Work and Conclusions section of this 
thesis.
Chapter 4. Conclusions and Future Work
The research described in Chapter 1 of the Results and Discussion established that there 
are strong correlations between calculated radical stabilisation energies (RSEs), the 
ease of formation of glycyl and related radicals in free radical brominations, and the 
extent of catalysis of the reactions o f analogous compounds by peptidylglycine a- 
amidating monooxygenase (PAM). A decrease in the RSE of around 10 kJ m o l1 
relative to that o f a normal peptide glycyl radical slowed, but did not stop, the rate of 
radical formation through either bromination or enzyme-catalysis. However, reducing 
the RSE by around 35-45 kJ m o l1, through either introduction of a trifluoromethyl 
substituent at the a-position or by replacing the acylglycine NH with a glycolate O or a 
y-keto acid CH2, stopped both bromination and enzyme processing. O f these changes, 
only the glycolate substitution did not adversely affect the enzyme binding affinity. 
Consequently glycolates were found to be a general class of PAM inhibitors because 
they do not readily undergo hydrogen atom transfer, yet they bind effectively to the 
enzyme. The further implication of this observation is that the substitution of the
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acylglycine of tight binding natural substrates of PAM with glycolate should afford 
enzyme inhibitors with high binding affinities.
In preliminary experiments, cell based assays were performed using the glycolate 
extended systems 63, 64, 75 and 76 to investigate whether they could be used to affect 
PAM activity in biological models. The systems investigated are illustrated in Figure 
101.
o
A
H
63 R = Benzyl 75 R = Benzyl
64 R = H 76 R = H
Figure 101. Systems Tested in Cell Based Assays.
Compounds 63, 64, 75 and 76 were selected for testing as they constituted different 
systems in that 75 and 76 are fatty acids and 63 and 64 are peptidic. The benzyl esters 
63 and 75 were investigated as it was believed they would have enhanced transport into 
cells in comparison to the free acids 64 and 76. Once inside the cells, it was anticipated 
that hydrolysis of 63 and 75 would occur to release the desired free acids 64 and 76.
Compounds 63, 64, 75 and 76 were first studied for their capacity to affect proliferation
o c
of the human lung cancer cell line A549. From these studies, IC50 and total growth 
inhibition (TGI) values were obtained. The IC50 for the free acids 64 and 76 were
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>1000 pM and 257 pM and the TGI values were >1000 pM and >1000 pM, 
respectively. The IC50 values for the benzyl esters 63 and 75 were 64 and 81 pM and 
the TGI values were 324 and 211 pM respectively. Therefore the benzyl esters 63 and 
75 were found to have significant activity as inhibitors of cancer cell growth. The 
enhanced activity of the benzyl esters 63 and 75 compared to their free acids 64 and 76 
confirmed the importance of the benzyl ester moiety for the design of PAM inhibiting 
drugs.
The second system studied involved the monitoring of the effect that 63, 64, 75 and 76 
have on substance P levels in rat dorsal root ganglian cells.86 As was discussed in the 
Introduction, substance P levels arc associated with inflammation and pain7 and these 
studies attempted to establish the efficacy of compounds 63, 64, 75 and 76 to treat 
related physiological disorders. It was discovered that only the benzyl esters 63 and 75 
were active, reducing substance P levels over a six hour period at a concentration of 50 
pM. As the free acids 64 and 76 were not active these studies further established the 
importance of the benzyl ester design of compounds 63 and 75.
Assays of 63, 64, 75 and 76 were also performed against an U87 cell line, using a 
radioimmunoassay (RIA) with 1251 labelled adrenomedullin to establish whether levels 
of this hormone could be influenced. Adrenomedullin is known for its activity in 
cardiovascular disease and renal faliure.88 In these assays, the benzyl ester 75 was 
found to be the most active reducing the level of secreted adrenomedullin by 80% when 
used at a concentration of 0.1-1 nM.
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PAM inhibition through the use of glycolate extended systems has therefore been 
shown to have potential in the development of therapeutic agents for the treatment of 
cancers, inflammation and pain and cardiovascular disorders. Future work will involve 
the development of more potent and specific inhibitors, tests of efficacy and toxicity in 
animal models and, subject to the satisfactory results of those studies, human trials.
Chapter 2 of the Results and Discussion section of this thesis described research 
towards the development of a-substituted glycines as hydrolytically cleavable amino 
acids. The hydrolysis reactions of the a-hydroxyglycines 7 and 8 to release benzamide 
10 were found to have similar rates at pH 7.5. The psuedo-first order rate constant for 
the hydrolysis of the methyl ester 8 to release 10 directly at pH 7.5 was 3.6 x 10 s sec"1 
which corresponds to a half-life of 5.3 hours. Similarly the psuedo-first order rate 
constant for the hydrolysis of the free acid 7 to release 10 at pH 7.5 was 3.3 x 10 s sec"1 
which corresponds to a half-life of 5.8 hours. This was in contrast to the previously 
published half-lives for the hydrolysis of 7 and 8 to release benzamide 10 of 6.7 and 
0.74 hours respectively.41 The previously published half-life for the hydrolysis reaction 
of 8 to give the amide 10 was found to be valid only with respect to the rate of loss of 
starting material and not with respect to the rate of amide release. As a result the rate of 
the hydrolysis reaction of 8 to release 10 was previously incorrect and has now been 
addressed.
The half-lives for the hydrolysis reactions of the a-substituted glycines 14, 16, 18, 21 
and 133 to form a-hydroxyglycine moieties were found to correlate with the efficiency 
of the a-substituent to act as a leaving group. Through these studies it was established 
that a-phenoxyglycine (in comparison to a-hydroxyglycine), used as a masking group
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for the C-terminal amide of peptide hormones or as a cleavable linker between such 
hormones with other molecules could reasonably be expected to extended the half-life 
of active drug release by 30 minutes at biological pH. The a-phenoxyglycine 21 
hydrolysed to form an a-hydroxyglycine whilst the a-methoxyglycine 16 did not. This 
was correlated with the pATas of methanol (15.0) and phenol (10.0) reflecting the 
inability of methoxide and the ability of phenoxide to act as leaving groups.43 As 21 
hydrolysed whilst 16 did not, the use of a-substituted glycines where the analogous acid 
of the a-substitutent possesses a pKa in between 10.0 and 15.0, may therefore extend the 
half-lives of such systems at pH 7.5. Potential alcohols that could be used to this end 
include C3F7CH2OH, HCCCH2OH and CHCl2CH2OH which possess pKas of 11.4, 
13.55 and 12.89 respectively.89,90 The use of such a-substituted glycines as masking 
groups for the C-terminal amide of peptide hormones, or as transient linkers between 
such hormones and macromolecules may afford greater control over the rate of release 
of active peptide drugs in vivo than possible with a-phenoxyglycine.
Chapter 3 of the Results and Discussion section of this thesis described research 
towards the development of a new photochemically cleavable amino acid. It was 
established that the 2-nitrophenylalanine systems 119, 122, 129 and 133 could be 
photolysed to release their respective amides 73, 10, 73 and 73 at biological pH. The 
most efficient system was A-benzoylvalyl-2-nitrophenylalanine methyl ester 119 which 
released the amide 73 at a rate comparable to that of starting material consumption in 
80 -  100% yield. This result was significant in that it established that 2- 
nitrophenylalanine could be photolysed to release amides more efficiently than Npg at 
biological pH.
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Preliminary studies were then performed to determine whether the C-terminal amide of 
oxytocin could be masked with a 2-nitrophenylalanine moiety, and unmasked through 
photolysis. Therefore, the masked oxytocin derivative 160 was designed and a reaction 
scheme for its photolysis is illustrated in Figure 102.
OoN
H U
Cys-Tyr-lle-GIn-Asn-Cys-Pro-Leu—
160
hv Oxytocin
Figure 102. Photolysis of a Masked Oxytocin Derivative 
160 to Release Oxytocin 161
Polypeptide 160 was designed such that its irradiation would result in the cleavage of 
the 2-nitrophenylalanine N-Cu bond, thereby releasing oxytocin. The photolysis of the 
2-nitrophenylalanine free acid 123 was unsuccessful. Therefore the 2- 
nitrophenylalanine of 160 was extended by a prolyl-glycine unit. This would also 
move the free acid far enough away from the 2-nitrophenylalanine residue such that any 
potential for it to interact with reaction intermediates formed during the photolysis 
would be eliminated.
In order that the polypeptide 160 could be synthesised by automated peptide synthesis, 
it was necessary to make the N-FMOC-2-nitrophenylalanine 162 (Figure 103).
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OH
9-Fluorenylmethyl Chloroformate 
Dioxane
10% Sodium Carbonate
▼
Figure 103. Synthesis of A/-FMOC-2-Nitrophenylalanine 162
2-Nitrophenylalanine 117 was stirred in dioxane and 10% sodium carbonate to which 
9-fluorenylmethyl chloroformate was added to give the /V-protected 2- 
nitrophenylalanine 162. The 'H NMR spectrum o f the product showed a peak for the 
2-nitrophenylalanine ß-carbon protons at 63.10 and 63.67 ppm along with the a-carbon 
proton at 64.62 ppm. Further the electrospray ionisation mass spectrum showed peaks 
for the protonated and sodiated molecular ions at m /z  432 and m /z 454 respectively 
indicating the reaction to have been successful. Compound 162 was then incorporated 
into the polypeptide 160 using automated peptide coupling procedures.91 The 
electrospray mass spectrum of the product showed a peak for the protonated molecular 
ion at m /z 1353 indicating the synthesis to have been successful.
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In a preliminary experiment, the polypeptide 160 was photolysed for 20 minutes at 300 
nm using 10 lamps under the standard conditions established in Chapter 3 of the 
Results and Discussion section of this thesis. UV-HPLC traces of the starting material, 
an authentic sample of oxytocin “ and the reaction solution are provided in Figures 104, 
105 and 106, respectively. The photolysis of 160 resulted in the formation of two peaks 
(Figure 106). The peak at 2.85 minutes is due to an as yet not elucidated product. 
However, the peak at 3.15 minutes was attributed to oxytocin by comparison to 
authentic sample using the established procedure. Therefore the photolysis of 160 to 
give oxytocin 161 was successful although only a 5% yield of the hormone was 
recorded.
Figure 104. UV-HPLC Trace of a 50 pM Standard Solution of 
Polypeptide 160
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Figure 105. UV-HPLC Trace of a 50 pM Standard Solution of 
Authentic Sample of Oxytocin 161
Figure 106. UV-HPLC Trace of Polypeptide 160 after Photolysis at 
300 nm using 10 Lamps for 20 minutes.
In order to increase the yield of oxytocin released, future work may involve the 
incorporation of 2-nitrophenylalanine into a polypeptide as an ester 163 (Figure 107). 
This may take advantage of the potential high efficiency and yield of amide obtained
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through the photolysis of 2-nitrophenylalanine esters as was observed for the reaction 
of the methyl ester 119.
Figure 107. Reaction Scheme for the Potential Photolysis of the 2- 
Nitrophenylalanine Ester 163 to Release Oxytocin 161.
Future work may also concentrate on increasing the reaction rate and efficiency of 
photolysis of 2-nitrophenylalanine. It was hypothesised that the efficiency of 
photolysis of 2-nitrophenylalanine systems was related to the nature of the 2- 
nitrophenylalanine carboxyl group. Therefore studies may be performed to determine 
the precise nature of this effect and methods by which the photolysis of 2- 
nitrophenylalanine systems could subsequently be improved. Furture studies could also 
include attempts at enhancing intersystem crossing from the excited singlet state 
Si(/m*) populated chromophore formed upon irradiation to the triplet state Ti(rat*). In 
addition, studies towards increasing the yield and rate of release of amides from the aci- 
nitro intermediates formed during 2-nitrophenylalanine photolysis may also be 
performed. To this end, a number of 2-nitrophenylalanine analogues are proposed 
(Figure 108).
-► Oxytocin
161
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HoN
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Figure 108. Proposed 2-Nitrophenylalanine Analogues
Acetophenone has been widely used as a triplet energy transfer reagent in 
photochemical reactions.93’96 Therefore the incorporation of an acetyl group at the para 
position of the ring to give the 2-nitrophenylalanine 164 may assist the intersystem 
crossing from the excited singlet state S\ (/m*) populated chromophore formed upon 
irradiation to the triplet state Ti(/m*). This may increase the rate of starting material 
consumption during the photolysis o f 2-nitrophenylalanine systems. Further it would 
be reasonable to expect that the acetyl group of 164 would help to stabilise the benzylic 
anion resonance form of an ad-nitro intermediate whilst destablising the benzylic 
cation resonance form, potentially increasing the rate of the final cleavage step. The 
substitution o f the ß-carbon of 2-nitrophenylalanine with a methyl group to give 165 
may also enhance the rate of starting material consumption during the irradiation of 2- 
nitrophenylalanine systems as the ß-carbon centred radical formed would be tertiary 
rather than secondary. The substitution o f the a-position of 2-nitrophenylalanine to 
give 166 and the ß-position to give 165 may also help to stabilise the cinnamates and 
cinnamides formed during 2-nitrophenylalanine photolysis through greater substitution 
of the conjugated systems produced. This could potentially increase the rate of the final 
cleavage step.
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Future work may also concentrate on the development o f new potentially 
photocleavable amino acids such as the 2-acetylphenylalanine 167 which is illustrated 
in Figure 109. The 2-acetylphenylalanine was designed though analogy to the l-[2-(2- 
hydroxyalkyl)phenyl]ethenone photoremovable protecting group which was developed
97by Atemnkeng et al.
168
Figure 109. Potential Photolysis Mechanism of 2- 
Acetylphenylalanine. R = NH2, NHR\ OH, OR’.
Upon photolysis o f 167 abstraction of a hydrogen atom from the ß-carbon would occur 
in a similar manner to that observed in a Norrish Type II reaction. The resultant 
diradical would then rearrange in a similar manner to the mechanism of 2- 
nitrophenylalanine photolysis to give 168. Compound 168, which is an analogue of the 
fld-nitro compounds proposed as intermediates in 2-nitrophenylalanine photolysis, 
would then eliminate the amide 47.
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Experimental
General
Melting points were determined on a Kofler hot-stage melting point apparatus under a 
Reichert microscope and are uncorrected. H and C NMR spectra were recorded on 
Varian Gemini 300 and VRX 500S spectrometers. Electron impact (El) mass spectra 
were obtained using a VG Autospec double-focussing trisector mass spectrometer 
operating at 70 eV. Electrospray ionization (ESI) mass spectra were recorded on a VG 
Quatro 2 triple-quadrupole mass spectrometer. Fast atom bombardment mass spectra 
(FAB) were obtained with a VG Analytical ZAB2-SEQ mass spectrometer. 
Microanalyses were performed by the Research School of Chemistry Microanalytical 
Service at the Australian National University, on a Carlo.Erba 1106 autoanalyser. 
Optical rotations were recorded using a Perkin Elmer 241 polarimeter.
High performance liquid chromatography (HPLC) was carried out on a Waters 
Alliance 2690 Chromatography Module, with a Waters 996 Photodiode Array Detector 
and a Waters Fraction Collector II, in conjunction with a Compaq Deskpro Data Station 
running Waters Millennium 32 chromatography management software. A Waters 
Symmetry Prep. C18 5 pm column (4.6 x 250 mm) was used for analytical separations 
and, and a YMC-Pack ODS-AQ 5 pm column (10 x 250 mm) for preparative 
separations described in Chapter 1 of the Results and Discussion. A Waters Symmetry 
Cis 3.5 pm column (4.6 x 75 mm) was used for the analytical separations described in 
Chapters 2 and 3 of the Results and Discussion. A Waters SymmetryPrep Cig 7 pm 
column (19 x 300 mm) was used for the preparative separation described in Chapter 2
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of the Results and Discussion. Preparative chromatography was performed with Merck 
Kieselgel 60 (230.400 mesh ATSM). An Osram Ultra-Vitalux (240 V, 300 W, E27) 
sunlamp was used as the light source to initiate radical brominations, at a distance of 
between 5.10 cm from the reaction vessel. Organic extracts were dried using 
anhydrous MgSCh. The photolysis of 2-nitrophenylalanine derivatives was performed 
in a Luzchem Photoreactor (LZC-ORG).
Recombinant peptidylglycine a-amidating monooxygenase (PAM) was purchased from 
Wako Pure Chemical Industries. Benzyl bromoacetate, decanoic acid, glycine 
hydrochloride tert- butyl ester and ß,ß,ß-trifluoroalanine were bought from 
Sigma.Aldrich Chemical Co. iV-Acetyl-(5)-phenyIalanyl-(5')-phenylalanine and N- 
acetylphenylalanine were obtained from Auspep Pty. Ltd.
Experimental for Chapter 1
Theoretical Procedures
Standard ab initio molecular orbital theory and density functional theory calculations 
were performed using the GAUSSIAN 03 program. Geometries and zero-point 
vibrational energies (scaled by 0.9806) were determined at the B3-LYP/6-31G(d) level, 
while improved relative energies were obtained by carrying out single-point 
calculations on these optimized structures at the RMP2 level with the 6-311+G(2df,p) 
and G31arge basis sets. Results quoted in the text correspond to 
RMP2/G31arge//B3-LYP/6-31G(d) values at 0 K. Radical stabilisation energies 
(RSEs) of .CHXY radicals were calculated as the energies of the reactions:
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CH4 + ‘CHXY *CH? + CH2XY (1)
This is equivalent to the difference between the C-H bond dissociation energy (BDE) in 
methane and the C-H BDE in the substituted methane (CH2XY):
RSE('CHXY) = BDE(CH4) - BDE(CH2XY) (2)
Defined in this way, a positive RSE indicates that the radical *CHXY is stabilised 
relative to ‘CH  ̂(compared with the corresponding closed-shell systems).
Gaussian archive entries for the B3-LYP/6-31G(d) optimized structures are presented 
in Table El. We note that the structures for 2, 5, 93b and 94b have been reported 
previously21'27 but they are included here for completeness. Total energies at the 
RMP2/G31arge//B3-LYP/6-31 G(d) and RMP2/6-311 +G(2df,p)//B3-LYP/6-31 G(d) 
levels are included in Table E2, while corresponding RSEs at these two levels are listed 
in Tables E2 and E3.
Table El. GAUSSIAN Archive Entries for the UB3-LYP/6-31G(d) Optimized 
Structures of Derivatives of Glycyl and Related Radicals
MeCONHCH2CO,Me 1
1\1\GINC-VPP05\SP\RMP2-FC\6-31G(d)\C5H9N103\AKC501\28-Mar-1998\0\\# RM 
P2/6-31G* SCF=DIRECT GUESS=CHECK GEOM=CHECK TEST MAXDISK=12582912\\CH3 
O2CCH2NHC0CH3 sp RMP2/6-3IG*//B3LYP/6-31G*\\0,1\C,-0.453984955,0.04227 
644 97,-0.46106 73375\N,-0.434416958,- 0.0062114363,0.9807989618\C,0.9689
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0 9 6 8 6 5 , - 0 . 0 2 6 2 4 9 8 5 1 7 , - 0 . 9 8 0 1 2 7 1 8 9 1 \ H , - 0 . 9 3 1 2 0 5 2 3 4 8 , 0 . 9 6 0 9 4 5 7 1 8 6 , - 0 . 8 2 6  
7 0 2 9 3 3 6 \ 0 , 1 . 9 5 5 6 3 7 6 5 1 8 , - 0 . 1 0 7 7 6 2 4 5 0 8 , - 0 . 2 7 7 3 6 1 4 9 5 5 \ 0 , 0 . 9 9 3 5 7 4 5 0 9 6 , 0 . 0 1  
5 2 6 0 6 1 3 5 , - 2 . 3 2 0 9 7 8 7 0 3 \ C , 2 . 3 0 1 0 4 0 7 6 9 4 , - 0 . 0 4 3 5 0 3 6 9 3 8 , - 2 . 9 2 1 6 2 4 2 9 9 5 \ H , 0 . 4  
7 6 1 1 3 8 1 4 8 , - 0 . 0 7 4 6 2 9 0 7 9 9 , 1 . 4 1 6 1 8 0 3 4 9 \ C , - 1 . 5 8 9 5 7 0 3 4 9 4 , 0 . 0 4 0 0 6 4 2 7 7 8 , 1 . 7 0 4  
2 0 5 7 3 5 9 \ O , - 2 . 6 8 7 6 2 5 3 6 5 8 , 0 . 1 2 3 8 5 1 5 6 9 2 , 1 . 1 6 5 4 9 0 6 1 3 5 \ C , - 1 . 4 2 2 3 6 9 6 6 5 2 , -  0 . 0  
1 9 0 5 4 5 5 3 2 , 3 . 2 1 4 9 8 0 7 1 2 4 \ H , - 1 . 0 3 6 3 9 8 3 0 6 7 , - 0 . 7 8 6 7 1 8 5 4 2 7 , - 0 . 8 8 4 0 2 6 3 1 6 2 \ H , 2 
. 1 2 8 1 9 5 2 7 9 6 , 0 . 0 0 1 3 8 0 1 9 4 9 , - 3 . 9 9 6 6 9 7 6 2 7 4 \ H , 2 . 9 1 0 1 4 0 6 9 2 , 0 . 8 0 2 2 2 2 1 8 5 5 , - 2 . 5  
9 2 7 9 6 5 7 7 6 \ H , 2 . 8 0 4 0 0 9 5 2 9 3 , - 0 . 9 7 4 9 4 8 5 7 2 1 , - 2 . 6 4 9 9 3 3 8 8 3 1 \ H , - 1 . 8 6 9 8 2 0 1 1 5 2 , 0  
. 8 7 7 5 3 6 4 1 7 1 , 3 . 6 5 4 9 0 9 7 4 5 9 \ H , - 1 . 9 7 6 9 8 8 3 6 4 6 , - 0 . 8 8 1 2 3 2 8 8 7 2 , 3 . 5 9 7 9 2 6 7 6 2 7 \ H ,  
- 0 . 3 7 9 9 7 5 8 7 1 3 , - 0 . 0 9 3 0 6 9 0 0 8 5 , 3 . 5 4 0 1 3 8 6 9 4 4 \ \ V e r s i o n = F u j i t s u - V P - U n i x - G 9 4 R  
e v E . 2 \ H F = - 4 7 3 . 6 4 8 0 5 9 2 \ M P 2 = - 4 7 4 . 9 7 6 4 9 0 3 \ R M S D = 7 . 4 2 2 e - 0 9 \ P G = C 0 1  [X(C5H9N1 
0 3 ) ] \ \ @
MeCONHCH'CChMe 2
1 \ 1 \ G I N C - P C \ S P \ R O M P 2 - F C \ 6 - 3 I G ( d ) \ C 5 H 8 N 1 0 3 ( 2 ) \ A K C 5 0 1 \ 3 0 - M a r - 1 9 9 8 \ 0 \ \ #  R 
O M P 2 / 6 - 3 1 G *  SCF=DI RECT GUESS=CHECK GEOM=CHECK TEST M A X D I S K = 5 2 4 2 8 8 0 0 0 0 \  
\ C H 3 0 2 C C H ' NHCOCH3 s p  R M P 2 / 6 - 3 l G * / / B 3 L Y P / 6 - 3 I G * \ \ 0 , 2 \ C , - 0 . 3 8 2 4 7 0 0 6 6 9 , 0 .  
0 1 8 6 7 2 3 6 3 8 , - 0 . 3 7 3 1 5 6 1 8 \ N , - 0 . 3 6 4 5 3 2 2 9 2 5 , - 0 . 0 1 6 0 0 0 1 2 1 , 0 . 9 9 0 5 7 5 5 0 8 5 \ C , 0 . 8  
9 7 7 6 8 5 1 5 9 , - 0 . 0 1 3 5 3 0 9 1 3 5 , - 1 . 0 3 2 7 2 9 2 9 2 7 \ H , - 1 . 3 3 7 7 4 6 5 7 8 2 , 0 . 0 6 6 9 3 2 9 9 4 1 , - 0 .  
8 7 3 8 3 8 8 1 6 9 \ 0 , 1 . 9 6 9 5 4 1 2 0 8 6 , - 0 . 0 6 8 5 7 1 8 1 0 1 , - 0 . 4 3 1 9 0 7 6 0 4 8 \ 0 , 0 . 7 8 4 9 3 8 7 7 3 2 , 0  
. 0 2 4 1 3 8 8 5 8 , - 2 . 3 8 2 5 1 1 6 3 4 7 \ C , 2 . 0 2 7 9 6 4 7 2 4 , - 0 . 0 0 5 0 7 0 5 7 2 5 , - 3 . 0 9 6 6 4 8 4 4 0 5 \ H , 0 
. 5 6 2 8 6 7 5 9 6 6 , - 0 . 0 5 8 2 0 0 0 6 9 5 , 1 . 4 0 4 4 7 6 0 0 1 7 \ C , - 1 . 5 0 2 4 9 7 0 9 8 6 , 0 . 0 0 6 9 3 0 7 2 9 2 , 1 .  
7 9 2 7 9 6 7 6 0 9 \ O , - 2 . 6 2 0 5 6 3 7 8 2 5 , 0 . 0 5 1 2 6 6 4 4 5 1 , 1 . 3 0 7 4 7 6 9 7 2 8 \ C , - 1 . 2 3 4 5 5 2 1 4 2 7 , 0  
. 0 0 1 5 1 4 4 6 3 6 , 3 . 2 8 4 9 7 8 8 8 0 4 \ H , 1 . 7 5 8 4 9 3 9 5 4 6 , 0 . 0 3 0 3 5 1 3 9 6 8 , - 4 . 1 5 2 7 0 0 5 4 6 4 \ H , 2 
. 6 4 7 9 4 9 9 8 2 2 , 0 . 8 5 5 7 6 2 1 4 5 7 , - 2 . 8 3 0 2 5 2 7 4 2 3 \ H , 2 . 5 8 1 6 6 6 6 3 7 , - 0 . 9 2 1 4 2 1 7 9 8 , - 2 . 8  
7 2 8 9 0 9 2 9 1 \ H , - 1 . 3 9 0 5 1 2 2 2 4 5 , 1 . 0 1 1 0 8 3 8 4 0 2 , 3 . 6 8 2 7 3 2 4 2 2 2 \ H , - 1 . 9 5 8 6 4 6 1 1 4 4 ,  - 0  
. 6 5 8 1 4 1 6 5 8 9 , 3 . 7 6 9 4 4 5 9 4 5 9 \ H , - 0 . 2 2 0 9 6 0 3 9 0 6 , - 0 . 3 2 0 1 3 0 3 7 1 , 3 . 5 4 3 0 8 7 8 7 0 3 \ \ V e  
r s i o n = S G I - G 9 4 R e v E . 2 \ H F = - 4 7 3 . 0 3 0 8 9 8 5 \ M P 2 = - 4 7 4 . 3 4 6 6 1 6 3 \ R M S D = 7 . 0 8 9 e - 0 9 \ P G  
= C01  [X ( C 5 H 8 N 1 0 3 ) ] \ \ @
CF3C0NHCH2C 02Me 4
l \ l \ G I N C - V P P 1 2 \ S P \ R M P 2 - F C \ 6 - 3 I G ( d ) \ C 5 H 6 F 3 N 1 0 3 \ A K C 5 0 l \ 3 0 - M a r - 1 9 9 8 \ 0 \ \ # P  
R M P 2 / 6 - 3 1 G *  SCF=DI RECT GUESS=CHECK GEOM=CHECK TEST M A X D I S K = 1 6 7 7 7 2 1 6 \ \  
CH302CCH2NHC0CF3 s p  R M P 2 / 6 - 3 1 G * / / B 3 L Y P / 6 - 3 1 G * \ \ 0 , 1 \ C , - 0 . 1 1 8 1 9 1 9 8 3 2 , 0 . 0  
8 4 1 3 7 5 0 9 2 , - 1 . 4 2 3 8 6 6 2 2 2 7 \ N , - 0 . 1 1 1 2 5 2 3 0 4 1 , - 0 . 0 2 3 5 0 7 2 6 5 3 , 0 . 0 1 7 3 4 1 3 5 3 4 \ C , 1 
. 3 0 5 4 9 5 9 8 1 2 , - 0 . 0 6 8 4 3 8 6 0 6 8 , - 1 . 9 2 7 5 7 8 4 7 0 5 \ H , - 0 . 5 2 5 0 1 2 8 5 9 8 , 1 . 0 5 0 1 6 9 8 5 8 4 , -
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Experimental
1.7471419266\0,2.2636369689,-0.2659424489,-1.2097545595\0,1.3556135739 
,0.04 21832917,-3.2605081494\C,2.665695439,-0.0884190896,-3. 8489821764\ 
H,0.7817874637,-0.2036357959,0.4611124665\C,-1.2481037278,0.1143135332 
,0.7319476218\0,-2.3550789652,0.3257799471,0.2661143162\C,-1.058483487 
2,0.0036246585,2.262574948\H,-0.7540995607,-0.6856094921,-1.8793567627 
\H,2.5127810385,0.0260708601,-4.921634464\H,3.331760262,0. 68 913 094 53,- 
3.4674456088\H,3.0881774379,-1.0697315663,-3.6203008801\F,-1.889926550 
4,-0.915714177,2.7690911045\F,0.2080573428,-0.3483005911,2.598668354\F 
,-1.3235167486,1.1829794016,2.8457950573\\Version=Fujitsu-VP-Unix-G94R 
evE.2\HF=-770.2166162\MP2=-772.0522848\RMSD=7.381e-09\PG=C01 [X(C5H6F3 
N103)]\\@
CF3CONHCH*CO,Me 5
1\1\GINC-VPP05\SP\ROMP2-FC\6- 3IG(d)\C5H5F3N103(2)\AKC501\31-Mar-1998\0 
\\#P ROMP2/6-31G* SCF=DIRECT GUESS=CHECK GEOM=CHECK TEST MAXDISK=20971 
520\\CH3O2CCH'NHCOCF3 sp RMP2/6-31G*//B3LYP/6-31G*\\0,2\C,-0.102352627
3.0. ,-1.3569836426\N,-0.0842256548,0.,0.0067974199\C,1.1898975766,0.,- 
2.0062066926\H,-1.0554562355,0.,-1.8646204514\0,2.2495779074,0.,-1.387 
1076531\0,1.0872547885,0.,-3.3518848058\C,2.3375145272,0.,-4.059625881 
7\H,0.8390677026,0.,0.4356720212\C,-1.2120204268,0.,0.792973712\0,-2.3
525400784.0. .0.3711063384,C,-0.9271791873,0.,2.3089771847\H,2.07239372
46.0. ,-5.1169039161\H,2.9208713526,0.8900860002,-3.8087645456\H,2.9208 
713526,-0.8900860002,-3.8087645456\F,0.4032178667,0.,2.5732111592\F, -1 
.4625905127,1.0871477471,2.879176664\F, -1.4625905127,-1.0871477471,2.8 
79176664\\Version=Fujitsu-VP-Unix-G94RevE.2\State=2-A"\HF=-769.5962938 
\MP2 = - 771.41864 74\RMSD=4. 485e-09\PG=CS [SG(C5H3F1N103) ,X(H2F2)]\\@
MeCONHCH(Me)CO,Me
1\1\GINC-VPP09\SP\RMP2-FC\6-3 IG(d)\C6HllN103\AKC501\ll-Apr-1998\0\\#P 
RMP2/6-31G* SCF=DIRECT GUESS=CHECK GEOM=CHECK TEST MAXDISK=8388608\\CH 
3CONHCHCH3C02CH3 sp RMP2/6-3 IG*//B3LYP/6-3IG*\\0,1\C,-0.3667196064,0.0 
7166053 73, - 0.3851585219\N,-0.3593680447,0.096 31424 76,1.0662887614\C,1. 
0808071321,-0.0362817008,-0.8478985426\C,-1.0607758274,1.3046628996,-0 
.9963952232\0,2.047717929,0.0659179095,-0.1192160876\O,1.1571717024,-0 
.2400960536,-2.1728676547\C,2.4886121862,-0.3267202763,-2.7137908888\H 
, 0.5434 545641,0.22 86 542 78,1.5041432191\C,-1.457 5634565,-0.2628307173,1
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Experimental
. 7 9 2 5 2 2 1 7 2 7 \ 0 , - 2 . 5 2 8 3 6 8 7 2 2 6 , - 0 . 5 4 6 1 2 3 3 3 5 1 , 1 . 2 6 4 5 7 5 9 0 7 4 \ C , - 1 . 2 6 8 4 9 2 9 5 3 2  
, - 0 . 2 8 1 4 7 3 7 1 3 7 , 3 . 3 0 2 0 7 4 8 0 0 9 \ H , - 0 . 9 0 6 9 9 8 2 5 8 1 , - 0 . 8 2 2 4 5 6 5 9 8 8 , - 0 . 7 1 9 1 6 1 7 1 2  
9 \ H , 2 . 3 5 7 0 4 0 2 1 1 5 , - 0 . 4 8 9 0 7 5 9 7 7 4 , - 3 . 7 8 3 4 4 8 0 9 1 7 \ H , 3 . 0 3 7 2 5 3 5 6 8 2 , 0 . 6 0 0 1 0 0 1 1  
3 8 , - 2 . 5 2 8 2 3 1 1 5 0 5 \ H , 3 . 0 3 0 5 0 4 1 1 9 3 , - 1 . 1 6 0 5 1 9 5 3 6 5 , - 2 . 2 6 0 4 8 7 3 5 5 9 \ H , - 2 . 0 0 2 3 1  
3 9 4 0 5 , 0 . 3 9 0 2 3 6 5 4 7 1 , 3 . 7 5 7 8 4 0 2 6 7 8 \ H , - 1 . 4 7 7 6 9 7 6 6 3 5 , - 1 . 2 9 0 4 8 6 0 4 8 , 3 . 6 7 1 1 0 9 7  
5 9 2 \ H , - 0 . 2 6 5 6 6 7 1 8 6 9 , 0 . 0 1 5 5 8 7 0 7 8 6 , 3 . 6 2 4 0 4 6 6 4 4 1 \ H , - 1 . 0 6 7 4 6 0 9 1 3 3 , 1 . 2 4 0 7 1 1  
54 9 4 , - 2 . 0 8 8 2 0 1 7 1 3 6 \ H , - 2 . 0 9 0 7 2 1 3 2 3  9 , 1 . 3 3 6 0 7 2  8 6 8 9 , -  0 . 6 3 3 9 9 8 4 2 7 1 \ H , - 0 . 5 4  9 
1 8 8 9 8 2 1 , 2 . 2 2 5 2 8 5 6 5 2 7 , - 0 . 6 9 5 6 9 2 8 7 1 7 \ \ V e r s i o n = F u j i t s u - V P - U n i x - G 9 4 R e v E . 2 \  
H F = - 5 1 2 . 6 8 4 7 5 1 8 \ M P 2 = - 5 1 4 . 1 4 8 3 9 1 \ R M S D = 3 . 8 9 5 e - 0 9 \ P G = C 0 1  [ X ( C 6 H 1 1 N 1 0 3 ) ] \ \  
@
MeC0NHC*(Me)C02Me 93a
1 \ 1 \ G I N C - V P P 0 5 \ S P \ R O M P 2 - F C \ 6 - 3 1 G ( d ) \ C 6 H 1 0 N 1 0 3 ( 2 ) \ A K C 5 0 1 \ 1 1 - A p r - 1 9 9 8 \ 0 \  
\ # P  R O M P 2 / 6 - 3 1 G *  SCF=DI RECT GUESS=CHECK GEOM=CHECK TEST MAXDI S K= 8 38 86 0  
8 \ \CH3NHCHCH3C02CH3 s p  R M P 2 / 6 - 3 I G * / / B 3 L Y P / 6 - 3 1 G * \ \ 0 , 2 \ C , - 0 . 2 8 9 5 5 5 8 4 6 4 ,  
- 0 . 0 0 4 3 9 8 9 7 4 2 , - 0 . 3 4 4 7 8 4 7 7 3 9 \ N , - 0 . 2 6 1 0 3 5 0 4 9 , - 0 . 0 0 3 8 0 6 3 2 , 1 . 0 3 3 7 4 4 4 9 8 4 \ C ,  
1 . 0 4 5 9 7 9 3 0 9 1 , - 0 . 0 0 8 0 0 7 2 9 4 9 , - 0 . 9 1 3 3 4 8 9 7 9 3 \ C , - 1 . 5 5 5 5 4 8 4 4 5 4 , - 0 . 0 0 1 9 0 4 6 2 8 7  
, - l . 1 3 3 4 1 0 5 1 6 4 \ 0 , 2 . 0 7 0 3 7 6 5 0 8 2 , - 0 . 0 0 9 9 4 5 7 4 8 8 , - 0 . 2 2 7 8 6 3 2 1 3 7 \ 0 , 1 . 0 6 0 1 7 8 0 5  
8 2 , - 0 . 0 0 8 3 9 8 0 2 3 7 , - 2 . 2 6 9 3 4 0 1 6 2 6 \ C , 2 . 3 6 5 6 9 6 1 0 8 4 , - 0 . 0 1 0 9 7 8 5 4 5 , - 2 . 8 6 1 2 5 7 1 7  
3 5 \ H , 0 . 6 8 9 5 5 3 3 3 1 7 , - 0 . 0 0 3 7 4 5 9 1 0 4 , 1 . 3 9 7 2 0 1 7 0 5 \ C , - 1 . 3 1 8 6 1 0 4 8 5 2 , 0 . 0 0 1 3 7 7 1 4  
2 1 , 1 . 9 3 0 9 3 1 2 2 4 6 \ 0 , - 2 . 4 9 0 6 7 6 6 5 8 2 , - 0 . 0 0 2 7 9 9 3 7 4 8 , 1 . 5 8 5 2 4 8 4 5 6 3 \ C , - 0 . 8 9 9 0 2 8  
5 4 2 5 , 0 . 0 3 6 6 4 4 9 6 5 8 , 3 . 3 9 1 3 7 5 6 6 3 5 \ H , 2 . 1 9 6 9 2 6 9 5 5 3 , - 0 . 0 1 1 3 5 1 4 0 7 8 , - 3 . 9 3 8 7 2 6 6  
3 9 8 \ H , 2 . 9 2 8 4 0 7 7 1 9 7 , 0 . 8 7 7 5 9 0 9 2 0 6 , - 2 . 5 6 1 4 4 3 4 4 2 \ H , 2 . 9 2 5 4 2 0 0 1 1 4 , - 0 . 9 0 1 0 4 0 2  
7 7 6 , - 2 . 5 6 0 3 2 5 5 2 8 \ H , - 1 . 1 1 8 6 8 7 2 7 0 3 , 1 . 0 2 8 7 9 4 0 5 2 4 , 3 . 8 0 1 8 0 4 4 4 2 3 \ H , - 1 . 5 0 3 0 4 1  
5 6 0 6 , - 0 . 6 8 6 7 6 7 9 4 0 5 , 3 . 9 4 5 4 1 8 2 3 1 9 \ H , 0 . 1 6 1 2 5 6 7 4 7 3 , - 0 . 1 8 0 1 5 8 1 5 8 6 , 3 . 5 5 2 0 0 3 2  
7 4 9 \ H , - 1 . 3 1 9 9 7 5 3 6 3 7 , - 0 . 0 0 0 0 9 5 7 1 4 7 , - 2 . 1 9 8 0 8 6 1 4 9 7 \ H , - 2 . 1 7 3 2 5 1 8 7 3 2 , - 0 . 8 7 6  
3 8 7 2 3 1 5 , - 0 . 8 9 9 4 1 0 0 3 8 2 \ H , - 2 . 1 7 1 9 7 9 2 0 8 , 0 . 8 7 2 5 5 5 0 9 5 2 , - 0 . 8 9 6 0 4 0 6 5 5 1 \ \ V e r s i  
o n = F u j i t s u - V P - U n i x - G 9 4 R e v E . 2 \ H F = - 5 1 2 . 0 6 6 2 5 7 6 \ M P 2 = - 5 1 3 . 5 1 7 7 3 9 \ R M S D = 5 . 3 9  
9 e - 0 9 \ P G = C 0 1  [ X ( C 6 H 1 0 N 1 O 3 ) ] \ \ @
MeC0NHCH(CF3)C02Me
1 \ 1 \ G I N C - V P P 1 2 \ S P \ R M P 2 - F C \ 6 - 3  I G ( d ) \ C 6 H 8 F 3 N 1 0 3 \ A K C 5 0 1 \ l l - A p r - 1 9 9 8 \ 0 \ \ # P  
R M P 2 / 6 - 3 1 G *  SCF=DI RECT GUESS=CHECK GEOM=CHECK TEST M A X D I S K = 8 3 8 8 6 0 8 \ \ C  
H3C0NHCHCF3C02CH3 s p  R M P 2 / 6 - 3  I G * / / B 3 L Y P / 6 - 3  I G * \ \ 0 , 1 \ C , - 0 . 1 2 3 7 4 2 5 4 9 4 , - 0  
. 2 2 0 0 7 1 2 0 9 , - 0 . 0 9 4 7 5 4 0 6 5 8 \ N , - 0 . 1 6 7 8 9 5 1 7 7 3 , - 0 . 1 3 9 1 1 2 0 8 5 3 , 1 . 3 4 0 5 0 0 0 1 1 5 \ C ,  
1 . 3 3 4 3  9 2 7 8 4 5 , - 0 . 3 7 5 1 6 5 4 2 4 7 , -  0 . 5 4 3 8 2 3 2 9 3 4 \ C , - 0 . 7 6 1 7 9 7 2 9 2 9 , 1 . 0 2 3 4 1 5 6 8 8 2 ,
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Experimental
- 0 . 7 4 2 0 0 8 0 4 0 2 \ O , 2 . 2 7 9 2 4 9 4 2 5 9 , - 0 . 2 1 5 2 8 2 6 7 6 8 , 0 . 1 9 7 9 7 3 9 9 8 1 \ 0 , 1 . 4 1 8 9 6 7 4 1 5 2  
, - 0 . 7 0 0 2 8 4 8 8 1 8 , - 1 . 8 3 6 3 4 2 0 7 9 8 \ C , 2 . 7 5 6 3 4 7 5 7 8 7 , - 0 . 8 3 0 3 4 2 0 3 1 6 , - 2 . 3 6 1 7 0 6 9 7 5  
9 \ H , 0 . 6 6 8 1 1 4 3 5 9 , 0 . 2 1 3 2 7 3 0 8 0 1 , 1 . 7 8 8 7 7 0 5 9 8 4 \ C , - 1 . 0 9 4 2 4 6 8 2 9 7 , - 0 . 8 6 2 5 0 3 4 6 0  
3 , 2 . 0 5 9 0 4 5 3 6 1 9 \ O , - 1 . 9 7 9 2 3 6 6 3 3 6 , - 1 . 5 0 6 5 8 8 9 9 9 6 , 1 . 5 1 5 8 7 3 7 1 9 \ C , - 0 . 9 5 4 2 5 7 5 0  
4 6 , - 0 . 7 6 7 2 5 5 6 4 1 8 , 3 . 5 6 7 8 2 8 7 6 5 8 \ H , - 0 . 7 1 9 8 7 3 8 1 8 3 , - 1 . 0 8 0 5 7 3 1 5 1 6 , - 0 . 4 1 4 5 5 6 1  
0 3 4 \ H , 2 . 6 2 8 4 4 7 0 0 3 9 , - 1 . 0 8 2 2 9 0 1 8 1 5 , - 3 . 4 1 3 7 8 0 5 4 1 4 \ H , 3 . 2 9 9 0 8 1 1 6 5 , 0 . 1 1 1 2 6 5 5  
9 7 , - 2 . 2 5 0 8 2 2 4 5 9 7 \ H , 3 . 2 9 3 3 1 2 5 3 8 2 , - 1 . 6 2 2 5 6 1 7 5 7 3 , - 1 . 8 3 4 6 9 8 0 9 2 9 \ H , - 1 . 7 5 5 9 1  
8 0 7 2 1 , - 0 . 1 3 0 1 6 3 7 2 2 6 , 3 . 9 5 6 9 7 2 1 2 9 1 \ H , - 1 . 0 8 7 2 4 8 5 8 6 8 , - 1 . 7 6 3 7 9 5 8 5 0 9 , 3 . 9 9 6 2 0  
0 6 6 1 3 \ H , 0 . 0 0 5 9 0 8 6 4 3 6 , - 0 . 3 5 4 7 9 9 2 1 1 7 , 3 . 8 9 2 3 2 7 8 4 5 9 \ F , - 0 . 9 1 1 5 7 7 9 1 4 , 0 . 8 6 2 9 0  
1 1 3 5 2 , - 2 . 0 6 9 2 9 3 4 7 2 4 \ F , - 1 . 9 6 9 4 3 7 6 6 0 6 , 1 . 2 6 9 7 2 3 0 1 1 1 , - 0 . 2 1 3 6 0 2 2 2 2 6 \ F , 0 . 0 0 8  
9 5 1 6 , 2 . 1 1 7 6 2 1 9 3 5 5 , - 0 . 5 4 2 8 2 0 9 4 1 8 \ \ V e r s i o n = F u j i t s u - V P - U n i x - G 9 4 R e v E . 2 \ H F =  
- 8 0 9 . 2 6 1 8 0 1 8 \ MP 2 = - 8 1 1 . 2 3 0 2 2  9 4 \ R M S D = 3 . 8 7 0 e - 0 9 \ P G = C 0 1  [ X ( C 6 H 8 F 3 N 1 0 3 ) ] \ \ @
MeC0NHC*(CF3)C 0 2Me 94a
1 \ l \ G I N C - R S C Q C 8 \ S P \ R O M P 2 - F C \ 6 - 3  I G ( d ) \ C 6 H 7 F 3 N 1 0 3 ( 2 ) \ A N N A \ 1 2 - A p r - 1 9 9 8 \ 0 \  
\ # P  R O M P 2 / 6 - 3 1 G *  SCF=DI RECT GUESS=CHECK GEOM=CHECK TEST M A XDI SK= 10 4857  
6 0 0 0 \ \ C H 3 N H C H C F 3 C 0 2 C H 3  s p  R M P 2 / 6 - 3 1 G * / / B 3 L Y P / 6 - 3 1 G * \ \ 0 , 2 \ C , 0 . 1 6 0 7 2 2 1 9 0  
5 , 0 . 0 6 8 4 2 4 3 5 2 8 , - 0 . 0 3 5 3 2 1 3 0 9 8 \ N , 0 . 1 7 9 9 0 9 6 0 4 5 , 0 . 1 1 7 5 4 9 5 9 , 1 . 3 3 6 2 2 7 5 4 2 \ C , 1 
. 5 1 2 7 5 7 1 4 8 3 , 0 . 0 5 6 9 8 8 2 1 3 4 , - 0 . 6 0 4 2 8 7 1 4 1 6 \ C , - 1 . 1 3 4 1 2 6 4 4 5 2 , 0 . 0 9 6 7 2 1 6 5 0 6 , - 0  
. 8 0 8 7 1 0 5 9 7 2 \ O , 2 . 5 0 1 8 3 8 1 0 2 9 , 0 . 1 5 5 2 1 7 4 2 9 3 , 0 . 1 1 8 0 4 5 8 2 9 6 \ O , 1 . 5 7 3 6 0 5 2 8 1 4 , - 0  
. 0 8 4 3 9 2 2 0 8 8 , - 1 . 9 3 6 1 2 7 8 7 1 6 \ C , 2 . 9 0 1 0 9 9 9 8 6 2 , - 0 . 1 0 6 4 0 1 3 4 3 8 , - 2 . 4 8 8 7 7 0 3 5 1 5 \ H  
, 1 . 1 3 0 0 9 5 4 1 9 8 , 0 . 2 5 3 6 0 4 2 6 4 5 , 1 . 6 8 0 6 3 0 7 2 6 1 \ C , - 0 . 8 1 7 8 0 1 3 5 7 2 , - 0 . 1 8 9 0 4 3 2 5 1 3 ,  
2 . 2 7 5 7 7 7 2 7 9 5 \ 0 , - 1 . 9 1 7 9 0 7 9 9 9 , - 0 . 5 9 2 6 5 5 6 3 9 5 , 1 . 9 6 1 7 9 5 3 6 1 \ C , - 0 . 3 7 5 7 3 0 0 6 2 6 ,  
0 . 0 5 4 0 2 9 9 0 3 2 , 3 . 7 0 7 2 8 7 5 3 4 \ H , 2 . 7 6 1 0 6 4 6 0 8 2 , - 0 . 2 2 8 1 0 1 6 4 2 , - 3 . 5 6 2 6 0 0 2 5 8 8 \ H , 3  
. 4 2 2 2 7 4 8 5 8 1 , 0 . 8 2 9 1 0 0 8 1 9 , - 2 . 2 6 9 9 1 3 0 7 3 2 \ H , 3 . 4 7 4 2 2 1 9 8 5 7 , - 0 . 9 4 0 5 1 2 0 5 5 6 , - 2 .  
0 7 5 7 8 4 6 2 1 4 \ H , - 0 . 3 2 3 3 4 5 1 3 0 3 , 1 . 1 3 0 5 5 9 9 3 4 6 , 3 . 9 0 9 8 2 0 8 7 2 9 \ H , - 1 . 1 0 9 8 1 7 4 7 1 9 , -  
0 . 3 9 5 2 4 1 7 7 8 8 , 4 . 3 7 6 9 0 4 3 0 4 3 \ H , 0 . 6 1 2 8 2 1 9 2 7 , - 0 . 3 7 3 3 9 4 0 3 6 , 3 . 9 1 0 5 2 5 7 8 7 9 \ F , - 0  
. 9 3 4 6 8 2 1 4 1 8 , 0 . 4 9 3 0 6 4 4 5 6 9 , - 2 . 0 7 9 7 3 3 4 2 \ F , - 1 . 7 2 9 6 9 7 4 2 9 4 , - 1 . 1 1 0 5 6 8 9 1 1 5 , - 0 .  
8 5 7 2 6 7 8 4 7 8 \ F , - 1 . 9 9 8 7 8 6 5 7 , 0 . 9 7 2 1 1 1 5 1 7 8 , - 0 . 2 5 7 3 0 2 6 8 3 8 \ \ V e r s i o n = I B M - R S 6 0 0  
0 - G 9 4 R e v E . 1 \ H F = - 8 0 8 . 6 2 8 9 1 0 5 \ M P 2  = - 8 1 0 . 5 8 5 4 2 6 \ R M S D = 8 . 9 6 9 e - 0 9 \ P G = C 0 1  [ X( C 
6 H 7 F 3 N 1 0 3 ) ] \ \ @
M eC 02CH2C 0 2Me
l \ l \ G I N C - S C 4 4 \ F O p t \ R B 3 L Y P \ 6 - 3 1 G ( d ) \ C 5 H 8 O 4 \ R O O T \ 1 7 - S e p - 2 0 0 1 \ 0 \ \ # N  B3LYP 
/ 6 - 3 I G ( D )  TEST SCF=DI RECT OPT M A X D I S K = 3 9 3 21 60 0 \ \ M eC OO C H2 CO 2M e a  B3LYP /  
6 - 3 I G ( d )  g e o m  o p t \ \ 0 , 1 \ 0 , - 0 . 5 3 1 8 5 0 0 6 6 , 1 . 2 8 4  5 4 0 0 6 2 9 , 0 . 4 8 9 3 6 1 1 9 1 5 \ C , 0 . 8
Experimental
6 5 5 7 5 2 7 0 7 . 1 . 0 9 8 9 6 2 6 1 3 5 . 0 .  2 6 8 9 6 5 4 7 0 3 . H , 1 . 2 2 2 2 2 3 6 9 8 7 , 2 . 0 3 4 3 8 3 1 1 2 6 , - 0 . 1 6 9  
6 9 1 1 9 4 6 \ C , 1 . 2 2 3 7 4 0 7 8 5 9 , - 0 . 0 4 1 0 0 6 2 7 2 7 , - 0 . 6 7 7 2 0 3 4 3 1 4 \ 0 , 2 . 3 6 8 2 8 7 9 6 6 4 , - 0 . 3  
9 5 2 4 7 1 1 4 4 , - 0 . 8 4 8 4 8 4 4 4 2 2 \ 0 , 0 . 1 5 6 9 9 1 0 9 3 4 , -  0 . 5 5 7 2 9 5 3 0 7 3 , - 1 . 3 0 6 7 6 0 5 0 1 3 \ C , 0 
. 4 4 5 9 0 2 4 2 7 6 , - 1 . 6 4 5 5 4 2 8 0 8 , - 2 . 2 0 3 3 9 2 6 8 7 9 \ H , 1 . 1 3 1 0 9 5 1 1 0 9 , - 1 . 3 2 0 0 2 5 6 3 4 2 , - 2  
. 9 9 0 1 4 8 4 1 8 6 \ H , - 0 . 5 1 5 6 5 2 7 3 3 1 , - 1 . 9 3 8 0 2 8 1 9 2 , - 2 . 6 2 5 2 4 8 9 2 1 1 \ H , 0 . 8 9 6 9 6 0 2 3 7 4 ,  
- 2 . 4 7 7 4 0 0 8 6 5 1 , - 1 . 6 5 6 8 0 9 5 0 9 5 \ H , 1 . 3 9 1 7 8 9 6 3 2 , 0 . 9 2 0 2 5 1 2 1 3 2 , 1 . 2 0 9 5 1 7 3 4 4 7 \ C ,  
- 1 . 1 1 9 7 4 6 8 0 3 9 , 0 . 3 6 0 0 8 0 5 1 9 9 , 1 . 2 9 8 2 1 7 8 9 3 1 \ 0 , - 0 . 5 0 9 9 0 5 4 1 1 3 , - 0 . 5 4 0 6 9 8 2 0 4 9 ,
1 . 8 2 6 7 5 4 4 7 1 1 \ C , - 2 . 5 9 9 3 7 4 1 6 8 2 , 0 . 6 2 3 8 7 5 6 9 3 5 , 1 . 4 1 9 1 7 8 2 0 5 6 \ H , - 3 . 0 2 8 6 6 8 3 7 7 4  
, - 0 . 0 4 8 2 0 7 7 9 1 3 , 2 . 1 6 2 8 1 1 4 1 8 7 \ H , - 3 . 0 7 9 9 8 4 8 0 4 4 , 0 . 4 5 4 6 0 3 7 8 7 2 , 0 . 4 4 9 3 9 2 3 6 0 8 \  
H , - 2 . 7 8 2 5 3 6 4 9 6 , 1 . 6 6 5 8 1 0 4 0 1 8 , 1 . 6 9 8 6 1 8 4 6 8 8 \ \ V e r s i o n = D E C - A X P - O S F / l - G 9 8 R e v  
A . 9 \ H F = - 4 9 6 . 2 5 8 9 4 0 4 \ R M S D = 6 . 9 0 4 e - 0 9 \ R M S F = l . 6 8 3 e - 0 5 \ D i p o l e = - 0 . 9 2 0 1 4 9 4 , 0 .  
4 0 7 2 9 8 , - 0 . 5 1 4 1 7 9 5 \ P G = C 0 1  [ X ( C 5 H 8 0 4 ) ] \ \ @
MeC02CH‘C 02Me 95a
l \ l \ G I N C - S C 4 l \ F O p t \ U B 3 L Y P \ 6 - 3 1 G ( d ) \ C 5 H 7 0 4 ( 2 ) \ R O O T \ 1 7 - S e p - 2 0 0 1 \ 0 \ \ # N  UR 
3 L Y P / 6 - 3 1 G ( D )  TEST SCF=DI RECT OPT=TIGHT M A X D I S K = 2 6 21 44 00 \ \ Me C OO C Hr C O2 M 
e a  r a d i c a l  UB3LYP /  6 - 3 1 G ( d )  g e o m  o p t \ \ 0 , 2 \ C , - 0 . 2 9 8 5 4 6 2 0 2 1 , 0 . 3 2 8 1 5 7 6 6 2
2 . 0 .  \ O , 1 . 0 5 3 4 6 3 9 9 9 8 , 0 . 3 3 0 5 8 5 3 8 7 4 , 0 . \ H , - 0 . 8 1 8 1 1 3  4 8 2 4 , 1 . 2 7 6 4 7 7 0 6 0 2 , 0 . \ C ,  
- 0 . 9 3 8 9 1 0 3 1 1 9 , - 0 . 9 6 8 6 9 8 9 0 6 l , 0 . \ O , - 0 . 3 7 0 7 1 8 5 0 1 , - 2 . 0 4  8 2 2  8 0 3 2  7 , 0 . \ 0 , - 2 . 2 9  
1 8 5 4  3 9 4  4 , - 0 . 8 1 3 1 8 0 4  2 0 8 , 0 . \ C , - 3 . 0 3 7 3 4 8 4 9 1 2 , - 2 . 0 3 7 5 0 8 4 9 0 1 , 0 . \ C , 1 . 7 0 6 8 1 0 3
7 0 2 . 1 . 5 5 6 5 8 4 2 7 9 4 . 0 .  \ 0 , 1 . 1 2 0 2 2 1 6 7 8 9 , 2 . 6 0 7 6 0 6 4 6 5 3 , 0 . \ C , 3 . 1 9 3 5 7 5 8 4 6 1 , 1 . 3 3
7 3 5 0 7 1 8 7 . 0 .  \ H , 3 . 7 0 1 5 0 6 2 6 0 7 , 2 . 3 0 1 9 4 6 4 5 0 7 , 0 . \ H , - 4 . 0 8 6 8 0 3 6 3 0 3 , - 1 . 7 4 1 1 0 7 8 3
1 3 . 0 .  \ H , - 2 . 8 0 6 2 9 7 8 0 4 3 , - 2 . 6 3 1 2 3 7 9 7 6 7 , 0 . 8 8 9 1 7 5 3 2 6 5 \ H , - 2 . 8 0 6 2 9 7 8 0 4 3 , - 2 . 6 3  
1 2 3 7 9 7 6 7 , - 0 . 8 8 9 1 7 5 3 2 6 5 \ H , 3 . 4 8 6 8 0 8 4 6 3 7 , 0 . 7 5 7 7 9 0 7 4 7 6 , 0 . 8 8 1 5 4 3 3 6 5 4 \ H , 3 . 4 8
6 8 0 8 4 6 3 7 . 0 .  7 5 7 7 9 0 7 4 7 6 . - 0 . 8 8 1 5 4 3 3 6 5 4 \ \ V e r s i o n = D E C - A X P - O S F / l - G 9 8 R e v A . 9 \ S  
t a t e = 2 - A " \ H F = - 4  9 5 . 6 0 7 5 7 2 2 \ S 2  = 0 . 7 5 5 5 3 8 \ S 2 - 1  = 0 . \ S 2 A = 0 . 7 5 0 0 2 \ R M S D = 9 . 1 9 4 e -  
0 9 \ R M S F = 3 . 4 7 0 e - 0 7 \ D i p o l e = 0 . 1 4 1 5 0 5 2 , 0 . 0 6 7 9 0 8 , 0 . \ P G = C S  [ S G ( C 5 H 3 0 4 )  , X ( H 4 )  
] \ \ @
MeC0CH2CH2C 02Me
l \ l \ G I N C - S C 9 6 \ F O p t \ R B 3 L Y P \ 6 - 3 1 G ( d ) \ C 6 H 1 0 O 3 \ D J H 5 0 1 \ 2 3 - M a y - 2 0 0 4 \ 0 \ \ # N  B3 
L Y P / 6 - 3 1 G *  SCF=TI GHT O P T = ( C A L C F C , TIGHT)  M A X D I S K = 5 2 4 2 8 8 0 0  I O P ( 1 / 8 = 1 0 ) \ \  
CH3COCH2CH2C02CH3a  1 3 c a  B3LYP /  6 - 3 1 G ( d )  g e o m  o p t \ \ 0 , 1 \ C , 3 . 6 3 2 1 4 8 4 6 4 6 ,  
0 . 6 9 8 1 7 3 3 6 9 1 , 0 . 2 2 7 5 8 8 1 6 6 4 \ C , 2 . 4 2 0 4 9 5 2 7 5 9 , - 0 . 1 7 8 8 3 7 3 6 2 6 , - 0 . 0 3 6 1 7 2 3 2 1 6 \ 0  
, 2 . 5 3  3 7 9 0 8 2 3 1 , - 1 . 3 3  64 6 2 1 5 3 6 , -  0 . 3 9 4 6 5 1 2 3 4 7 \ C , 1 . 0 5 8 3 6 3 6 6 6 8 , 0 . 4 7 3 7 2 5 2 0 7 6 ,  
0 . 1 6 3  9 7 0 9 1 0 7 \ C , - 0 . 0 9 8 0 0 4 7 1 4 3 , - 0 . 5 2 0 1 7 2 2 6 5 2 , 0 . 1 0 8 4 3 3 5 2 6 8 \ C , - 1 . 4 3 8 3 6 6 7 3 0
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Experimental
3 . 0 .  1 6 4 6 3 7 7 5 8 8 , - 0 . 0 6 0 0 9 4 3 7 8 6 \ 0 , - 1 . 6 0 7 2 2 7 0 5 7 7 , 1 . 3 0 1 2 0 3 6 1 2 2 , - 0 . 4 4 9 8 6 0 9 4 3  
4 \ 0 , - 2 . 4 5 1 3 1 6 8 3 6 7 , - 0 . 6 7 1 0 4 4 7 2 8 , 0 . 2 5 8 0 5 5 3 7 8 \ C , - 3 . 7 7 2 4 1 5 2 1 6 7 , - 0 . 1 3 4 2 1 7 1 9
8 6 . 0 .  0 7 9 8 1 8 8 7 4 6 \ H , 0 . 9 2 6 8 1 5 5 8 1 6 , 1 . 2 3 7 8 5 1 7 2 0 9 , - 0 . 6 1 4 7 2 3 1 1 2 6 \ H , 1 . 0 5 9 7 0 1 4 1  
3 1 , 1 . 0 3 3 2 3 6 9 8 3 4 , 1 . 1 0 9 1 3 6 4 2 \ H , 0 . 0 4 6 0 1 9 9 1 0 3 , - 1 . 2 0 4 2 8 4 3 8 5 4 , - 0 . 7 3 7 3 0 2 5 8 4 7 \  
H , - 0 . 1 2 8 1 2 0 7 3 8 , - 1 . 1 5 9 8 4 7 6 9 9 3 , 0 . 9 9 6 1 3 6 2 1 6 2 \ H , 4 . 5 3 9 2 7 3 8 8 3 3 , 0 . 1 8 6 3 5 2 5 4 7 1 ,  
- 0 . 0 9 9 8 6 5 7 1 6 7 \ H , 3 . 5 4 0 5 4 0 8 5 7 3 , 1 . 6 6 3 5 0 6 7 5 9 7 , - 0 . 2 8 4 4 4 3 6 2 0 6 \ H , 3 . 7 0 8 6 5 2 9 4 2 7  
, 0 . 9 1 2 8 3 2 5 8 7 5 , 1 . 3 0 1 5 2 1 7 9 4 7 \ H , - 4 . 4 5 4 3 3 4 4 2 6 2 , - 0 . 9 3 0 9 0 9 1 0 2 8 , 0 . 3 7 8 4 8 8 4 6 7 8 \  
H , - 3 . 9 1 5 8 5 8 0 8 4 3 , 0 . 7 5 0 0 5 0 0 5 5 3 , 0 . 7 0 6 5 1 5 9 9 5 6 \ H , - 3 . 9 3 7 9 9 1 2 4 5 2 , 0 . 1 4 1 7 7 9 6 3 4 5  
, - 0 . 9 6 5 0 7 8 1 2 8 1 \ \ V e r s i o n = D E C - A X P - O S F / l - G 0 3 R e v B . 0 5 \ S t a t e = l - A \ H F = - 4 6 0 . 3 4 3  
5 4 5 \ R M S D = 7 . 7 4 9 e - 0 9 \ R M S F = 1 . 0 6 7 e - 0 6 \ D i p o l e = - 0 . 2 4 5 3 6 6 4 , 0 . 3 9 8 7 8 1 8 , 0 . 4 8 7 7 4 0  
7 \ P G = C 0 1 [ X ( C 6 H 1 0 O 3 ) ] \ \ @
MeC0CH2CH*C02Me 96a
l \ l \ G I N C - S C l l \ F O p t \ U B 3 L Y P \ 6 - 3 I G ( d ) \ C 6 H 9 0 3 ( 2 ) \ D J H 5 0 1 \ 2 3 - M a y - 2 0 0 4 \ 0 \ \ # N  
U B 3 L Y P / 6 - 3 1 G *  SCF=TI GHT OPT=TIGHT MA XDI SK = 52 42 88 00 \ \ C H3 CO C H2 CH 2C O 2C H3  
1 3 r c a  B3LYP /  6 - 3 1 G ( d )  g e o m  o p t \ \ 0 , 2 \ C , - 2 . 7 8 3 8 9 7 5 9 8 7 , - 1 . 9 5 1 5 2 4 1 8 0 4 , 0 . 5  
23  93 8 5 7 8 7 \ 0 , - 1 . 4 2 9 5 1 4 5 4 0 2 , - 1 . 8 8 6 3 0 4 0 1 3 7 , 0 . 0 5 7 2 7 2 1 2 5 5 \ C , - 0 . 7 1 5 0 2 7 9 4 1 1 , -  
0 . 8 2 1 1 0 9 6 8 4 7 , 0 . 5 0 2 8 1 4 6 7 7 4 \ 0 , - 1 . 1 7 7 6 5 7 4 1 6 4 , 0 . 0 3 3 8 6 8 6 3 5 8 , 1 . 2 5 1 0 9 6 6 8 7 4 \ C ,
0 . 6 3 8 8 4 6 7 9 8 3 , - 0 . 8 2 3 7 4 7 4 4 1 7 , - 0 . 0 1 6 3 3 6 2 3 4 5 \ C , 1 . 6 0 7 1 7 9 7 3 7 4 , 0 . 2 3 5 1 7 4 0 3 1 1 , 0  
. 3 6 4 0 8 2 3 1 1 6 \ C , 1 . 5 9 0 5 1 8 2 1 4 3 , 1 . 3 6 8 6 8 4 1 1 1 6 , - 0 . 7 0 7 1 3 7 0 7 0 4 \ 0 , 2 . 3 3 9 9 4 9 4 3 8 2 , 1  
. 3 2 7 6 8 9 2 8 0 5 , - 1 . 6 5 7 7 9 6 8 7 7 7 \ C , 0 . 5 8 9 6 5 8 1 2 7 4 , 2 . 4 8 0 7 0 0 8 6 9 , - 0 . 4 7 8 9 6 6 4 9 6 6 \ H , 1 
. 3 3 8 3 5 9 1 3 8 5 , 0 . 6 5 3 5 6 0 3 5 2 9 , 1 . 3 3 9 2 3 6 9 8 3 4 \ H , 2 . 6 2 6 6 6 1 4 2 6 9 , - 0 . 1 6 1 3 8 9 2 5 6 , 0 . 3 8  
3 1 9 3 2 0 4 2 \ H , 0 . 9 1 1 4 9 2 2 3 8 8 , - 1 . 5 7 1 9 6 6 8 5 5 2 , - 0 . 7 5 3 0 5 0 2 0 9 2 \ H , 0 . 4 7 7 4 2 2 0 6 0 1 , 3 . 0  
7 7 2 8 0 2 5 9 3 , - 1 . 3 8 6 7 1 6 0 7 2 2 \ H , - 0 . 3 7 2 7 9 9 6 6 8 9 , 2 . 0 7 9 3 6 0 4 4 1 7 , - 0 . 1 4 6 2 0 4 2 9 6 5 \ H , 0 
. 9 5 6  9 8 6  7 6 4  7 , 3 . 1 2 6  9 9 1 2  8 5 2 , 0 . 3 2 9 8 2 0 3 4 8 l \ H , - 3 . 2 0 2 3 0 0 9 8 7 6 , - 2 . 8 5 6 6 6 1 2 7 2 6 , 0 .  
0 8 2 6 1 0 0 9 8 9 \ H , - 2 . 8 1 4 7 7 3 4 8 1 5 , - 2 . 0 0 6 9 7 5 0 9 4 2 , 1 . 6 1 5 8 5 8 2 2 9 3 \ H , - 3 . 3 4 6 9 3 1 3 6 9 5 ,  
- 1 . 0 7 1 2 9 7 3 1 1 7 , 0 . 2 0 0 3 0 1 6 3 4 7 \ \ V e r s i o n = D E C - A X P - O S F / l - G 0 3 R e v B . 0 5 \ S t a t e = 2 - A  
\ H F = - 4 5 9 . 6 8 7 6 3 5 8 \ S 2 = 0 . 7 5 7 0 5 9 \ S 2 - 1 = 0 . \ S 2 A = 0 . 7 5 0 0 3 6 \ R M S D = 6 . 1 6 7 e - 0 9 \ R M S F =  
1 . 6 7 4 e - 0 6 \ D i p o l e = - 0 . 5 0 8 2 4 , - 0 . 3 4 8 2 8 1 7 , 0 . 3 8 0 9 8 7 3 \ P G = C 0 1  [ X ( C 6 H 9 0 3 ) ] \ \ @
MeC(0)0Me
l \ l \ G I N C - S C 9 6 \ F r e q \ R B 3 L Y P \ 6 - 3 1 G ( d ) \ C 3 H 6 0 2 \ D J H 5 0 1 \ 0 2 - J u n - 2 0 0 4 \ 0 \ \ # N  B3L 
Y P / 6 - 3 1 G ( D )  SCF=TI GHT FREQ M A X D I S K = 3 9 3 2 1 6 0 0 \ \ C H 3 C O O C H 3  B3LYP /  6 - 3 1 G ( d  
) f r e q \ \ 0 , 1 \ C , 0 . 1 0 9 7 2 7 2 5 , - 0 . 4 8 1 4 6 5 7 5 , 0 . \ 0 , 1 . 3 2 0 7 8 7 2 5 , - 0 . 4 8 1 4 6 5 7 5 , O . \ 0 ,  
- 0 . 6 3 6 8 4 2 7 5 , 0 . 6 4 8 3 7 4 2 5 , 0 . \ C , -  0 . 7 7 3 2 9 2 7 5 , - 1 . 7 0 7 5 1 5 7 5 , 0 . \ C , 0 . 1 0 9 3 9 7 2 5 , 1 .  
8 7 5 8 2 4 2 5 , 0 . \ H , - 0 . 1 5 0 7 6 2 7 5 , - 2 . 6 0 2 7 4 5 7 5 , 0 . \ H , - 1 . 4 2 2 1 2 2 7 5 , - 1 . 7 0 4 9 3 5 7 5 , 0 . 8
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Experimental
8201\H,-1.42212275,-1.70493575,-0.88201\H,-0.63593275,2.67188425,0.\H,
0.74219725,1.94220425,0.88921\H,0.74219725,1.94220425,-0.88921\\Versio 
n=DEC-AXP-OSF/l-G03RevB.05\State=l-A'\HF=-268.3884834\RMSD=2,988e-09\R 
MSF=1.274e-05\Dipole=-0.6573154,0.2410275,0.\ PG=CS [SG(C3H202),X(H4)]\\@
*CH2C(0)0Me
l\l\GINC-SC4\Freq\UB3LYP\6-3IG(d)\C3H502(2)\DJH501\02-Jun-2004\0\\#N U 
B3LYP/6-3IG(D) SCF=TIGHT FREQ MAXDISK=39321600\\CH2COOCH3 radical UB3L 
YP / 6 - 3 IG(d) freq\\0,2\C,-1.8444723077,0.3638041026,0.\C,-0.397112307
7.0. 3638041026.0.\0,0.2999776923,1.3688341026,O.\0,0.1098676923,-0.899
2058974.0. \C,1.5411676923,-0.9759058974,0.\H,1.7782376923,-2.040405897
4.0. \H,1.9549376923,-0.4906458974,0.88885\H,1.9549376923,-0.4906458974 
,-0.88885\H,-2.4065523077,-0.5622958974,0.\H,-2.3578223077,1.316754102
6.0. \\Version=DEC-AXP-OSF/l-G03RevB.05\State=2-A"\HF=-267.7237418\S2=0 
.757593\S2-1 = 0.\S2A=0.750034\RMSD=3.3 3 9e-0 9\RMSF=7.23 9e-06\Dipole=-0.2 
479394,-0.64155,0.\ PG=CS [SG(C3H302),X(H2)]\\@
MeCONHMe
l\1\GINC-SC43\FOpt\RB3LYP\6-3IG(d)\C3H7N101\ROOT\2 0-Sep-2 001\0\\#N B3L 
YP/6-31G(D) TEST SCF=D1RECT OPT=TIGHT MAXDISK=26214400\\CH3NHCOMe B3LY 
P / 6-3IG(d) geom opt\\0,1\C,-0.4911143789,0.,0.1435553401\O,-0.490897
4537.0. .1.3681980287\N,0.6563870228,0.,-0.6032282476\C,-1.7865417781,0 
., - 0.6569472348\C,1.9780335208,0.,-0.004 24 64 693\H,-1.6406727833,0 . ,-1 . 
7420994326\H,-2.3722417196,0.8813078343,-0.3780784065\H,-2.3722417196, 
-0.8813078343,-0.3780784065\H,0.5808145651,0.,-1.6094047741\H,1.839859
9538.0. .1.0779424945\H,2.5473439954,-0.8916373005,-0.2937188935\H,2.54 
734 3 9954,0.89163 73005,-0.2937188935\\Version=DEC-AXP-OSF/l-G98RevA.9\S 
tate=l-A'\HF=-248.5235535\RMSD=2.929e-09\RMSF=2.663e-06\Dipole=0.35188
42.0. ,-1.3878438\PG=CS [SG(C3H3N101),X(H4)]\\@
MeCONHCH,*
l\l\GINC-SC25\FOpt\UB3LYP\6-31G(d)\C3H6N101(2)\ROOT\16-Sep-2001\0\\#N 
UB3LYP/6-3IG(D) TEST SCF=DIRECT OPT=TIGHT MAXDISK=26214400\\CH2NHCOMe 
radical UB3LYP / 6-31G(d) geom opt\\0,2\H,0.8992551135,0.,2.1248188299 
\C,-0.169356388,0.,1.9820748476\H,-0.885991519,0.,2.7887828732\N,-0.63
66319189,0.,0.6871411159\C,0.1856851684,0.,-0.4287718583\C,-0.53200691
162
Experimental
6 1 , 0 .  , - 1 . 7 6 7 0 1 2 9 3 3 2 \ H , - 1 . 6 2 4  0 93 3 5 1 8 , 0 . , - 1 . 6 8 5 9 9 1 9 9 5 7 \ H , - 0 . 2 2 1 8  9 5 8  5 7 7 , -  
0 . 8 8 1 1 3  74 8 2 9 , - 2 . 3 3 8 2 0 2 3 1 5 9 \ H , - 0 . 2 2 1 8 9 5 8 5 7 7 , 0 . 8 8 1 1 3 7 4 8 2 9 , - 2 . 3 3 8 2 0 2 3 1 5 9 \  
0 , 1 . 4 0 5 2 1 1 0 2 9 8 , 0 . , - 0 . 3 2 7 1 6 6 0 4 0 8 \ H , - 1 . 6 3 6 5 7 4 5 1 8 6 , 0 . , 0 . 5 3 8 3 9 5 1 0 2 3 \ \ V e r s i  
o n = D E C - A X P - O S F / l - G 9 8 R e v A . 9 \ S t a t e = 2 - A " \ H F = - 2 4 7 . 8 6 4 3 8 4 3 \ S 2 = 0 . 7 5 5 4 7 5 \ S 2 - 1  
= 0 . \ S 2 A = 0 . 7 5 0 0 2 \ R M S D = 4 . 5 4 8 e - 0 9 \ RMSF = 1 . 7 3 3 e - 0 6 \ D i p o l e  = - 1 . 4 8 8 7 9 8 8 , 0 . , 0 . 0  
2 5 3 8 8  8 \ P G= CS  [ S G ( C 3 H 4 N 1 0 1 ) , X ( H 2 ) ] \ \ @
M eC (0)0C H 2*
l \ l \ G I N C - S C 3 2 \ F r e q \ U B 3 L Y P \ 6 - 3 I G ( d ) \ C 3 H 5 0 2 ( 2 ) \ D J H 5 0 1 \ 0 2 - J u n - 2 0 0 4 \ 0 \ \ # N  
U B 3 L Y P / 6 - 3 1 G ( D )  SCF=TI GHT FREQ MAXDI S K= 3 9 3 2 1 6 0 0 \ \ C H2 OC OC H3  r a d i c a l  UB3 
LYP /  6 - 3 I G ( d )  f r e q \ \ 0 , 2 \ C , - 0 . 4 2  0 0 2  9 9 7 4 4 , 0 . 1 9 0 7 2 9 8 9 7 4 , - 0 . 0 0 0 7 6 4 9 7 4 4 \ 0 ,  
- 0 . 2 7 9 8 8 3 9 7 4 4 , 1 . 3 8 9 8 1 8 8 9 7 4 , 0 . 0 0 1 1 8 8 0 2 5 6 \ C , - 1 . 7 2 4 1 7 0 9 7 4 4 , - 0 . 5 6 3 6 5 2 1 0 2 6 ,  
- 0 . 0 0 4 3 4 6 9 7 4 4 \ 0 , 0 . 6 3 7 0 0 8 0 2 5 6 , - 0 . 6 8 9 6 6 6 1 0 2 6 , 0 . 0 0 2 3 2 9 0 2 5 6 \ H , - 2 . 5 5 1 0 9 7 9 7 4
4 . 0 .  1 4 6 1 6 7 8 9 7 4 , - 0 . 0 3 9 0 6 4 9 7 4 4 \ H , - 1 . 7 7 2 4 4 1 9 7 4 4 , - 1 . 2 3 6 2 4 8 1 0 2 6 , - 0 . 8 6 7 0 3 2 9 7  
4 4 \ H , - 1 . 8 0 4 0 9 0 9 7 4 4 , - 1 . 1 8 1 8 9 6 1 0 2 6 , 0 . 8 9 6 2 9 7 0 2 5 6 \ C , 1 . 9 0 5 1 8 5 0 2 5 6 , - 0 . 1 7 6 5 0 1
1 0 2 6 . 0 .  0 3 7 0 1 8 0 2 5 6 , H , 2 . 6 7 2 8 9 3 0 2 5 6 , - 0 . 9 2 0 8 4 0 1 0 2 6 , - 0 . 1 1 3 0 4 0 9 7 4 4 \ H , 2 . 0 3 1 8 4
1 0 2 5 6 . 0 .  8 8 8 1 3 3 8 9 7 4 , - 0 . 0 9 6 7 3 0 9 7 4 4 \ \ V e r s i o n = D E C - A X P - O S F / l - G 0 3 R e v B . 0 5 \ S t a  
t e = 2 - A \ H F = - 2 6 7 . 7 2 0 2 6 2 1 \ S 2 = 0 . 7 5 3 5 2 9 \ S 2 - 1 = 0 . \ S 2 A = 0 . 7 5 0 0 0 8 \ R MS D = 3 . 1 4 O e - 09  
\ R M S F = 1 . 3 9 6 e - 0 6 \ D i p o l e = - 0 . 1 0 6 0 7 5 2 , - 0 . 7 1 3 8 0 6 8 , - 0 . 0 9 0 1 5 4 3 \ D i p o l e D e r i v = l . 
6 2 4 6 1 2 1 , - 0 . 0 4 0 0 6 6 , 0 . 0 0 2 6 1 3 4 , - 0 . 6 8 2 8 3 9 3 , 1 . 4 4 3 8 2 8 9 , - 0 . 0 1 2 0 7 9 1 , - 0 . 0 0 9 1 0 8 6  
, - 0 . 0 0 4 7 1 6 8 , 0 . 2 7 0 2 0 1 3 , - 0 . 5 9 5 0 6 3 3 , - 0 . 1 5 0 7 9 5 7 , 0 . 0 0 2 3 8 8 9 , 0 . 3 6 4 2 1 1 1 , - 1 . 0 3 8
3 5 9 3 . 0 .  0 0 7 4 9 0 5 . 0 . 0 0 3 0 6 7 1 , - 0 . 0 0 1 8 4 6 , - 0 . 3 2 0 2 4 7 4 , - 0 . 1 6 2 8 4 7 3 , - 0 . 1 3 1 7 1 6 7 , 0 .  
0 0 2 8 5 0 2 , - 0 . 1 8 8 1 9 3 8 , - 0 . 0 6 4 5 7 4 8 , - 0 . 0 0 0 2 9 0 3 , 0 . 0 1 3 5 3 7 6 , 0 . 0 0 7 3 9 3 8 , 0 . 0 5 2 1 0 0 4  
, - 1 . 4 3 6 1 2 8 8 , 0 . 1 8 2 5 2 1 5 , 0 . 0 0 3 0 2 1 8 , 0 . 3 5 4 5 2 6 4 , - 0 . 7 1 1 7 4 9 9 , 0 . 0 0 6 0 6 , - 0 . 0 0 8 9 3 5  
3 , - 0 . 0 0 8 9 2 8 8 , - 0 . 1 3 5 2 0 7 6 , - 0 . 0 2 6 4 5 1 9 , 0 . 0 3 9 3 5 5 5 , - 0 . 0 0 2 7 2 0 6 , 0 . 0 7 2 3 8 4 7 , 0 . 0 0
5 0 7 5 1 . 0 .  0 0 3 5 1 0 2 , - 0 . 0 0 5 4 1 6 7 , 0 . 0 0 1 8 4 3 9 , 0 . 0 8 2 4 8 7 1 , 0 . 0 2 8 3 6 0 9 , - 0 . 0 0 3 5 2 3 4 , 0 .  
0 2 1 4  78  9 , - 0 . 0 1 0 2 2 4  4 , 0 . 0 3  6 5 5 6  8 , - 0 . 0 7  54 6 0 9 , - 0 . 0 0  94 93 7 , - 0 . 0 8 1 1 0 0 2 ,  - 0 . 0 0 5  95
7 2 . 0 .  02, 594 8 5 , - 0 . 0 0 9 3  7 5 9 , - 0 . 0 1 9 5  9 7 9 , - 0 . 0 1 3  8 83 7 , 0 . 0 4  6 0 2 1 1 , 0 . 0 7 1 7 5 1 2 , 0 . 0 0
9 6 1 1 3 . 0 .  0 7 5 0 9 0 8 , - 0 . 0 1 4 4 1 9 9 , 0 . 5 3 7 6 3 1 , 0 . 0 3 3 9 6 3 4 , - 0 . 0 1 4 4 4 7 8 , 0 . 1 0 3 3 6 0 7 , 0 . 2
7 8 0 9 2 4 . 0 .  0 0 1 4 2 5 1 , - 0 . 1 1 7 4 6 6 1 , 0 . 0 2 0 7 4 0 4 , - 0 . 2 5 7 2 5 2 5 , - 0 . 0 1 8 4 2 0 4 , 0 . 0 2 3 7 0 1 8 ,  
0 . 0 0 3  94 8 2 , 0 . 0 3  6 0 5 9 2 , - 0 . 0 0 5 5 0 6 , - 0 . 0 0 7 5 9 7 1 , 0 . 0 7 3 1 0 9 , - 0 . 0 3  5 4 4  6 3 , 0 . 1 6 1 1 4  62 
, 0 . 0 2 2 3  5 9 3 , 0 . 0 5 5  93 5 5 , 0 . 0 0 0 4  6 5 , - 0 . 0 3  54 0 0 9 , 0 . 0 1 0 6 1 5 6 , 0 . 0 0 5 1 9 0 4 , 0 . 0 5 1 0 9 5 2  
, 0 . 0 2 6 9 6 9 3 , 0 . 1 6 7 1 4 9 6 \ P o l a r = 4 9 . 8 4 1 9 5 6 8 , - 1 . 1 6 7 8 3 5 , 3 7 . 5 7 9 0 4 0 4 , - 0 . 1 5 1 4 8 3 , -  
0 . 1 0 0 5 5 8 7 , 2 2 . 8 7 9 0 8 8 \ P G = C 0 1  [ X ( C 3 H 5 0 2 ) ] \
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Table E2. Calculated Total Energies (0 K, Hartrees)3
RMP2/6-311+G(2df,p)b RMP2/G3largeö
c h 4 ^10.35356796 -40.36015706
*c h 3 -39.69644468 -39.70159948
MeC0NHCH2C 02Me (1) -772.7824639 ^175.4107229
MeCONHCH*C02Me (2) -772.1521235 -474.7822748
CF3C0NHCH2C 02ME (4) -772.7824639 -772.8079849
MeCONHCH*C02Me (5) -772.1521235 -772.1760476
MeCONHCH(Me)C02Me -514.5569434 -514.5835432
MeCONHC’(Me)C02Me
(93a)
-513.9299441 -513.9550152
MeC0NHCH(CF3)C 02Me -811.981203 -812.010342
MeC0NHC*(CF3)C 02Me
(94a)
-811.3396918 -811.3669765
MeC02CH2C 02Me -495.233293 ^95.2548591
MeC02CH*C02Me (95a) -494.593209 -494.6132193
MeC0CH2CH2C 02Me -459.2973161 ^459.321037
MeC0CH2CH’C 02Me (96a) -458.6536539 ^158.675758
MeC02Me -267.79156 -267.8057895
*CH2C(0)0M e -267.75086 -267.1549448
MeCONHMe -247.9188892 -247.9345014
MeCONHCHT -247.2775387 -247.2916712
M eC(0)0CH2* -267.74996 ^40.36015706
MeCH=CHCH2C 02Me -384.1571633 -384.1792338
MeCH=CHCH*C02Me -383.5383467 -383.5588545
"Electronic energies have been corrected with scaled (by 0.9806) B3-LYP/6- 
31G(d) zero-point vibrational energies. ^Calculated on B3-LYP/6-31G(d) 
optimized geometries.
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Table E3. Calculated Radical Stabilisation Energies (0 K, kJ m ol1)3
radical RMP2/6-311+G(2df,p) RMP2/G3large
2 79.6 79.1
5 70.3 69.9
93a 79.1 78.8
94a 41.0 39.9
95a 44.7 44.4
96a 35.3 34.9
CH2C(0)OM e 20.6 20.2
MeCONHCH2* 41.4 41.3
M eC(0)O C H 2* 17.1 17.1
17 100.6 100.2
aRadical stabilization energies (RSEs) were calculated 
from the total energies in Table E2 as the energy changes 
in the isodesmic reactions R’ + C H 4 -> RH + ’CH3. The 
RSEs correspond to the differences between the bond 
dissociation energies (BDEs) o f methane and RH, and 
reflect the stability of R* compared with ’CH3, relative to 
the corresponding closed-shell systems. Our reported 
RSEs correspond to values at 0 K.
Bromination Reactions
Treatment of A/-benzoylglycine methyl ester 61 with A/-bromosuccinimide.
jV-Bromosuccinimide (16.6 mg, 0.09 mmol) was added to a solution of N- 
benzoylglycine methyl ester 61 (20 mg, 0.10 mmol) in carbon tetrachloride (5 mL), 
under nitrogen, and the mixture was heated at reflux for 30 min whilst being irradiated 
with a sunlamp. The mixture was then cooled and filtered. The filtrate was concentrated
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under reduced pressure, to give /V-benzoyl-a-bromoglycine methyl ester 90 as an off- 
white solid, with physical and spectroscopic properties consistent with those previously 
reported.98 'H  NMR (300 MHz, CDC13): 5 3.92 (s, 3H), 6.68 (d, J = 9.0 Hz, 1H), 
7.45.7.58 (m, 4H), 7.82.7.85 (m, 2H).
Treatment of methyl C^-benzoylglycolate 59 with A/-bromosuccinimide
Treatment o f methyl O-benzoylglycolate 59 with A-bromosuccinimide, as described 
above for reaction of the benzamide 61, gave only unreacted starting materials, even 
after extended reaction times and when an excess o f the succinimide was used.
Relative rates of reaction of 61 and 59 with A/-bromosuccinimide
The relative rates of reaction of 61 and 59 with /V-bromosuccinimide were determined 
in competitive experiments using mixtures of 61 and 59. After treatment with a slight 
excess of the brominating agent, all of 61 was consumed after a reaction time of 30 
min, but there was no evidence for any reaction o f 59, even after extended reaction 
times, within the limits o f detection using 'H NMR spectroscopy. On this basis the 
relative rates of reaction of 61 and 59 were determined to be 1.0 and <0.005 
respectively.
Assay Procedures, Representative Data Sets and HPLC Traces
Interactions of 15, 64, 70, 72, 76, 79, 85, and 98a,b with PAM
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Assays for PAM inhibition were performed with 3 mM ascorbic acid, 2 pM copper 
sulfate, 100 pg/mL bovine liver catalase, 0.01% Tween 20, 1% ethanol and 0.1 mM 
substrate [(/?)-Tyr-(S)-Val-Gly], and varying concentrations of inhibitors in 100 mM 
MES buffer at pH 6.6. Assays were initiated by the addition of the appropriate amount 
of enzyme to give a final volume of 60 pL, then the mixtures were incubated at 37 °C 
for 1 h. The assays were quenched by the addition of 30 pL of 1 M NaOH, then the 
mixtures were neutralized with 30 pL of 1 M HC1. Two 20 pL aliquots were then taken 
and diluted to 110 pL with water. The duplicate diluted solutions were then analyzed 
directly using HPLC, and the ratio o f substrate [(/?)-Tyr-(S)-Val-Gly] to product [(R)- 
Tyr-(S)-Val-NH2] determined by integration, to give the amount processed.
Assays for the binding strength of /V~benzoyl-(S)-valylglycine 72 with PAM were 
performed with 3 mM ascorbic acid, 2 pM copper sulfate, 100 pg/mL bovine liver 
catalase, 0.01% Tween 20 and 1% ethanol, with varying concentrations of A-benzoyl- 
(STvalylglycine 72 in 100 mM MES buffer at pH 6.6. Assays were initiated by the 
addition of the appropriate amount of enzyme to give a final volume of 20 pL, then the 
mixtures were incubated at 37 °C for 1 h. The assays were quenched by the addition of 
10 pL of 1 M NaOH, then the mixtures were neutralized with 10 pL of 1 M HC1. Two 
20 pL aliquots were then taken and diluted to 110 pL with water. The duplicate diluted 
solutions were then analyzed directly using HPLC, and the ratio o f substrate [N-Bz-(S)- 
Val-Gly] to product |7V-Bz-(S)-Val-NH2] determined by integration, to give the amount 
processed.
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The follow ing figures E l,  E2, E3, E4 and E5 are representative HPLC traces o f assays 
o f 64 at concentrations o f 0, 2.0, 4.0, 8.0, 16.0 pM respectively. The first peak 
observed in the trace is that o f the processed substrate whilst the second peak is starting 
material.
-v-
Figure E 1. HPLC trace o f an assay o f 64 at an inhib itor concentration o f 0 pM
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Figure E2. HPLC trace of an assay of 64 at an inhibitor concentration o f 2.0 jaM
Figure E3. HPLC trace of an assay of 64 at an inhibitor concentration o f 4.0 faM
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Figure E4. HPLC trace o f an assay o f 64 at an inhibitor concentration o f 8.0 pM
Figure E5. HPLC trace o f an assay o f 64 at an inhib itor concentration o f 16.0 pM
Peak integrations were then used to determine the percentage turnover for each assay.
The follow ing table E4 is a representative data set for assays performed with 64 against 
PAM.
Table E4. Representative data set for assays performed with 
64 against PAM.
(1) T u rn over 1 T u rn over 2 A v e ra g e S d ev S d ev  (% )
0.00 0.91 0.87 0.89 0.0304 3.4221
2.00 0.91 0.86 0.88 0.0304 3.4376
4.00 0.88 0.82 0.85 0.0445 5.2378
8.00 0.81 0.79 0.80 0.0127 1.5850
16.00 0.81 0.78 0.79 0.0191 2.4121
32.00 0.72 0.60 0.66 0.0806 12.1952
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The first column lists inhibitor concentration. As assays were 
performed in duplicate, the second and third columns list 
substrate turnover. The fourth column lists substrate turnover 
as an average of the values given in columns 2 and 3.
The inverse of the average rate of substrate turnover were then plotted against inhibitor 
concentration to produce a Dixon plot. A representative Dixon plot for the assay of 64 
against PAM is provided below in Figure E6.
y = 0.0123x + 1.1253 
R2 = 0.9915
>  1.0
^  0.8
0.000 5.000 10.000 15.000 20.000 25.000 30.000 35.000
(I)
Figure E6. Representative Dixon plot for the assay of 64 against PAM.
The IC50 value of 64 was then obtained as the value of -x when y = 0 from the equation 
obtained for the line of best fit illustrated in Figure E6.
Synthetic Procedures
Methyl O’-benzoylglycolate 59
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Methyl bromoacetate (60 pL, 0.63 mmol) and potassium carbonate (100 mg, 0.73 
mmol) were added to a solution of benzoic acid (50 mg, 0.41 mmol) in acetone (30 mL) 
and the mixture was heated at reflux overnight, then it was cooled and concentrated 
under reduced pressure. Chromatography of the residue gave the title compound (40 
mg, 50%) as a clear oil. lH  NMR (300 MHz, CDC13): 6 3.80 (s, 3H), 4.87 (s, 2H), 
7.44-7.62 (m, 3H), 8.08-8.12 (m, 2H). 13C NMR (75 MHz, CDC13): 6 168.4, 166.1, 
133.7, 130.1, 129.3, 128.7, 61.2, 52.5. HRMS (El) calcd. For C 10H i0O4 [M+]: m/z 
194.0579, found 194.0579. Anal. Calcd. for C i0H i0O4: C, 61.85, H, 5.19. Found: C, 
61.84, H, 5.22%.
Benzyl O'X/V-Acetyl-fSJ-phenylalanyl-fSJ-phenylalanyOglycolate 63
Benzyl bromoacetate (0.46 mL, 2.9 mmol) was added to a suspension of (V-acetyl-(S)- 
phenylalanyl-(5')-phenyalanine 62 (0.50 g, 1.0 mmol) and potassium carbonate (0.14 g, 
1.0 mmol) in acetone (100 mL). The mixture was stirred and heated at reflux for 24 h, 
then it was cooled and filtered. The filtrate was concentrated under reduced pressure to 
give a colorless solid which was recrystallized from ethyl acetate/hexanes to give the 
title compound (0.60 g, 84%) as a colorless powder. Mp 169 °C. [ccd] -27.12° (c 0.001, 
ethanol). NMR (300 MHz, CD3OD): 5 1.82 (s, 3H), 2.75 (dd, 7 = 14.1,9.3 Hz, 1H), 
2.94 (dd, 7 = 14.1, 9.3 Hz, 1H), 3.05 (dd, 7=  14.1, 5.7 Hz, 1H), 3.22 (dd, 7= 14.1, 5.1 
Hz, 1H), 4.60 (dd, 7 = 9.3, 5.7 Hz, 1H), 4.68 (d, 7= 15.9 Hz, 1H), 4.75 (d, 7= 15.9 Hz, 
1H), 4.76 (dd, 7 = 9.3, 5.1 Hz, 1H), 5.20 (s, 2H), 7.15-7.38 (m, 15H). 13C NMR (75 
MHz, CD3OD): 6 174.4, 173.8, 172.9, 169.9, 139.3, 138.9, 137.7, 131.2, 131.1, 130.5, 
130.4, 130.3, 130.2, 128.7, 125.5, 68.9, 63.2, 56.5, 55.6, 39.6, 39.1, 23.2. MS (ESI)
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(+ve): m/z 503.2 [M+H+], 525.1 [M+Na+], 541.1 [M+K+]. HRMS (EI) calcd. for 
C29H3oN20 6 [M+*] 502.2104, found 502.2103. Anal. Calcd. for C29H3oN20 6: C, 69.31; 
H, 6.02; N, 5.57. Found: C, 69.24; H, 6.43; N, 5.49%.
(^-(/V-Acetyl-tSJ-phenylalanyl-tSJ-phenylalanyOglycolic Acid 64
Benzyl Oa-(A-acetyl-(5')-phenylalanyl-(5')-phenylalanyl)glycolate 63 (0.30 g, 0.60 
mmol) was added to a suspension of activated palladium on carbon (10%, 30 mg) in 
tetrahydrofuran (50 mL) under a hydrogen atmosphere and the mixture was stirred 
overnight at room temperature, then it was filtered through celite. The filtrate was 
concentrated under reduced pressure to give a colorless solid which was recrystallized 
from ethanol/hexanes to give the title compound (203 mg, 82%) as colorless crystals. A 
portion of this material was purified by HPLC eluting with mixtures of acetonitrile and 
0.1% acetic acid in water. Mp 152 °C. [an] -23.8° (c 0.001, ethanol). *H NMR (300 
MHz, CD3OD): 5 1.82 (s, 3H), 2.77 (dd, J  = 14.1, 9.3 Hz, 1H), 2.99 (dd, J  =  14.1, 
9.0 Hz, 1H), 3.07 (dd, J =  14.1,5.4 Hz. 1H), 3.27 (dd, J  =  14.1,4.8 Hz, 1H), 4.60 (d, J  
=  15.9 Hz, 1H), 4.59^1.64 (m, 1H), 4.64 (d,7= 15.9 Hz, 1H), 4.74^1.82 (m, 1H), 7.14- 
7.28 (m, 10H). I3C NMR (75 MHz, CD,OD): 5 172.3, 171.8, 170.9, 137.3, 136.9, 
129.3, 129.1, 128.3, 128.2, 126.7, 126.5, 61.0, 54.5, 53.7, 37.6, 37.1, 21.2. MS (ESI) 
(+ve): m/z 435.1 [M+Na+], 451.1 [M+K+]. Anal. Calcd. for C jjH ^O s.lM H iO : C, 
63.37; H, 5.92; N, 6.72. Found : C, 63.45; H, 5.95; N, 6.72%.
N-Benzoyl-(S)-valine Methyl Ester 67
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5-Valine (1.0 g 8.5 mmol) was added to methanol (100 mL), which had been pretreated 
with thionyl chloride (1.2 g 10.3 mmol), and allowed to stir overnight. The solution 
was evaporated under reduced pressure to yield a white powder, which was redissolved 
in methanol and evaporated under reduced pressure twice to remove excess 
hydrochloric acid. The resultant colourless hydrochloride salt was dissolved in 
dichloromethane (50 mL) by the addition of triethylamine (1.7 g 17.1 mmol), and 
benzoyl chloride (1.2 g, 8.5 mmol) was added dropwise with stirring. A precipitate 
formed and the mixture was stirred overnight. The mixture was washed with 2M 
hydrochloric acid (2 x 50 mL) and then saturated sodium bicarbonate solution (2 x 50 
mL). The organic layer was then dried, filtered and evaporated under reduced pressure 
to obtain the crude product which was then recrystallised from ethyl acetate/hexane to 
give the title compound as colourless needles (1.05 g, 53%). M p 86 °C (lit.,66 86 °C). 
*H NM R (300 MHz, CDC13): 5 0.96 (t, J = 6.3 Hz, 6H), 2.20-2.27 (m, 1H), 3.72 (s, 
3H), 4.74 (dd, J = 5.1, 8.7 Hz, 1H), 6.75 (d, J = 8.4 Hz, 1H), 7.38-7.49 (m, 3H), 7.76- 
7.79 (m, 2H). 13C NM R (75 MHz, CDC13): 5 172.8, 167.5, 134.3, 131.9, 128.7, 127.3, 
57.7, 52.4,31.7, 19.2, 18.2.
A/-Benzoyl-(S)-valine 68
V-Benzoyl-(S)-valine Methyl Ester 67 (5.53 g, 23.5 mmol) was dissolved in 
tetrahydrofuran (200 mL) and 2M sodium hydroxide (200 mL) and allowed to stir for 
three hours. The solution was subjected to rotary evaporation to remove the 
tetrahydrofuran and the aqueous layer was acidified to pH 3.0 with 5M hydrochloric 
acid. The solution was then washed with ethyl acetate (3 x 50 mL) and the combined
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organics were dried, filtered and concentrated under reduced pressure to give a crude 
white solid. The crude was then recrystallised from hot ethanol to give the title 
compound (3.17 g, 61%). Mp 129 °C (lit.,99 127 °C). *H NMR (300 MHz, CDC13): 5 
1.04 (d, J  = 6.9 Hz, 6H), 2.28 (m, 1H), 4.51 (d, J  = 6.6 Hz, 1H), 7.41-7.52 (m, 3H), 
7.82-7.85 (d, 2H). 13C NMR (75 MHz, CDC13): 6 173.9, 169.5, 134.3, 131.7, 128.4, 
127.4, 58.7,30.6, 17.8.
Benzyl OP-(N-Benzoy\-(S)-va\y\)g\yco\a\e 69
Af-Benzoyl-(S)-valine 68 (0.36 g, 1.62 mmol) was dissolved in acetone (100 mL) to 
which potassium carbonate (134 mg, 1.62 mmol) and benzyl bromoacetate (0.25 mL, 
1.62 mmol) were then added. The resulting suspension was heated at reflux overnight, 
then it was allowed to cool and was filtered. The filtrate was concentrated under 
reduced pressure and the residual colorless solid was recrystallized from ethyl acetate 
to afford the title compound (0.54 g, 90%) as a colorless solid. Mp 92 °C. [a]o -22.9 
°C (c 0.001, ethanol). NMR (300 MHz, CDCI3): 5 1.04 (d, J  =  6.9 Hz, 3H), 1.07 (d, 
J  =  6.9 Hz, 3H), 2.34-2.45 (m, 1H), 4.64 (d, J =  15.9 Hz, 1H), 4.86 (d, J  = 15.9 Hz, 
1H), 4.91 (dd, J  = 8.7, 3.9 Hz, 1H), 5.21 (s, 2H), 6.60 (d, J  =  8.7 Hz, 1H), 7.33-7.55 
(m, 8H), 7.79-7.82 (m, 2H). 13C NMR (75 MHz, CDCI3): 5 171.8, 167.6, 167.4, 135.1, 
134.3, 132.0, 128.9, 128.7, 127.3, 67.5, 61.4, 57.4, 31.7, 19.3, 17.8. HRMS (El) calcd. 
for C21H23NO5 [M+*] 369.1576, found 369.1574. Anal. Calcd. for C21H23NO5: C, 68.28; 
H, 6.28; N, 3.79. Found: C, 68.38; H, 6.60; N, 3.67%.
(^-(/V-Benzoyl-fSJ-valylJglycolic Acid 70
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Benzyl Oa-(iV-benzoyl-(S)-valyl)glycolate 69 (0.5 g, 1.35 mmol) was dissolved in 
tetrahydrofuran (100 mL) to which activated palladium on carbon (20%, 100 mg) was 
then added. The reaction vessel was purged with hydrogen and evacuated, three times, 
and the solution was then stirred under a hydrogen atmosphere for 12 h at room 
temperature. The suspension was then filtered through celite and the filtrate was 
concentrated under reduced pressure to give the title compound (358 mg, 95%) as a 
colorless solid. A portion of this material was purified by HPLC eluting with mixtures 
of acetonitrile and 0.1% acetic acid in water. Mp 100 °C. [oto] -12.5° (c 0.001, 
ethanol). NMR (300 MHz, CD3OD): 5 1.05 (d, 7=5.7 Hz, 3H), 1.07 (d, 7 = 6.0 Hz, 
3H), 2.32-2.38 (m, 1H), 4.36 (d,7= 15.0 Hz, 1H),4.63 (d,7=6.6 Hz, 1H),4.64 (d,7 = 
15.0 Hz, 1H), 7.43-7.56 (m, 3H), 7.85-7.88 (m, 2H). 13C NMR (75 MHz, CD3OD): 
171.4, 169.8, 169.6, 134.2, 131.6, 128.3, 127.4, 60.9, 58.6, 30.6, 18.5, 17.7. HRMS 
(El) calcd. for Ci4H17N 05 [M+‘] 279.1107, found 279.1105. Anal. Calcd. for 
C14H17NO5: C, 60.21; H, 6.13; N, 5.02. Found: C, 59.92; H, 6.27; N, 4.84%.
/V-Benzoyl-(S)-valylglycine terf-butyl ester 71
Glycine hydrochloride terf-butyl ester (0.49 g, 2.3 mmol), BOP (1.3 g, 2.9 mmol) and 
diisopropylethylamine (1.0 mL, 4.52 mmol) were added to a solution of A-benzoyl-(S)- 
valine 68 (0.64 g, 2.9 mmol) in dichloromethane (100 mL). The solution was allowed 
to stir overnight at room temperature before it was concentrated under reduced 
pressure. The residue was taken up in ethyl acetate (50 mL) and the solution was 
washed with saturated aqueous sodium bicarbonate (3 x 50 mL) and aqueous
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hydrochloric acid (1 M, 50 mL), then it was dried and concentrated under reduced 
pressure. The solid residue was recrystallized from ethyl acetate/hexanes to give the 
title compound (0.67 g, 89%). Mp 172 °C. [a]r> -1.3° ( c  0.001, ethanol). !H NMR (300 
MHz, CDCI3): 5 1.02 (d, J  =  5.8 Hz, 3H), 1.04 ( d, J  = 6.1 Hz, 3H), 1.46 (s, 9H), 2.24 
(m, 1H), 3.85 (dd, J =  18.2, 4.8 Hz, 1H), 4.04 (dd, J  = 18.2,5.5 Hz, 1H), 4.55 (dd, J  =  
8.7, 6.7 Hz, 1H), 6.65 (broad, 1H), 6.89 (d, J  = 8.7 Hz, 1H), 7.39 (m, 3H), 7.81 (m, 
2H). 13C NMR (75 MHz, CDCI3): 6 171.5, 168.7, 167.6, 134.3, 132.0, 128.8, 127.3, 
82.6, 58.9, 42.3, 31.7, 28.3, 19.5, 18.5. HRMS (El) calcd. for C i8H26N204 [M+‘] m / z  
334.1892, found 334.1892. Anal. Calcd. for C ,8H26N20 4: C, 64.65; H, 7.84; N, 8.38. 
Found: C, 64.48; H, 8.02; N, 8.22%.
A/-Benzoyl-(S)-valylglycine 72
N-Benzoyl-(S)-va\ylglycine t e r t -butyl ester 71 (29 mg, 0.086 mmol) was dissolved in 
dichloromethane (20 mL), to which triethylsilane (45 pL) and trifluoroacetic acid (0.85 
mL) were then added. The mixture was stirred overnight at room temperature before it 
was concentrated under reduced pressure. The residue was recrystallized from ethyl 
acetate/hexanes to give the title compound (25 mg, 88%) as a colorless solid. Mp 180 
°C. [a]D-32.2° (c 0.001, ethanol). 'H NMR (300 MHz, CD,OD): 5 1.04 (d, J  =  6.6 Hz, 
3H), 1.06 (d, 7 = 6.6 Hz, 3H), 2.19-2.26 (m, 1H), 3.88 (d, 7 =  18.0 Hz, 1H),4.02 (d, 7 = 
18.0 Hz, 1H), 4.45 (d, J  = 7.8 Hz, 1H), 7.43-7.56 (m, 3H), 7.82-7.85 (m, 2H). 13C 
NMR (75 MHz, CD,OD): 5 173.1, 171.5, 169.1, 134.2, 131.7, 128.4, 127.3, 59.6, 40.6, 
30.9, 18.7, 17.9. MS (ESI) (+ve): m / z  278.9 [M+H+], 301.3 [M+Na+], Anal. Calcd. for
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Ci4Hi8N20 4: C, 60.42; H, 6.52; N, 10.07. Found: C, 60.34; H, 6.69; N, 9.95%.
A/-Benzoyl-(S)-valinamide 73
N-Benzoyl-(5')-valine methyl ester 67 (0.2 g, 0.85 mmol) was dissolved in methanol (5 
mL) and cooled in dry ice. To this cooled solution, ammonia was added and the 
mixture was placed in a sealed pressurised vessel and stirred overnight. The solution 
was then concentrated under reduced pressure and the crude white solid taken up in 
ethyl acetate and filtered to wash away any of the remaining starting material. 
Recrystallisation of the product from hot ethanol then gave the title compound as a 
white solid (0.1 g, 52%). Mp. 221-223 °C (lit.,100 220-221 °C). ‘H NMR (300 MHz, 
CD,OD): 8 1.02 (t, J  = 6.3 Hz, 6H), 2.14-2.12 (m, 1H), 4.40 (d, 7 = 7.5 Hz, 1H), 7.44- 
7.55 (m,3H), 7.83-7.85 (m,2H). MS (ESI) (+ve): m /z 221.1 [M+H+], 243.1 [M+Na+],
Benzyl 0“-decanoylglycolate 75
Decanoic acid 74 (0.20 g, 1.2 mmol) was dissolved in acetone (50 mL) to which 
potassium carbonate (0.16 g, 1.2 mmol) and benzyl bromoacetate (0.14 mL, 1.2 mmol) 
were added. The mixture was heated at reflux for 12 h, then it was filtered. The filtrate 
was concentrated under reduced pressure and the residual oil was subjected to column 
chromatography (ethyl acetate/hexanes) to give the title compound (196 mg, 52%) as a 
colorless oil. !H NMR (300 MHz, CDClj): 8 0.90 (t, = 6.9 Hz, 3H), 1.28 (m, 12H),
1.65 (m, 2H), 2.42 (t, J  =  7.5 Hz, 2H), 4.65 (s, 2H), 5.19 (s, 2H), 7.35 (m, 5H). 13C 
NMR (75 MHz, CDC1,): 8 173.3, 168.0, 135.3, 128.9, 128.8, 128.6, 67.4, 60.9, 34.2,
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32.3, 29.8, 29.7, 29.5, 25.2, 23.1, 14.6. HRMS (EI) calcd. for C19H28O4 [M +’] 
320.1988, found 320.1989.
C^-Decanoylglycolic acid 76
Benzyl O'-decanoylglycolate 75 (0.78 g, 2.4 mmol) was dissolved in methanol 
(50 mL), to which activated palladium on carbon (10%, 156 mg) was added. The 
mixture was placed under an atmosphere of hydrogen and stirred overnight at room 
temperature. The suspension was then filtered through celite, and the filtrate was 
concentrated under reduced pressure, to give a colorless solid, which was recrystallized 
from ethyi acetate/hexanes to give the title compound (0.45 g, 80%) as a colorless solid. 
Mp 54 °C. lH  NMR (300 MHz, CDC13): 6 0.90 (t, J = 6.9 Hz, 3H), 1.30 (m, 12H), 
1.56-1.67 (m, 2H), 2.41 (t, J = 7.5 Hz, 2H), 4.59 (s, 2H). 13C NMR (75 MHz, CD3OD): 
6 175.5, 172.2, 62.3, 35.4, 33.9, 31.4, 31.3, 31.0, 26.7, 24.6, 15.3. HRMS (El) calcd. 
for C12H23O4 [M+H+]: 231.1596, found 231.1599. Anal. Calcd. for C12H22O4: C, 62.58; 
H, 9.63. Found: C, 62.21; H, 9.81%.
Benzyl C^-benzoylglycolate 78
Benzoic acid 77 (5.4 g, 44 mmol) was added to a suspension of potassium carbonate 
(6.1 g, 44 mmol) in acetone (100 mL). Benzyl bromoacetate (6.9 mL, 44 mmol) was 
then added and the resulting suspension was heated at reflux overnight. After cooling, 
the mixture was filtered and the filtrate was concentrated under reduced pressure to 
give the title compound (10.8 g, 91%) as a colorless solid. Mp 54 °C. NMR (300 
MHz, CDCI3): 6 4.86 (s, 2H), 5.20 (s, 2H), 7.32 (m, 5H), 7.41 (m, 2H), 7.54 (m, 1H),
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8.07 (m, 2H). 13C NMR (75 MHz, CDC13): 5 167.4, 165.6, 134.9, 133.2, 129.7, 128.9, 
128.4, 128.3, 128.2, 128.1,66.9,61.0. MS (EI): m/z 270 (M+\  5%), 211 (12), 163(12), 
148 (65), 120 (20), 105 (100), 91 (85), 77 (60). HRMS (EI) calcd. for C i6H ,40 4  [M+*] 
m/z 270.0892, found 270.0892. Anal. Calcd. for C i6H i40 4: C, 71.10, H, 5.22. Found: C, 
71.05, H, 5.27%.
C^-Benzoylglycolic acid 79
Palladium on carbon (10%, 2 g) was placed in a dry flask which was then purged with 
nitrogen and evacuated, three times, followed by purging with hydrogen and 
evacuating, three times. The vessel was then kept under an atmosphere of hydrogen. 
Benzyl O'-benzoylglycolate 78 (2.0 g, 7.4 mmol) in methanol (60 mL) was added and 
the resulting suspension was stirred overnight at room temperature. The suspension was 
then filtered through celite, and the filtrate was concentrated under reduced pressure to 
give the title compound (1.3 g, 98%) as a colorless solid. A portion (1.1 g) of this 
material was recrystallised from chloroform to give colorless crystals (0.47 g). Mp 110 
°C (lit. 13 111-112 °C). NMR (300 MHz, CD3OD) 8  4.83 (s, 2H), 7.48 (m, 2H), 7.60 
(m, 1H), 8.07 (m, 2H). 13C NMR (75 MHz, CDCI3): 8  172.4, 167.4, 134.2, 130.7, 
130.5, 129.3, 62.8. MS (El): m/z 180 (M+\  24%), 148 (10), 136 (15), 105 (100), 91 
(18), 77 (60). HRMS (El) calcd. for C9H80 4 [M+*] m/z 180.0423, found 180.0424. 
Anal. Calcd. for C9H80 4: C, 60.00, H, 4.48. Found C, 59.74 , H, 4.52%.
ferf-Butyl (A/-acetylphenylalanyl)acetate 82
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A suspension of /V-acetylphenylalanine 80 (0.50 g, 2.4 mmol) and 1,1- 
carbonyldiimidazole (0.41 g, 2.5 mmol) in tetrahydrofuran (10 mL) was stirred at room 
temperature under a nitrogen atmosphere for 0.5 h. It was then added dropwise to a 
solution that had been prepared from tetrahydrofuran (5 mL), diisopropylamine (2 mL, 
14 mmol), /i-butyl lithium (1.6 M in hexanes, 6 mL, 9.4 mmol) and tert-butyl acetate 
(1.3 mL, 9.6 mmol), maintained at -78 °C. The resulting mixture was stirred for 40 
min, then aqueous hydrochloric acid (1 M, 25 mL) was added and the solution was 
allowed to warm to room temperature. It was then extracted with ethyl acetate (3 x 50 
mL) and the combined organic extracts were dried and concentrated under reduced 
pressure to give a colorless oil (0.58 g, 79%). *H NMR (300 MHz, CDCI3): 6 1.45 (s, 
9H), 1.95 (s, 3H), 3.02 (dd, J =  14.1,6.5 Hz, 1H), 3.16 (dd, J = 14.1,6.5 Hz, 1H), 3.35 
(d, J = 15.9 Hz, 1H), 3.41 (d, J = 15.9 Hz, 1H), 4.92 (apparent q, J = 6.5 Hz, 1H), 6.10 
(d, J = 6.5 Hz, 1H), 7.14 (m, 2H), 7.25 (m. 3H). 13C NMR (75 MHz, CDC13): 6 202.1, 
170.2, 166.2, 136.3, 129.3, 128.8, 127.2, 82.3, 59.4, 48.4, 36.6, 28.0, 23.0. HRMS (E l) 
calcd. for C 17H23NO4 [M +‘] m/z 305.1627, found 305.1633. Anal. Calcd. for 
C 17H23N0 4: C, 66.86; H, 7.59; N, 4.59. Found C, 67.04; H, 7.20; N, 4.32%.
Benzyl 3-(A/-acetylphenylalanyl)-3-(ferf-butoxycarbonyl)propionate 83
A solution of terf-butyl (A-acetylphenylalanyl)acetate 82 (0.84 g, 2.75 mmol) in 
tetrahydrofuran (10 mL) was added to a solution of sodium hydride (59 mg, 2.75 
mmol) in tetrahydrofuran (20 mL). To this solution, benzyl 2-bromoacetate (0.44 mL, 
2.75 mmol) in dichloromethane (5 mL) was added dropwise. The mixture was stirred at 
room temperature for 24 h, then aqueous hydrochloric acid (1 M, 100 mL) was added. 
The solution was extracted with ethyl acetate (3 x 70 mL) and the combined organic
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extracts were dried and concentrated under reduced pressure. The residue was 
chromatographed on silica, eluting with a gradient of ethyl acetate/hexanes, to give a 
1:1 mixture of diastereomers of the title compound as a colorless oil (0.77 g, 62%). 
NMR (300 MHz, CDC13): 6 1.37 (s, 9H), 1.40 (s, 9H), 1.89 (s, 3H), 1.92 (s, 3H), 2.85- 
3.06 (m, 6H), 3.18 (dd, J =  14.4, 6.5 Hz, 1H), 3.24 (dd, J  = 14.1,6.5 Hz, 1H),4.04 (t, J  
= 6.9 Hz, 1H), 4.22 (t, J  = 7.2 Hz, 1H), 5.08 (s, 2H), 5.08 (apparent q, J  = 6.5 Hz, 1H), 
5.10 (s, 2H), 5.29 (apparent q, J  = 6.5 Hz, 1H), 6.23 (d, J  = 6.5 Hz, 1H), 6.25 (d, J  = 6.5 
Hz, 1H), 7.14-7.35 (m, 10H). 13C NMR (75 MHz CDC13): 6 203.3, 202.8, 171.7, 
171.2, 170.3, 169.6, 167.0, 166.7, 136.9, 136.3, 135.7, 129.5, 128.8, 128.7, 128.6, 
128.5, 128.4, 127.2, 127.0, 83.7, 83.1, 67.0, 66.9, 58.9, 58.8, 52.9, 51.9, 37.3, 35.9, 
33.0, 32.2, 27.9, 23.2, 23.1. HRMS (El) calcd. for C26H31N 0 6 [M+’] mJz  453.2151, 
found 453.2147.
Benzyl 3-(A/-acetylphenylalanyl)propionate 84
A solution of benzyl 3-(ALacetylphenylalanyl)-3-(terr-butoxycarbonyl)propionate 83 
(0.40 g, 0.83 mmol) and trifluoroacetic acid (3 mL) in dichloromethane (30 mL) was 
heated at reflux for 24 h, then it was cooled and concentrated under reduced pressure. 
The residual oil was chromatographed on silica, eluting with a gradient of ethyl 
acetate/hexanes, to give the title compound as a colorless solid (0.19 g, 70%). Mp 39 
°C. 'H NMR (300 MHz, CDCl,): 8 1.94 (s, 3H), 2.59-2.64 (m, 2H), 2.73-2.79 (m, 
2H), 2.97 (dd, J  = 14.1,6.5 Hz, 1H), 3.13 (dd, J  = 14.1,6.5 Hz, 1H),4.87 (apparent q,
= 6.5 Hz, 1H), 5.10 (s, 2H), 6.20 (d, J  = 6.5 Hz, 1H), 7.12-7.37 (m, 10H). I3C NMR 
(75 MHz, CDCI3): 5 207.2, 172.5, 170.2, 136.2, 135.9, 129.4, 128.9, 128.8, 128.5, 
128.4, 127.3, 66.8, 59.2, 37.3, 35.5, 28.0, 23.2. HRMS (El) calcd. for C21H23NO4 [M+']
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m/z 353.1627, found 353.1643. Anal. Calcd. for C21H23N04: C, 71.37; H, 6.56; N, 3.96. 
Found: C, 70.98; H, 6.43; N, 3.96%.
3-(A/-Acetylphenylalanyl)propionic Acid 85
A suspension of benzyl 3-(A-acetylphenylalanyl)propionate 84 (66 mg, 0.19 mmol) and 
activated palladium on carbon (12 mg) in tetrahydrofuran (20 mL) was stirred under an 
atmosphere o f hydrogen for 24 h, then it was filtered through celite. The filtrate was 
concentrated under reduced pressure and the residual oil was recrystallized from 
chloroform to give the title compound as a colorless solid (30 mg, 61%). Mp 53 °C. !H 
NMR, (300 MHz, CD3COCD3): 6 1.86 (s, 3H), 2.53 (t, J = 6.6 Hz, 2H), 2.74-2.88 (m, 
3H), 3.17 (dd, J = 14.1, 14.1 Hz, 1H), 4.64^1.72 (m, 1H), 7.18-7.28 (m, 5H), 7.47 (d, J 
= 7.2 Hz, 1H). 13C NMR (75 MHz, CD3COCD3): 207.9, 175.1, 172.0, 137.5, 129.0, 
128.3, 126.5, 59.9, 35.9, 34.6, 27.4, 21.0. HRMS (El) calcd. for C,4H ,7N 0 4 [M +’l m/z 
263.1158, found 263.1158. Anal. Calcd. for C i4H 17N 0 4: C, 63.87; H, 6.51; N, 5.32. 
Found: C, 63.58; H, 6.52; N, 5.38%.
Experimental for Chapter 2
Synthetic Procedures
A/-Benzoyl-a-acetoxyglycine Methyl Ester 14
A-Benzoylglycine 61 (200 mg, 1.03 mmol) and A-bromo succinimide (185 mg, 1.04 
mmol) was stirred in carbon tetrachloride (30 mL) under nitrogen at reflux. The 
refluxing solution was then irradiated with a 300W sun lamp for 10 minutes and
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allowed to cool, after which sodium acetate (253 mg, 3.09 mmol) was added. The 
solution was stirred overnight, filtered and purified by column chromatograph eluting 
with mixtures of ethyl acetate/hexane to give the title compound as clear oil (153 mg, 
60%). ‘H NMR (300 MHz, CDCI3): 8 2.77 (s, 3H), 3.81 (s, 3H), 6.77 (d, = 8.4 Hz,
1H), 7.41-7.55 (m, 4H), 7.79-7.82 (m, 2H). 13C NMR (75 MHz, CDC1,): 8 175.9, 
167.1, 166.7, 132.8, 132.7, 128.9, 127.7, 55.6, 54.0 28.4. MS (ESI) (+ve): m/z 274.3 
[M+Naf.
/V-Benzoyl-a-methoxyglycine Methyl Ester 17
(V-Benzoylglycine methyl ester 61 (400 mg, 2.06 mmol) and Af-bromo-succinimide 
(370 mg, 2.06 mmol) was stirred in carbon tetrachloride (100 mL) at reflux under 
irradiation with a 300W sun lamp for ten minutes after which irradiation was ceased. 
The refluxing mixture was allowed to cool and a solution of methanol (1 ml, 62 mmol) 
and diisopropylethylamine (0.09 mL, 2.06 mmol) in carbon tetrachloride (25 mL) was 
added and allowed to stir overnight. The solution was then filtered and reduced by 
rotary evaporation and purified by column chromatography using a gradient of 
ethylacetate/hexane to give the title compound as a colourless solid (330 mg, 72%). 
Mp. 77 °C (lit.,44 77.5-78.5). 'H NMR (300 MHz, CDC13): 8 3.50 (s, 3H), 3.81 (s, 3H), 
5.76 (d, J  = 9 Hz, 1H), 7.31-7.56 (m, 4H), 7.78-7.86 (m, 2H). 13C NMR (75 MHz, 
CDCI3): 8 168.8, 167.8, 133.2, 132.5, 128.9, 127.5, 78.8, 57.0, 53.2.
A/-Benzoyl-a-ethoxyglycine Methyl Ester 19
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/V-Benzoylglycine methyl ester 61 (400 mg, 2.06 mmol) and jV-bromo-succinimide 
(370 mg, 2.06 mmol) was stirred in carbon tetrachloride (100 mL) at reflux under 
irradiation with a 300W sun lamp for ten minutes after which irradiation was ceased. 
The refluxing mixture was allowed to cool and a solution of ethanol (1 mL, 62 mmol), 
diisopropylethylamine (0.09 mL, 2.06 mmol) in carbon tetrachloride (25 mL) was 
added and allowed to stir overnight. The solution was then filtered, reduced by rotary 
evaporation and purified by column chromatography using a gradient of 
ethylacetate/hexane to give the title compound as a colourless solid (330 mg, 67%) in 
67% yield. Mp. 73°C (lit.,101 65-66 °C). NMR (300 MHz, CDCI3): 6 1.25 (t, J=  8.1 
Hz, 3H), 3.73-3.82 (m, 2H), 5.85 (d, J = 9 Hz, 1H), 7.18 (d, J = 8.7 Hz, 1H), 7.43-7.57 
(m, 3H), 7.58-7.86 (m, 2H). 13C NMR (75 MHz, CDC13): ö 169.0, 167.6, 133.3, 132.5, 
128.9, 127.5, 77.5, 65.6, 53.3, 15.3. HRMS (ESI) (+ve): m/z calcd. for C,2H,5N04Na 
[M+Na]+ 260.0898, found [M+Na]+ 260.0889.
A/-Benzoyl-a-phenoxyglycine Methyl Ester 21
jY-Benzoylglycine 61 (100 mg, 0.51 mmol) and Af-bromo succinimide (92 mg, 0.52 
mmol) was stirred in carbon tetrachloride (30 mL) under nitrogen at reflux. The 
refluxing solution was then irradiated with a sun lamp for 10 minutes, allowed to cool, 
after which phenol (200 mg, 2.12 mmol) and diisopropylethylamine (0.1 mL, 5.7 
mmol) in carbon tetrachloride (10 mL) was added. The solution was stirred overnight, 
filtered, concentrated under reduced pressure and purified by high performance liquid 
chromatography eluting with a gradient of acetonitrile/water to give the title compound 
(48 mg, 32%). Mp 116 °C. 'H NMR (300 MHz, CD,OD): 6 3.85 (s, 3H), 6.44 (s, 1H), 
6.99-7.53 (m, 8H), 7.81-7.85 (m, 2H). I3C NMR (75 MHz, CD,OD): 5 168.4, 156.6,
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133.2, 132.3, 129.5, 128.5, 127.5, 127.4, 122.6, 116.6,77.1,52.3. HRMS (ESI) (+ve): 
m/z calcd. for Ci6H,5N04 [M+H]+ 286.1079, [M+Na]+ 308.0898, found 286.1081 
[M+H]+, 308.0902 [M+Na]+.
A/-Benzoyl-a-succinimidoglycine Methyl Ester 22
/V-Benzoylglycine 61 (100 mg, 0.51 mmol) and N-bromo succinimide (92 mg, 0.52 
mmol) was stirred in carbon tetrachloride (30 mL) under nitrogen at reflux. The 
refluxing solution was then irradiated with a 300W sun lamp for 10 minutes, allowed to 
cool. To this cooled mixture a solution of succinimide (500 mg, 5.0 mmol) and 
diisopropylethylamine (0.18 mL, 10.3 mmol) in acetonitrile (15 mL) was added and 
allowed to stir overnight. The stirred solution was then filtered and the crude solid 
purified by column chromatography with a gradient of ethyl acetate/hexane and 
recrystallised from ethyl acetate/hexane to give the title compound as a white solid 
(30mg, 19.6%). Mp. 97 °C. *H NMR (300MHz, CDC13): 5 2.78 (s, 4H), 3.01 (s, 3H), 
6.77 (d, J  = 8.4 Hz), 7.41-7.63 (m, 4H), 7.80-7.82 (m, 2H). 13C NMR (75 MHz, 
CDCI3): 6  175.8, 167.0, 166.6, 132.8, 132.7, 128.9, 127.6, 55.6, 54.1, 28.3. HRMS 
(ESI) (+ve): m/z calcd. for Ci4H,4N20 5 291.0980 [M+H]+, found 291.0978 [M+H]+.
Experimental for Chapter 3
Synthetic Procedures
Diethyl 2-(Acetamido)-2-[(2-nitrophenyl)methyl)]malonate 116
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Sodium metal (360 mg) was dissolved with stirring in ethanol (22 mL) and diethyl 
acetamidomalonate (3.32 g, 15.3 mmol) was added to the still warm solution. This was 
allowed to stir for 10 minutes, then 2-nitrobenzyl bromide (3.25 g, 15.0 mmol) 
dissolved in benzene (9 mL) was added dropwise over 10 minutes. The resulting 
mixture was stirred for 4 hours at room temperature before being cooled to 0 °C. The 
mixture was then filtered and the filtrate collected. The solvent was then removed 
under reduced pressure to give the title compound as colourless crystals (4.22 g, 80%). 
Mp. 104-105.5 (lit.,102 103-105 °C). *H NMR (300 MHz, (CD3)2SO/CDCl3): 5 1.16 (t, 
J  = 7 Hz, 6H), 1.87 (s, 3H), 2.85 ( s, 2H), 4.12 (q, J  = 7 Hz, 4H), 7.25 (d, J  = 8 Hz, 1H), 
7.54 (t,7  = 8H z, 1H), 7.66 (t, 7 = 8  Hz, 1H), 7.90 (d ,7  = 8H z, 1H).
2-Nitrophenylalanine Hydrochloride 117
Diethyl 2-(acetamido)-2-[(2-nitrophenyl)methyl)]malonate 116 (1.35 g, 3.83 mmol) 
was heated at reflux in concentrated hydrochloric acid (15 mL) for 6 hours. After being 
allowed to cool to room temperature, the resulting mixture was filtered. The residue 
was then recrystallised from hot ethanol to give the title compound as yellow crystals 
(600 mg, 74%). Mp 208 °C (dec.) (lit.,102 206-208 °C). ‘H NMR (300 MHz, CDjOD): 
5 3.42 (dd, J  =7.5, 14.0, 1H), 3.67 (dd, J  = 7.5, 14.0 Hz, 1H), 4.354 (t, 7 =  7.5 Hz, 1H), 
7.56-7.61 (m, 2H), 7.69-7.72 (m, 1H), 8.09-8.12 (m, 1H). 13C NMR (75 MHz,
CD,OD): 5 169.8, 149.5, 133.9, 133.4, 130.2, 129.2, 125.4, 53.2, 33.8.
2-Nitrophenylalanine Methyl Ester Hydrochloride 118
187
Experimental
2-Nitrophenylalanine hydrochloride 117 (50 mg, 0.24 mmol) was stirred in methanol 
(20 mL) which had been pretreated with thionyl chloride (4 mL). The solution was 
allowed to stir overnight and was then evaporated under reduced pressure to give a 
white powder, which was redissolved in methanol and evaporated under reduced 
pressure twice to remove excess hydrochloric acid. The crude product was then 
recrystallised from hot ethanol to give the title compound as a white solid (52 mg, 
85%). Mp. 198 °C. ‘H NMR (300 MHz, CD3OD): 5 3.47 (dd, J  = 7.2, 13.5 Hz, 1H), 
3.61 (dd, J = 7.8, 13.5 Hz), 3.71 (s, 3H), 4.42 (t, J  = 7.5 Hz, 1H), 7.54-7.62 (m, 2H), 
7.70-7.76 (m, 1H), 8.09-8.12 (m, 1H). 13C NMR (75 MHz, CD3OD): 6 169.0, 149.5, 
134.0, 133.3, 129.9, 129.3, 125.4, 53.3, 52.5, 33.8. HRMS (ESI) (+ve) calcd for 
C ioH,2N204 m/z 225.0875 [M]+, found mJz 225.0869 [M]+. Anal. Calcd. for 
C10H13N2O4CI: C, 46.08; H, 5.03; N, 10.75. Found: C, 46.02; H, 4.82; N, 10.62%.
Preparation of the Diastereomers of A/-Benzoylvalyl-2-nitrophenylalanine 
Methyl Ester 119
A-Benzoylvaline 68 (170 mg, 0.77 mmol) was stirred in dichloromethane (20 mL) 
along with BOP (681 mg, 1.44 mmol) and diisopropylethylamine (0.26 mL, 1.44 
mmol) for 20 minutes. To this solution, 2-nitrophenylalanine methyl ester 118 (200 
mg, 0.77 mmol) was added and the mixture was stirred overnight. The solution was 
concentrated under reduced pressure, dissolved in ethyl acetate (30 mL) and washed 
with sodium bicarbonate (3 x 50 mL), 5N citric acid (3 x 50 mL) and brine (3 x 50 mL). 
The organic layer was then dried, filtered and concentrated under reduced pressure and 
the crude solid recrystallised from ethyl acetate/hexane to give the title compound (200
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mg, 61%) as a 1:5 mixture of diastereomers as determined by 'H NMR spectroscopy. 
Mp 169 °C. NMR (300 MHz, CDC13): 5 0.81 (d, 7 = 6.9 Hz, 3H), 0.86 (d, 7 = 6.9 
Hz, 3H), 0.95 (d, 7 = 2.5 Hz, 3H), 0.98 (d, 7 = 2.5 Hz, 3H), 2.04 - 2.18 (m, 2H), 3.22 
(dd, 7 = 9.6, 14.0, 1H), 3.28 (dd, 7 = 9.3, 13.8 Hz, 1H), 3.53 (dd, 7 = 5.4, 13.8 Hz, 1H), 
3.57 (dd, 7 = 4.2, 14.0 Hz, 1H), 3.70 (s, 3H), 3.76 (s, 3H), 4.43 (dd, 7 = 6.6, 8.7 Hz, 
1H), 4.47 (dd, 7 = 6, 8.4 Hz, 1H), 4.91-5.01 (m, 2H), 6.63 (d, 7 = 9.3 Hz, 1H), 6.69 (d, 7 
= 8.4 Hz, 1H), 6.84 (d, 7 = 7.5 Hz, 1H), 6.93 (d, 7 = 8.4 Hz, 1H), 7.33-7.55 (m, 12H), 
7.75-7.78 (m, 4H), 7.89-7.92 (m, 2H). 13C NMR (75 MHz, CDC13): 6 171.3, 171.3, 
169.4, 169. 3, 167.7, 167.6, 147.4, 147.3, 134.6, 134.4, 134.1, 134.1, 133.1, 132.9, 
132.2, 132.0, 129.9, 128.8, 128.7, 127.3, 125.9, 58.7, 58.4, 55.3, 55.0, 53.4, 53.3, 32.1, 
31.8, 19.3, 18.5. HRMS (ESI) (+ve) calcd. for C21H23N3O6 m/z 450.1641 [M+Na]T, 
found m/z 450.1643 [M +Naf. Anal. Calcd. for C22H25N3O6: C, 61.82; H, 5.89; N, 9.83. 
Found: C, 61.54; H, 5.90; N, 9.70%. HPLC (analytical) rt = 5.7 min, column: Waters 
Symmetry Cig 3.5 pm column (4.6 x 75 mm); gradient 9:1 water/acetonitrile to 1:9 
water/acetonitrile over 10 minutes; flow rate: 1.0 mL min'1.
A/-Benzoyl-2-nitrophenylalanine Methyl Ester 120
2-Nitrophenylalanine methyl ester 118 (90 mg, 0.40 mmol) was dissolved with stirring 
in ethyl acetate (20 mL) to which triethylamine (0.9 mL, 6.74 mmol) and benzoyl 
chloride (0.03 mL, 0.45 mmol) was added. The solution was refluxed with stirring 
overnight after which water (50 mL) was added and refluxing was continued for a 
further 3 hours. The solution was then allowed to cool and the organic layer separated 
from the aqueous layer. The organic layer was then washed with 2M hydrochloric acid 
(3 x 50 mL) and saturated sodium bicarbonate (3 x 50 mL) followed by brine (2 x 50
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mL). The organic layer was then dried, filtered and evaporated under reduced pressure 
and the crude solid was recrystallised from ethanol/hexane to give the title compound 
(100 mg, 75%) as an off white solid. Mp 119 °C. lH NMR (300 MHz, CDC13): 6 3.46 
(dd, 7 = 8.4, 13.5 Hz, 1H), 3.58 (dd, 7 = 6.0, 13.5, Hz, 1H), 3.76 (s, 3H), 5.10 (m, 1H), 
7.04 (d, 7 = 6.6 Hz, 1H), 7.48 (m, 6H), 7.71 (m, 2H), 7.92 (m, 1H). 13C NMR (75 
MHz, CDCI3): 6 171.9, 167.2, 149.9, 133.6, 133.5, 132.9, 132.1, 131.8, 128.8, 128.5, 
127.2, 125.2, 53.8, 53.0, 34.8. Anal. Calcd. for Ci7H,6N205: C, 62.19; H, 4.91; N, 8.53. 
Found: C, 62.14; H, 4.81; N, 8.39%. HRMS (ESI) (+ve): Calcd. for Ci7Hi6N20 5 m/z 
329.1137 [M+H]+, m/z 351.0956 [M+Na]+, found m/z 329.1137 [M+H+], 351.0957 
[M+Na+].
A/-Benzoyl-2-nitrophenylalanine 121
yV-Benzoyl-2-nitrophenylalanine methyl ester 120 (40 mg, 0.12 mmol) was added to a 
solution of tetrahydrofuran (5 mL) and 1M sodium hydroxide (5 mL) and stirred 
overnight. The solution was then acidified to pH 3 with 1M hydrochloric acid, 
extracted with ethyl acetate (3 x 20 mL). The combined organic layers were dried, 
filtered and evaporated under reduced pressure to give a crude solid which was 
recrystallised from hot ethanol/hexane to give the title compound (30 mg, 85%) as a 
white solid. Mp. 183 °C. !H NMR (300 MHz, CD3OD): 6 3.28 (dd, 7 = 10.5, 13.8 Hz, 
1H), 3.79 (dd, 7 = 4.8, 13.8 Hz, 1H), 5.06 (m, 1H), 7.38-7.57 (m, 6H), 7.67-7.70 (m, 
2H), 7.96-7.99 (m, 1H), 8.67 (d, 7 = 8.4 Hz, 1H). 13C NMR (75 MHz, CD3OD): 6 
173.1, 168.9, 149.8, 133.9, 133.1, 132.9, 132.7, 131.6, 128.3, 128.1, 127.1, 124.8, 52.9, 
34.5. Anal. Calcd. for C^H^O«?: C, 61.14; H, 4.49; N, 8.91. Found: C, 60.95; H,
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4.57; N, 8.74%. HRMS (FAB) (+ve): calcd. for Ci6H |4N20 5 m/z 315.0980 [M+H]+, 
found m/z 315.0987 [M+H]+ .
Preparation of the Diastereomers of A/-Benzoyl-2-nitrophenylalanylalanine 
Methyl Ester 122
A-Benzoyl-2-nitrophenylalanine 121 (80 mg, 0.25 mmol) was stirred in
dichloromethane (20 mL) along with diisoproylethylamine (0.08 mL, 0.5 mmol) and 
BOP (112 mg, 0.25 mmol) for 30 minutes after which alanine methyl ester 
hydrochloride (35.5 mg, 0.25 mmol) was added. The solution was allowed to stir 
overnight then evaporated under reduced pressure and the crude brown oil taken up in 
ethyl acetate (30 mL). The solution was then washed with 5N citric acid (3 x 50 mL), 
saturated sodium bicarbonate (3 x 50 mL) and brine (3 x 50 mL) and the organic layer 
dried, filtered and evaporated under reduced pressure. The crude product was then 
recrystallised from ethanol to give the title compound as a mixture of diastereomers (40 
mg, 40%). Mp. 173 °C. NMR (300 MHz, CDC13): 8 1.31 (d, J  = 7.5 Hz, 3H), 1.39 
(d, J  = 7.5 Hz, 3H), 3.30-3.38 (m, 2H), 3.60-3.68 (m, 2H), 3.689 (s, 3H), 3.70 (s, 3H), 
4.36-4.45 (m, 2H), 5.03-5.10 (m, 2H), 7.40-7.50 (m, 12H), 7.74-7.76 (m, 6H), 7.90- 
8.00 (m, 2H). 13C NMR (125 MHz, CD3OD) (major diastereoisomer): 8 174.1, 171.8, 
167.9, 151.4, 135.7, 134.4, 134.2, 132.8, 131.2, 129.7, 129.5, 128.7, 126.1, 54.7, 52.9, 
49.5, 35.9, 18.3. Anal. Calcd. for C16H14N205.V4CH30H : C, 59.27; H, 5.58; N, 10.12. 
Found: C, 58.92; H, 5.34; N, 9.81%. HRMS (ESI) (+ve): calcd. for C2oH2iN30 6 m/z 
422.1328 [M+Na]+, found m/z 422.1337 [M+Na]+. HPLC (analytical) rt = 5.4 min, 
column: Waters Symmetry Cig 3.5 pm column (4.6 x 75 mm); gradient 9:1 
water/acetonitrile to 1:9 water/acetonitrile over 10 minutes; flow rate: 1.0 mL min '.
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Preparation of the Diastereomers of A/-Benzoylvalyl-2-nitrophenylalanine 
123
/V-Benzoylvalyl-2-nitrophenylalanine methyl ester 119 (80 mg, 0.189 mmol) was 
stirred in tetrahydrofuran (10 mL) and 2M NaOH (10 mL) overnight. The solution was 
then acidified to pH 3.0 using 2M hydrochloric acid and extracted with ethyl acetate (3 
x 30 mL). The combined organics were then dried, filtered and concentrated under 
reduced pressure. The resultant white solid was recrystallised from hot ethanol to give 
the title compound (52 mg, 64%). Mp 240 °C. NMR (300 MHz, CD3OD): 8 0.86 
(d, J = 6.9 Hz, 6H), 0.98 (d, J = 6.6 Hz, 3H), 0.99 (d, J = 6.6 Hz, 3H), 2.089 (m, 2H), 
3.08 (dd, J = 10.5, 13.8 Hz, 1H), 3.21 (dd, J = 10.5, 13.8 Hz, 1H), 3.74 (m, 2H), 4.37 
(dd, J = 13.2, 7.5 Hz, 2H), 4.86 (m, 2H), 7.39 (m, 12H), 7.86 (m, 6H). 13C NMR (75 
MHz, CD3OD): 8 174.8, 174.5, 170.6, 151.7, 151.6, 136.2, 135.4, 135.3, 135.2, 135.0, 
134.3, 133.7, 130.4, 130.2, 130.0, 129.3, 126.8, 126.7, 61.7, 61.4, 54.5, 54.0, 37.0, 36.3, 
32.8, 20.6, 20.0, 19.5. Anal. Calcd. for C21H23N30 6: C, 61.01; H, 5.61; N, 10.16. 
Found: C, 60.73; H, 5.61; N, 9.95%. HRMS (ESI) (+ve): Calcd. for C2iH23N30 6 m/z 
414.1665 [M + H f, found m/z 414.1681 [M+H+].
A/-Acetylphenethylamine 125
Phenethylamine 124 (10 g, 10.32 mL, 82.5 mmol) was stirred in acetic anhydride (30 
mL) and triethylamine (8.35 g, 11.5 mL, 82.5 mmol) overnight. Water (50 mL) was 
then added and the solution allowed to stir for a further 30 minutes after which it was
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extracted with ethyl acetate (3 x 50 mL). The organic layer was dried, filtered and 
evaporated under reduced pressure and the crude product recrystallised from ethyl 
acetate/hexane to give the title compound (10 g, 75%) as a white solid. Mp. 68 °C ’H 
NMR (300 MHz, CDC13): 5 1.93 (s, 3H), 2.80 (t, 7 = 7.0 Hz, 2H), 3.50 (q, 7 = 7.0, 12.9 
Hz, 2H), 5.73 (s, broad, 1H), 7.17-7.33 (m, 5H). 13C NMR (75 MHz, CDC13): 6 170.5, 
139.1, 128.9, 128.8, 126.8, 41.0, 35.8, 23.5. HRMS (FAB) (+ve): calcd. for 
C,oH 13NO m/z 136.0997 [M ]+ , found m/z 163.0996 [M ]+.
A/-acetyl-2-(2-nitrophenyl)ethylamine 126
(V-Acetylphenethylamine 125 (10 g, 61.8 mmol) was stirred in nitric acid (50 mL) and 
sulphuric acid (50 mL) at 0°C for 1 hour after which it was poured into ice water. The 
solution was then extracted with ethyl acetate (3 x 50 mL) and the combined organics 
were dried, filtered and evaporated to dryness under reduced pressure to give a mixture 
of /V-acetyl-2-nitrophenyethylamine and yV-acetyl-4-nitrophenylethylamine. The ortho 
isomer was isolated from a portion of this mixture by high performance liquid 
chromatography to give the title compound103 as a yellow oil. NMR (300 MHz, 
CDC13): 5 1.97 (s, 3H), 3.22 (t, 7 = 6.6 Hz, 2H), 3.62 (q, 7 = 6.6, 13.2 Hz, 2H), 5.80 (s, 
broad, 1H), 7.67 (m, 2H), 8.40 (d, J  = 6 Hz, 1H), 8.78 (s, 1H). 13C NMR (75 MHz, 
CDjOD): 5 170.8, 147.3, 133.5, 132.7, 129.8, 127.9, 123.9, 40.3, 32.9, 23.3. HRMS 
(E l) (+ve): Calcd for C |0H |2N2O3 m /z  208.0848 [M + ], found 208.0846.
2-Nitrophenethylamine Hydrochloride 127
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/V-Acetyl-2-nitrophenethylamine 126 (200 mg, 0.96 mmol) was stirred in concentrated 
hydrochloric acid (20 mL) at reflux for 3 hours. The solution was allowed to cool and 
the evaporated to dryness under reduced pressure. The crude solid was then 
recrystallised from hot ethanol to give the title compound104 (95 mg, 47 %) as a yellow 
solid. Mp. 205 °C. 'H NMR (300 MHz, CD,OD): 5 3.30 (m, 2H), 3.37 (m, partially 
obscured, 2H), 7.88 (m, 2H), 8.52 (m, 1H), 8.85 (s, 1H). I3C NMR (75 MHz, CDjOD): 
8 153.5, 151.5, 142.6, 138.2, 131.6, 124.3, 50.9, 34.7. HRMS (ESI) (+ve): Calcd. for 
C8H ioN20 2 m /z  167.0820 [M+H]+, found m /z  167.0817 [M+H]+.
A/-(2-Nitrophenylethyl)-A/°-benzoylvalinamide 128
jY-Benzoylvaline 68 (50 mg, 0.23 mmol) was stirred in dichloromethane (20 mL) along 
with BOP (101 mg, 0.23 mmol) and diisopropylethylamine (0.08 mL, 0.46 mmol) for 
30 minutes. 2-Nitrophenethylamine hydrochloride 127 (47 mg, 0.23 mmol) in 
dichloromethane (5 mL) was then added and the solution allowed to stir overnight. The 
solution was then evaporated to dryness under reduced pressure and the crude oil taken 
up in ethyl acetate and washed with 5N citric acid (3 x 20 mL), saturated sodium 
bicarbonate (3 x 20 mL) and brine (2 x 20 mL). The organic layer was then dried, 
filtered and evaporated to dryness under reduced pressure to give the title compound105 
as a white solid (55 mg, 68 %). Mp 163 °C. *H NMR (300 MHz, CDC13): 6 0.80 (d, J  
= 6 Hz, 3H), 0.85 (d, J  = 6.6 Hz, 3H), 2.10 (m, 1H), 3.27 (dd, J  = 9.6, 13.8 Hz, 1H), 
3.53 (dd, J  = 5.7, 13.8 Hz, 1H), 4.46 (m, 2H), 4.95 (dd, J  = 5.7, 9.6 Hz, 1H), 6.69 (d, J  
= 7.2 Hz, 1H), 6.95 (d, J  = 6.6 Hz, 1H), 7.32-7.52 (m, 6H), 7.75-7.78 (m, 2H), 7.89- 
7.92 (m, 1H). 13C NMR (75 MHz, CD3OD): 6 171.5, 167.6, 149.8, 134.0, 133.5,
133.0, 132.1, 131.8, 128.9, 128.6, 127.3, 125.3, 58.7, 53.1, 34.9, 31.3, 19.5. LRMS
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(ESI) (+ve): calcd. for C20H23N3O4 m/z 369.17, found 370.2 [M+H]+, 392.1 [M+Na]+, 
418.2 [M+K]+. HRMS (ESI) (+ve): Calcd. for C20H23N3O4 m/z 369.1689 [M+H]+, 
found m/z 369.1690 [M+H]+. HPLC (analytical) rt = 5.6 min, column: Waters 
Symmetry Qg 3.5 pm column (4.6 x 75 mm); gradient 9:1 water/acetonitrile to 1:9 
water/acetonitrile over 10  minutes; flow rate: 1 .0  mL min"1.
Preparation of the Diastereomers of A/-Benzoylvalyl-2- 
nitrophenylalanylalanine Methyl Ester 129
/V-Benzoylvalyl-2-nitrophenylalanine 123 (21.5 mg, 0.05 mmol) was stirred in 
dichloromethane (30 mL) along with diisoproylethylamine (0.01 mL, 0.05 mmol) and 
BOP (23 mg, 0.05 mmol) for 30 minutes after which alanine methyl ester hydrochloride 
(7.5 mg, 0.05 mmol) was added. The solution was allowed to stir overnight then 
evaporated under reduced pressure and the crude brown oil taken up in ethyl acetate (30 
mL). The solution was then washed with 5N citric acid (3 x 50 mL), saturated sodium 
bicarbonate (3 x 50 mL) and brine (3 x 50 mL) and the organic layer dried, filtered and 
evaporated under reduced pressure. The crude product was purified by HPLC eluting 
with a gradient of acetonitrile/0 .0 1% trifluoroacetic acid in water to give the title 
compound (15 mg, 60 %) as a white solid. Mp. 247 °C (dec.). !H NMR (300 MHz, 
CD3OD): 5 0.88-0.95 (m, 24H), 1.32-1.48 (m, 12H), 1.95-2.10 (m, 4H), 3.059-3.30 (m, 
4H), 3.47-3.65 (m, 4H), 3.585 (s, 3H), 3.66 (s, 3H), 3.70 (s, 3H), 3.71 (s, 3H), 3.99-4.07 
(m, 4H), 4.23-4.30 (m, 4H), 4.33-4.48 (m, 4H), 7.27-7.34 (m, 4H), 7.43-7.56 (m, 24H), 
7.78-7.83 (m, 8 H), 7.90-7.96 (m, 4H). HRMS (ESI) (+ve): Calcd. for C25H30N4O7 m/z 
499.2193 [M+H]+, found m/z 499.2186 [M+H]+. HPLC (analytical) rt = 5.4 min,
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column: Waters Symmetry Ci8 3.5 jam column (4.6 x 75 mm); gradient 9:1 
water/acetonitrile to 1:9 water/acetonitrile over 10 minutes; flow rate: 1.0 mL min'1.
Diethyl 2-(Acetamido)-2-[(2-nitro-4,5-dimethoxyphenyl)methyl)]malonate 
130
Sodium metal (360 mg) was dissolved with stirring in ethanol (22 mL) and diethyl 
acetamidomalonate (3.32 g, 15.3 mmol) was added to the still warm solution. This was 
allowed to stir for 10 minutes, then 2-nitrobenzyl bromide (3.25 g, 15.0 mmol) 
dissolved in benzene (9 mL) was added dropwise over 10 minutes. The resulting 
mixture was stirred for 4 hours at room temperature before being cooled to 0 °C. The 
mixture was then filtered and the filtrate collected. The solvent was then removed 
under reduced pressure to give the title compound as colourless crystals (4.22 g, 80%). 
Mp. 175 °C JH NMR (300 MHz, CD3OD/(CD3)2SO): 6 1.27 (t, J  = 7.2 Hz, 6H), 1.98 
(s, 3H), 3.92 (s, 3H), 3.93 (s, 3H), 4.01 (s, 2H), 4.15-4.28 (m, 4H), 6.76 (s, 1H), 7.57 (s, 
1H). 13C NMR (75 MHz, CD3OD/(CD3)2SO): 5 171.0, 167.6, 152.5, 148.4, 143.3, 
124.2, 115.2, 108.6, 67.1, 62.6, 56.0, 34.2, 21.8, 13.6. Anal. Calcd. for Ci8H24N20 9: C, 
52.42; H, 5.87; N, 6.79. Found: C, 52.43; H, 5.62; N, 6.71%. HRMS (FAB) (+ve): 
Calcd. for Ci8H24N20 9 m/z 412.1482 [M+H]+, found m/z 412.1487 [M+H]+.
2-Nitro-4,5-dimethoxyphenylalanine Hydrochloride 131
Diethyl 2-(acetamido)-2-[(2-nitro-4,5dimethoxyphenyl)methyl)]malonate 130 (3 g, 
7.28 mmol) was heated at reflux in concentrated hydrochloric acid (30 mL) for 6 hours.
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After being allowed to cool to room temperature, the resulting mixture was filtered. 
The crude solid was then washed through the filter paper with ethanol to remove the 2- 
nitro-4,5-dimethoxyphenylalanine from an unknown white solid. The filtrate was then 
evaporated to dryness under reduced pressure to give the title compound as yellow 
crystals (1.2 g, 53 %). Mp. 200 °C (dec.). JH NMR (300 MHz, CD3OD): 5 3.39 (dd, J  
= 8.1, 13.8 Hz, 1H), 3.72 (dd, J  = 6.6, 13.8 Hz, 1H), 3.91 (s, 3H), 3.97 (s, 3H), 4.34 (q, 
7= 6.6, 8.1 Hz, 1H), 7.07 (s, 1H), 7.74 (s, 1H). 13C NMR (75 MHz, CD3OD): 6 170.0, 
153.9, 148.8, 141.6, 124.9, 115.1, 108.7, 56.1, 55.7, 53.3, 34.3. HRMS (FAB) (+ve): 
Calcd. for CnH14N20 6m/z 271.0930 [M+H]+, found m /z  271.0935 [M+H]+.
2-Nitro-4,5-dimethoxyphenylalanine Methyl Ester Hydrochloride 132
2-Nitro-4,5-dimethoxyphenylalanine hydrochloride 131 (50 mg, 0.16 mmol) was stirred 
in methanol (20 mL) which had been pretreated with thionyl chloride (4 mL). The 
solution was allowed to stir overnight and was then evaporated under reduced pressure 
to give a yellow powder, which was redissolved in methanol and evaporated under 
reduced pressure twice to remove excess hydrochloric acid. The crude product was 
then taken up in ethanol and filtered and the filtrate was collected and evaporated under 
reduced pressure to give a yellow solid (20 mg, 40 %). Mp. 160 °C (dec.) NMR 
(300 MHz, CD3OD):6 3.42 (dd, J =  7.5, 13.8 Hz, 1H), 3.73 (dd, obscured, 1H), 3.76 (s, 
3H), 3.91 (s, 3H), 3.98 (s, 3H), 4.42 (t, J  = 7.5 Hz, 1H), 7.12 (s, 1H), 7.72 (s, 1H). I5C 
NMR (75 MHz, CDjOD): 6 169.1, 153.9, 148.9, 141.5, 124.6, 114.9, 108.6, 54.1, 53.2,
52.6, 34.1. HRMS (FAB) (+ve): Calcd. for C 10H 12N2O4 225.0875 [M +H+f,
found m /z  225.0877 [M+H+]+.
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Preparation of Diastereomers of A/-Benzoylvalyl-2-nitro-4,5- 
dimethoxyphenylalanine Methyl Ester 133
A-Benzoylvaline 68 (35 mg, 0.15 mmol) was stirred in dichloromethane (10 mL) along 
with BOP (69 mg, 0.15 mmol) and diisopropylethylamine (0.05 mL, 0.3 mmol) for 30 
minutes. 2-Nitro-4,5-dimethoxyphenylalanine methyl ester hydrochloride 123 (40 mg, 
0.14 mmol) was then added and the solution allowed to stir overnight. The solution 
was then evaporated to dryness under reduced pressure and the crude oil taken up in 
ethyl acetate and washed with 5N citric acid (3 x 20 mL), saturated sodium bicarbonate 
(3 x 20 mL) and brine (2 x 20 mL). The organic layer was then dried, filtered and 
evaporated to dryness under reduced pressure to give the title compound as a white 
solid (22 mg, 32%). Mp. 198 °C. *H NMR (300 MHz, CDC13): 5 0.84 (d, 7 = 6.6 Hz, 
3H), 0.88 (d, 7 = 6.9 Hz, 3H), 0.99 (d, 7 = 6.6 Hz, 6H), 2.14 (m, 4H), 3.30 (dd, 7 = 9.0,
13.8 Hz, 1H), 3.31 (dd, 7 = 9.0, 13.2 Hz, 1H), 3.51 (dd, 7 = 9.0, 13.2), 3.54 (dd, 7 = 9.0,
13.8 Hz) 3.71 (s, 3H), 3.76 (s, 3H), 3.83 (s, 3H), 3.89 (s, 3H), 3.91 (s, 3H), 3.95 (s, 3H), 
4.44 (dd, 7 = 9.0, 16.5 Hz, 1H), 4.46 (dd, 7 = 9.0, 14.4 Hz), 4.93 (m, 2H), 6.65 (d, 7 = 
6Hz, 1H), 6.72 (s, 1H), 6.78 (s, 1H), 6.96 (d, 7 = 9 Hz, 1H), 7.40 - 7.54 (m, 10H), 7.72 - 
7.78 (m, 2H). 13C NMR (300 MHz, CDC13) (major diastereoisomer): 8 178.1, 167.6, 
161.8, 143.1, 132.9, 131.2, 132.9, 131.3, 128.8, 128.1, 128.0, 127.3, 126.5, 121.0, 63.1, 
57.7, 52.8, 31.7, 31.4, 19.0. (minor diastereoisomer) 8 173.8, 172.8, 167.7, 134.3, 
133.3, 131.7, 128.9, 128.0, 127.9, 127.3, 124.2, 58.6, 53.4, 31.3. Anal. Calcd. for 
C24H29N30 8: C, 58.06; H, 6.09; N, 8.46. Found: C, 57.82; H, 6.05; N, 8.20%. HRMS 
(El). Calcd. for C24H29N30 8 m/z 487.1955 [M+ ], found m/z 487.1948 [M+]. HPLC 
(analytical) rt = 5.5 min, column: Waters Symmetry Ci8 3.5 pm column (4.6 x 75 mm);
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gradient 9:1 water/acetonitrile to 1:9 water/acetonitrile over 10 minutes; flow rate: 1.0 
mL min"1.
Preparation of 2-nitrophenylalanylprolylglycine extended oxytocin 160
N-FMOC-2-nitrophenylalanine 162 was incorporated into polypeptide 160 by 
automated peptide synthesis.91
A/-FMOC-2-Nitrophenylaianine 162
To a solution of 2-nitrophenylalanine hydrochloride 117 (1.5 g, 6.09 mmol) in dioxane 
(10 mL) and 10% sodium bicarbonate (20 mL) was added slowly with stirring and ice 
bath cooling a solution of 9-fluorenylmethyl chloroformate (1.9 g, 7.3 mmol) in 
dioxane (10 mL). The mixture was stirred at 0 °C for 4 hrs and at room temperature for 
12 hrs, poured into water (450 mL) and extracted with ether (3 x 50 mL). The aqueous 
layer was cooled in an ice bath, acidified to pH 3.0 with concentrated hydrochloric acid 
and extracted with ethyl acetate. The organic layer was dried, filtered and evaporated 
under reduced pressure to give the title compound as a clear oil (2.1 g, 80%). !H NMR 
(300 MHz, CD3OD): 5 3.10 (dd, J  = 10.5, 13.8 Hz, 1H), 3.67 (dd, J  = 4.8, 13.8 Hz, 
1H), 4.06 (t, J  = 6.9 Hz, 1H), 4.18 (d, J  =  3 Hz, 2H), 4.62 (m, 1H), 7.25-7.59 (m, 6H), 
7.74-7.77 (m, 2H), 7.93-7.96 (m, 1H). 13C NMR (75 MHz, CD3OD): 6 173.4, 157.2, 
149.7, 144.0, 141.3, 133.3, 132.9, 132.5, 128.0, 127.6, 127.0, 125.1, 124.7, 119.7, 66.8, 
54.3, 54.2, 34.9. HRMS (ESI) (+ve): Calcd. for C24H2oN20 6 m/z 455.1219 [M+Na]+, 
found 455.1231 [M+Na]+.
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Exploitation of Factors Affecting the Stability and Ease of 
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Abstract: Peptidylglycine a-amidating monooxygenase catalyzes the biosynthesis of peptide hormones 
through radical cleavage of the C-terminal glycine residues of the corresponding prohormones. We have 
correlated ab initio calculations of radical stabilization energies and studies of free radical brominations 
with the extent of catalysis displayed by peptidylglycine a-amidating monooxygenase, to identify classes 
of inhibitors of the enzyme. In particular we find that, in closely related systems, the substitution of glycolate 
for glycine reduces the calculated radical stabilization energy by 34.7 kJ mol-1, decreases the rate of 
bromination with A/-bromosuccinimide at reflux in carbon tetrachloride by a factor of at least 2000, and 
stops catalysis by the monooxygenase, while maintaining binding to the enzyme.
Introduction
Peptidylglycine a-amidating monooxygenase (PAM) cata­
lyzes the biosynthesis of a wide variety of C-terminal peptide 
amides through oxidative cleavage of the corresponding glycine- 
extended precursors (Scheme 1). The products include mam­
malian peptide hormones,1 as well as physiologically active 
peptides of other organisms such as insects2-3 and cnidarians,4,5 
and the C-terminal amide moiety is vital to the activity of many 
of these compounds. Amidated peptide hormones are important 
in cellular communication, in particular as neuropeptides,1 5and 
are implicated in a broad range of pathological conditions, 
including asthma,6 inflammation,7 8910and cancers.8-10 The bio­
synthesis of amides from glycine-extended precursors other than 
peptides, such as fatty acids,11 bile acids,12 nicotinic acid,13 and
1 Australian National University.
* University of Sydney.
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aspirin,14 has also been attributed to PAM. Fatty acid amides 
are known to affect a number of neurochemical communication 
pathways, including sleep regulation,15’16 while the amidation 
of aspirin may be important in its metabolic processing.
The importance of PAM in pathological conditions has led 
to interest in its regulation and the development of a number of 
inhibitors. One of the first was rran.s,-4-phenylbut-3-enoic acid,17 
which is effective in vivo in reducing serum PAM activity18 as 
well as showing anti-inflammatory and analgesic effects.19
(12) King, L.; Barnes, S.; Glufke, U.; Henz, M. E.; Kirk, M.; Merkler, K. A.; 
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Others include a,/Lunsaturatcd acids,20“22 a peptide terminating 
in a-vinylglycine,23 and diastereorqers of a peptide terminating 
in an a-styrylglycine 24 These are all mechanism-based inhibitors 
in that they show turnover-dependent inactivation of the enzyme. 
Inhibitors of other types have also been reported, such as 
inorganic sulfite,25 benzyl hydrazine,26 and /V-formylamides,27 
as well as derivatives of /Lmercaptostyrene28 and homocys­
teine.29 .
PAM consists of two functional subunits, peptidylglycine 
a-hydroxylating monooxygenase (PHM, E.C. 1.14.17.3) and 
peptidylamidoglycolate lyase (PAL, E.C. 4.3.2.5.) (Scheme 1). 
PHM catalyzes the copper-, molecular oxygen-, and ascorbate- 
dependent hydroxylation of a C-terminal glycine residue of a 
peptide substrate. The product hydroxyglycine is then hydro­
lyzed to the corresponding amide and glyoxylate, a process that 
is catalyzed by PAL at physiological pH. The determination of 
the crystal structure of PHM in both reduced and oxidized 
forms,30“32 and kinetic33“35 and mutagenesis studies,36 have 
resulted in a detailed picture of the mechanism of action of this 
enzyme. In particular, it has been concluded that, in the first 
step, a copper-bound superoxide radical abstracts the pro-S 
hydrogen from the glycine residue, to give a glycyl radical.
In the present work we have sought to exploit factors affecting 
the formation of such radicals in order to design analogues of 
the substrates of PAM that competitively bind to, but are not 
processed by, the enzyme and therefore inhibit reaction of the 
substrates. To this end, we have compared the results of ab initio 
calculations and studies of relative reaction rates in free radical 
brominations, which identify factors affecting the stability and 
ease of formation of glycyl and related radicals,37-38 with the 
kinetic parameters defining the interactions of analogous 
compounds with PAM.
Publication of our results is very timely in the light of a quite 
recent paper by Prigge et al.,32 in which crystallography of 
frozen protein soaked with a slowly reacting substrate was used
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to identify and characterize the precatalytic complex of PHM 
with copper, oxygen, and the substrate. That study was the first 
to delineate the role of copper in the activation of dioxygen in 
this or any other enzyme system. The authors also drew a 
correlation between the reactivity of PHM substrates and the 
stability of the corresponding radical intermediates. They 
reported that our earlier theoretical studies37 showed a peptide 
a-carbon-centered alanyl radical to be 9.1 kJ mol“1 less stable 
than a corresponding glycyl radical and noted that, even so, 
■A/-acetyl-(S)-tryptophanyl-(/?)-alanine is still processed by the 
enzyme during X-ray diffraction. They also predicted, on the 
basis of our calculations with related amino acids, that an 
a-carbon-centered threonyl radical would be even less stable 
than an alanyl radical, and accordingly found that a peptide 
containing (/^-threonine instead of (R)-alanine at the C-terminus 
was less effectively turned over by the enzyme. Our calculations 
of glycyl and alanyl radical stability37 were based on the radicals 
3c and 5d (Chart 1). Contrary to the above discussion, their 
relative radical stabilization energies (RSEs), which correspond 
to the negative of the relative bond dissociation energies of the 
corresponding closed-shell molecules, actually showed the alanyl 
radical 5d to be less stable than the glycyl radical 3c by only 
1.6 kJ mol“1. We have not studied threonine derivatives, but 
Rauk et al.39 used two different methods to calculate that an 
a-carbon-centered threonyl radical is destabilized relative to a 
glycyl radical by only 7—14 kJ mol“ 1. Consequently, the 
destabilization of alanyl and threonyl radicals appears to have 
been somewhat over-estimated by Prigge et al.,32 with the result 
that the relationship between the stabilization energies of radicals 
and the ease of their formation through PAM catalysis warrants 
further investigation. We also include in the present study a 
further comparison with the relative rates of formation of 
radicals in conventional brominations.
Results
The natural substrates of PAM all have in common an 
yV-acylated glycine, and they are therefore comprised of acyl, 
amido, methylene, and carboxyl groups. Since the carboxyl 
group of a substrate is known to be important for binding to 
PAM,31 we have not examined alternatives to this moiety in 
the present study. However, the effect of modifying each of 
the other groups was explored. A range of A-acyl substituents 
was investigated, since these are known to affect the stability 
and ease of formation of glycyl radicals38,40 and to be tolerated 
by PAM. Although derivatives of a-substituted amino acids tend 
not to bind to PAM, small a-alkyl substituents, such as the 
methyl group of (/^-alanine,32,41 the vinyl moiety of (R)-. 
vinylglycine,42 and the hydroxyethyl group of (/?)-threonine,32 
are accommodated. The incorporation of a trifluoromethyl group 
was therefore studied since /?,/?,/3-trifluoroalanine derivatives 
are known to be resistant to a-carbon-centered radical forma­
tion.37 The effect of replacing the amido group with an ester or 
ketone using derivatives of glycolate or y-keto acids instead of 
.A-acylglycines was also explored. Glycolate inhibitors of PAM 
have been previously reported22,42 in studies of broad ranges of
(39) Rauk, A.; Yu, D.; Taylor, J.; Shustov, G. V.; Block, D. A.; Armstrong, D.
A. Biochemistry 1999, 38, 9089—9096.
(40) Easton, C. J. Chem. Rev. 1997, 97, 53—82.
(41) Landymore-Lim, A. E. N.; Bradbury. A. F.; Smyth, D. G. Biochem Biophys.
Res. Comnun. 1983. 117, 289—293.
(42) Ping, D.: Mounier, C. E.; May, S. W. J. Biol. Chem  1995, 270, 29250-
29255.
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Table 1. Correlation of Studies of Free Radical Brominations and ab Initio Calculations of Radical Stabilization Energies with the Extent of 
Catalysis Displayed by Peptidylglycine a-Amidating Monooxygenase
PART C
kinetic parameters for interactions of various substrates and inhibitors with 
PART a PART B peptidylglycine a-amidating monooxygenase
relative rates of reaction oM a 8a radical stabilization energies Z \
with W-bromosuccinimide to give the [0 K, RMP2/G3large] _____ __________ Kinetic parameters_______________
. . , . corresponding radicals 1 c-8c of derivatives of glycyl and related radicals ,, ,, „glycine derivative ---------- 1 -----_-------------------- ----------------- ILL----------------------  Kw,app K IC»'
or substitute compd relative rate of reaction1 radical RSE* compd (̂ mol min- ' mg-1) (mM) (mM) (mM)
A-benzoyl la i.cy lb 6.5‘ 1.3'
A'-pentafluorobenzoyl 2a 0.25f
N-acety\ 3a 1.2f 3c 79.1 3b 6.4' 9.3'
A'trifluoroacetyl 4a 0.05f 4c 69.9 4b 1.4' 4.1'
other A-acyl 10a 12.6' 0.1'
11a 0.03
12a 3.3* 0.0012*
13a 8.2' 0.096'
14a 5.6* 0.0079*
a-methyl 5a 0.337' 5d 78.8
a-trifluoromethyl 6a <0.0005V 6d 39.9 9a inhibitor 5
9b inhibitor 5
glycolate 7a <0.0005^ 7d 44.4 7b inhibitor 0.25
10b inhibitor 0.04
l ib inhibitor 0.5
12b inhibitor 0.05
13b inhibitor 0.0598*
14b inhibitor 0.0452*
y-keto acid 8a <0.0005; 8d 34.9 15 inhibitor 6
16 inhibitor 3
“ From mixtures of substrates, in carbon tetrachloride at reflux. b Radical stabilization energies (RSEs) were calculated as the energy change in the isodesmic 
reaction R* +  CFR —- RH + ‘CER. The RSEs correspond to the differences between the bond dissociation energies (BDEs) of methane and RH,45 and reflect 
the stability of R* compared with 'CFR, relative to the corresponding closed-shell systems. c Corresponds to loss of 50% of the catalytic activity of PAM in 
processing the substrate (R)-tyrosyl-(S)-valylglycine at a concentration of 0.1 mM, under conditions where &M,app for the substrate is 0.2 mM. Although 
A’M.app, K\, and IC50 values are not directly comparable as measures of enzyme binding affinity, they are adequate as used in the present work, mainly to 
establish that compounds interact with PAM. ‘‘ Assigned as unity. '  Data from ref 11. f  Data from ref 38. " Data from ref 42. h Data from ref 44. ' Data from 
ref 37.7 No detectable bromination.
compounds, but there has been no analysis of, nor explanation 
for, their behavior. One y-keto acid has been previously 
investigated, but it was found not to interact with PAM, either 
as a substrate or an inhibitor.43
Compiled in Table 1 (part A) are the relative rates of reaction 
of the acylated glycine derivatives la -4 a , as well as the
derivatives of alanine 5a. trifluoroalanine 6a, glycolate 7a, and 
y-ketopropionate 8a, with A7-bromosuccinimide at reflux in 
carbon tetrachloride. They were derived by measuring the
(43) Tamburini, P. P.; Jones, B. N.; Consalvo, A. P.; Young, S. D.; Lovato, S. 
J.; Gilligan, J. P.; Wennogle, L. P.; Erion, M.; Jeng, A. Y. Arch. Biochem. 
Biophys. 1988, 267, 623- 631.
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relative rates of consumption of la -8 a  from mixtures.37’38’44 
Since the reactions involve radical bromination, with hydrogen 
atom transfer from the carbon adjacent to the ester group of 
each substrate determining the relative rate at which that 
compound is brominated, the relative rates of reaction cor­
respond to the relative ease of formation of the radicals lc —8c.
For comparison with the relative rates of bromination of la — 
8a, and the relative ease of formation of the radicals le —8c in 
those reactions, RSEs for the radicals 3c, 4c, and’5d—8d were 
determined (Table 1, part B). The RSEs relate the stability of 
the radicals in question to that of methyl radical (relative to the 
corresponding closed-shell species), with a more stable radical 
having a more positive RSE.45 The geometries and zero-point 
vibrational energies were determined at the B3-LYP/6-31G(d) 
level, while improved relative energies were obtained by 
carrying out single-point calculations on these optimized 
structures at the RMP2 level with the 6-311+G(2df,p) and 
G31arge basis sets.46 The results quoted in Table 1, part B, 
correspond to RMP2/G31arge//B3-LYP/6-31G(d) RSEs at 0 K. 
The radicals lc, 2c, and 5c—8c were not studied because their 
aryl groups would substantially increase the complexity of the 
calculations. The acetamides 5d—8d were examined instead of 
the benzamides 5c—8c. The effect of different acyl groups was 
examined with only 3c and 4c, and not lc  and 2c. The level of 
theory used in these calculations is significantly higher than 
that used in our earlier studies.37’38 Nevertheless, the results are 
in good agreement where comparisons are possible. In particular, 
they show the RSEs of the radicals 3c and 5d to differ only 
slightly (by 0.3 kJ mol-1), consistent with our previous work 
(which gave a difference of 1.6 kJ mol-1).
Also shown in Table 1 (part C) are kinetic parameters for 
the interactions of the glycine derivatives lb, 3b, 4b, and 10a— 
14a, the trifluoroalanine derivatives 9a and 9b, the glycolates 
7b and 10b—14b, and the y-keto acids 15 and 16 with PAM. 
The data for the glycine derivatives lb, 3b, and 4b, and the 
glycolate 7b, allow for a direct comparison with the rates of 
bromination of the analogous esters la, 3a, 4a, and 7a, and the 
stability and ease of formation of the corresponding radicals 
lc, 3c, 4c, and 7c. The properties of the glycine derivatives 
10a—14a and the glycolates 10b—14b allow for further analysis 
of the relationships between these two classes of compounds. 
It was not feasible to examine the interaction of either the 
trifluoroalanine derivative 6b or the y-keto acid 8b with PAM, 
for comparison with the glycine derivative lb, due to their poor 
enzyme-binding affinities. Instead, the effect of these substitu­
tions was explored using the more tightly binding trifluoroala­
nine derivatives 9a and 9b, and the y-keto acids 15 and 16, 
and relating their behavior to that of the analogous glycinated 
dipeptide derivatives 13a and 14a. The data for lb, 3b, 4b, 
10a, 12a-14a, 13b, and 14b have been previously re­
ported.11’22’42 The trifluoroalanine derivatives 9a,b, the glycolates 
7b and 10b—12b, the dipeptide 11a, and the y-keto acids 15 
and 16 were prepared as described in the Supporting Informa­
tion. Their interactions with PAM were assayed using modified
(44) Burgess, V. A.; Easton, C. J.; Hay, M. P. J. Am. Chern. Soc. 19S9, 111, 
1047-1052.
(45) See, for example: (a) Parkinson, C. J.; Mayer, P. M.; Radom, L. Theor. 
Chem Acc. 1999,102, 92—96. (b) Parkinson, C. J.; Mayer, P. M.; Radom, 
L. J. Chem. Soc., Perkin Trans. 2 1999, 2305—2313. (c) Henry, D. J.; 
Parkinson, C. J.; Mayer, P. M.; Radom, L. J. Phys. Chem 2001,105,6750— 
6756.
(46) These levels of theory have been found to be suitable for the calculation 
of radical stabilization energies: see ref 45c.
literature procedures.19’22’28 There was no evidence of enzyme- 
catalyzed reaction for 7b, 9a,b, 10b-12b, 15, or 16. A double­
reciprocal plot of MV vs I/[S] was used to determine the 
value for 11a, and Dixon plots of MV vs [I] were used to 
determine the IC50 values for 7b, 9a,b, 10b 12b, 15, and 16.
9a diastereomer 1 10aX = NH
9b diastereomer 2 10b X = 0
11a X = NH 
11b X = 0
12a X = NH 
12b X = 0
13a X = NH 
13b X = O
14a X = NH 
14b X = 0
Discussion
/V-Benzoyl-, pentafluorobenzoyl-, acetyl-, and trifluoroacetyl- 
glycine methyl esters la —4a differ only in their /V-acyl 
substituents. In their reactions with A-bromosuccinimide, the 
benzamide la  is 4 times more reactive than the pentafluoro- 
benzamide 2a, and the acetamide 3a is 24 times more reactive 
than the trifluoroacetamide 4a (Table l, part A). These relative 
reactivities can be attributed to differences between the jr-electron- 
donating abilities of the various amido groups, to stabilize and 
therefore facilitate formation of the corresponding radicals lc — 
4c. The inductively electron-withdrawing fluorines of the 
pentafluorobenzamide 2a and the trifluoroacetamide 4a decrease 
the extent of resonance stabilization and rates of formation of 
the radicals 2c and 4c, relative to those radicals lc  and 3c 
derived from the non-halogenated precursors la and 3a, 
respectively. This effect of the fluorines is reflected in the 
calculated RSEs in the cases of the radicals 3c and 4c, where 
the trifluoroacetamide 4c is less stable than the acetamide 3c 
by 9.2 kJ mol-1 (Table 1, part B). The fluorines also exert an 
inductive effect that decreases the pKas of the carboxylic acid 
analogues of the amido groups, due to stabilization of the 
corresponding carboxylate anions (the pAas of benzoic acid, 
pentafluorobenzoic acid, acetic acid, and trifluoroacetic acid are 
4.2, 1.5,4.8, and 0.6, respectively47). As a result, there is a strong 
correlation between the effect of the fluorines on the relative
(47) Krygowski, T. M.; Guilleme, J. J. Chem. Soc., Perkin Trans. 2 1982. 531 
534.
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reactivity of the glycine derivatives (la-4a), the relative acidity 
of the acids, and the RSEs of the radicals 3c and 4c. The effect 
of the fluorines on the reactivity of la 4a and the acidity of 
the corresponding carboxylic acids is greatest with the trifluo- 
roacetamide 4a and trifluoroacetic acid, relative to the acetamide 
3a and acetic acid, respectively.
In analogous systems, the fluorines have a related impact on 
the interactions of A-acetylglycine 3b and A-trifluoroacetyl- 
glycine 4b with PAM. They decrease the overall rate of turnover 
(̂ M.app) of 4b relative to 3b, via the corresponding glycyl 
radicals, by a factor of 4.5 (Table 1, part C). Consequently, the 
correlation of the differences between the RSEs of the (V-acetyl- 
and trifluoroacetyl-glycyl radicals 3c and 4c, the relative rates 
of bromination of A-acetyl- and trifluoroacetyl-glycine methyl 
esters 3a and 4a, and the pAas of acetic and trifluoroacetic acids 
extends to the relative rates of the enzyme-catalyzed reactions 
of A-acetyl- and trifluoroacetyl-glycine 3b and 4b. The fluorines 
reduce the RSE of the radical 4c (by 9.2 kJ mol“ 1), the rate of 
bromination of the ester 4a (by a factor of 24), the pK a of 
trifluoroacetic acid (by 4.2 units), and the rate of turnover of 
the acid 4b by the enzyme (by a factor of 4.5). By way of 
comparison, replacing the acetyl substituent of A-acetylglycine 
methyl ester 3a, A-acetylglycine 3b, and acetic acid with the 
benzoyl group of (V-benzoylglycine methyl ester la, A-ben- 
zoylglycine lb , and benzoic acid has relatively little effect on 
any of these properties. It decreases the rate of bromination of 
the ester la by a factor of only 1.2, decreases the pK a of benzoic 
acid by only 0.6, and changes the rate of the enzyme-catalyzed 
reaction of the acid lb  by less than 2%.
The effect of the fluorines, although reducing the rate of 
turnover, is clearly insufficient to prevent the PAM-catalyzed 
reaction of A-trifluoroacetylglycine 4a. On the basis of the 
calculations with the A-acetyl- and trifluoroacetyl-glycyl radicals 
3c and 4c, this indicates that a reduction in the RSE of 9.2 kj 
mol-1 is not sufficient to stop glycyl radical formation by the 
enzyme. This is consistent with reductions in the RSEs of alanyl 
and threonyl radicals relative to those of the corresponding 
glycyl radicals, of 0.3 and 7 -1 4  kJ mol-1, respectively,37,39 
being too small to block the enzyme-catalyzed reactions of 
alanine and threonine derivatives.32 The effect of the trifluoro- 
methyl substituent on the stability of the trifluoroalanyl radical 
6d is much larger, reducing the calculated RSE relative to that 
of the corresponding glycyl radical 3c by 39.2 kJ mol-1 (Table 
1, part B). This substituent also prevents bromination of 
A-benzoyl-/3,/3,/Ttrifluoroalanine methyl ester 6a (Table 1, part 
A) and the processing of the trifluoroalanine-containing dipep­
tides 9a,b by PAM (Table 1, part C). A-Benzoyl-/?,/?,/?- 
trifluoroalanine methyl ester 6a was inert on treatment with 
A-bromosuccinimide, either alone or as a mixture with A- 
benzoylglycine methyl ester la, that nevertheless reacted 
smoothly to give the corresponding a-bromoglycine derivative. 
There was no evidence of reaction of either of the trifluoroala­
nine-containing dipeptides 9a or 9b being catalyzed by PAM, 
even though competitive experiments with (A’)-tyrosyl-(S)- 
valylglycine established that both 9a and 9b bind to the enzyme, 
albeit with IC50 values of around 5 mM (Table 1, part C). It is 
therefore apparent that the decrease in the RSE brought about 
by introducing the trifluoromethyl group is sufficient to prevent 
radical formation by PAM. However, this does not give effective 
enzyme inhibitors, as the trifluoromethyl substituent prevents
tight binding to the enzyme. This is seen from the IC50 value 
of 5 mM for each of the trifluoroalanine derivatives 9a and 9b. 
As an indirect comparison, the ARi.app value of the corresponding 
glycine derivative 14a is 7.9 ,«M.
In a manner similar to the effect of introducing the triflu­
oromethyl group, replacing the glycine moiety with glycolate, 
which is a simple substitution of the glycine NH by O, reduces 
the RSE of the glycolyl radical 7d compared with that of the 
corresponding glycyl radical 3c by 34.7 kJ mol-1 (Table 1, part 
B). This can be attributed to the decreased jr-electron donating 
and increased cr-electron-withdrawing ability of the acetoxy 
group of 7d relative to the acetamido substituent of 3c, as 
reflected in the RSEs of the radicals MeCONHCH2* and MeCCE- 
CH2* of 41.3 and 17.1 kJ mol“ 1, respectively.48 The effect is 
magnified hi the captodatively stabilized49,50 glycyl and glycolyl 
radicals 3c and 7d, where the extent of the synergy displayed 
by the acetamido and acetoxy substituents in combination with 
the carboxyl group corresponds to 17.6 and 7.1 kJ mol“1. These 
values are based on the differences between the RSEs of 
MeCONHCH2* (41.3 kJ mol“ 1), ’C^CCriM e (20.2 kJ mol“ 1), 
and 3c (79.1 kJ mol“ 1) and M eC02CH2* (17.1 kJ mol“1), *CH2- 
C 0 2Me, and 7d (44.4 kJ mol“ 1), respectively. The substitution 
of glycine by glycolate prevents bromination of methyl Oa- 
benzoylglycolate 7a (Table 1, part A). It also blocks catalysis 
of the reactions of the glycolates 7b and 10b—14b by PAM 
(Table 1, part C). The glycine derivatives lb  and 10a-14a are 
all turned over by the enzyme, but there is no evidence of 
reaction of any of the corresponding glycolates 7b and 10b— 
14b. In this case, the substitution does not severely disrupt 
binding to the enzyme. The IC50 and K\ values of the glycolates 
7b and 10b-14b are all in the 0.04-0.5 mM range. The 
corresponding glycine derivatives lb and 10a-14a have K \ \ ^ v 
values between 1 /rM and 1 mM. Therefore, the glycolates 
constitute a general class of inhibitors of the enzyme because 
they do not readily undergo hydrogen atom transfer, yet they 
bind effectively to PAM.
Replacing the acylglycine with a y-keto acid or ester, through 
substitution of the glycine NH by CH2, has effects similar to 
the swapping of glycine for glycolate. The RSE of the keto ester 
radical 8d is less than that of the analogous glycyl radical 3c 
by 44.2 kJ mol“ 1 (Table 1, part B). The y-keto ester 8a is inert 
to bromination (Table 1, part A), and the y-keto acids 15 and 
16 are not processed by PAM (Table 1, part C), even though, 
unlike the example reported previously,43 these keto acids 15 
and 16 do bind to some extent to the enzyme, with IC50 values 
of 6 and 3 mM, respectively. Again it is apparent that a reduction 
in the RSE of around 35-45 kJ mol“ 1 is sufficient to stop both 
the bromination with A-bromosuccinimide and the catalysis by 
the monooxygenase.
From the ÄTi.app values of the glycine derivatives 13a and 
14a, 96 and 7.9 ,wM, respectively, the K\ values of the 
corresponding glycolates 13b and 14b, 59.8 and 45.2/rM, and 
the IC5C values of the analogous y-keto acids 15 and 16, 6 and 
3 mM (Table 1, part C), it appears that the replacement of an 
acylglycine with a y-keto acid has a more adverse effect on the
(48) RSE values quoted in the text, in addition to those listed in Table 1, were 
also calculated using the RMP2/G31arge level of theory.
(49) Welle, F. M.; Beckhaus, H.-D.; Rüchardt, C. J. Org. Chem. 1997, 62, 552— 
558.
(50) Schulze, R.; Beckhaus, H.-D.; Rüchardt, C. Chent Ber. 1993, 126, 1031 
1038.
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binding to PAM than does the substitution of glycine by 
glycolate. One explanation for this is that both acylglycines and 
glycolates can form hydrogen bonds'with the enzyme, through 
NH and the corresponding O, respectively, to facilitate binding, 
but this is not possible with the methylene of an analogous 
y-keto acid. An alternative explanation for the less effective 
binding of the y-keto acids relates to their greater conformational 
freedom in free solution. As a result of conjugation of the amide 
NH of an acylglycine and the analogous ester O of an 
acylglycolate, in each case there is easy rotation only around 
the bonds to the a-carbon. By contrast, with a y-keto acid there 
is easy rotation around the bonds to both the a- and ^-carbons. 
Assuming that the acylglycines, glycolates, and keto acids all 
bind to PAM with similar orientations, and that the planarity 
of the amide and ester groups of the acylglycine and acylgly­
colate is maintained, there is therefore a greater degree of 
conformational constraint and loss of entropy on binding of a 
y-keto acid.
In any event, it is clear that introducing an a-trifluoromethyl 
substituent into the glycine residue of a P A M  substrate, or 
replacing the acylglycine of a substrate with either a glycolate 
or a y-keto-acid, stops catalysis by the enzyme, because it 
reduces by around 35—45 kJ mol-1 the RSE of the radical that 
would be formed. By contrast, swapping the acylglycine for a 
ß ,y -unsaturated acid is likely to increase the RSE of the radical 
intermediate by around 21.1 kJ mol-1, based on the values 
calculated for the acetamido and propenyl radicals 3c and 17, 
79.1 and 100.2 kJ mol-1, respectively. Thus, it is not surprising 
that, as outlined in the Introduction, /?,y-unsaturated acids are 
processed by P A M . 17’23-2'*
M e ^ ^ Y 0Me
O
17
Conclusion
In summary, there are strong correlations between calculated 
radical stabilization energies (RSEs), the ease of formation of
glycyl and related radicals in free radical brominations, and the 
extent of catalysis of the reactions of analogous compounds by 
peptidyiglycine a-amidating monooxygenase (PAM). A de­
crease in the RSE of around 10 kJ mol-1 relative to that of a 
normal peptide glycyl radical slows but does not stop the rate 
of radical formation through either bromination or enzyme 
catalysis. However, reducing the RSE by around 35—45 kJ 
mol-1, either through introduction of a trifluoromethyl sub­
stituent at the a-position or by replacing the acylglycine NH 
with a glycolate O or a y-keto acid CH2, stops both bromination 
and enzyme processing. Of these changes, only the glycolate 
substitution does not adversely affect the enzyme binding 
affinity. Consequently, glycolates are a general class of PAM 
inhibitors because they do not readily undergo hydrogen atom 
transfer, yet they bind effectively to the enzyme. We are now 
beginning to study the associated in vivo effects of this class 
of compounds, and already we have found that both the 
glycolates 10b and 12b actively reduce the levels of the peptide 
hormone Substance P produced by rat DRG cells over a 6 h 
period.51
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